Effects of neonicotinoid pesticide exposure on bee health: Molecular, physiological and behavioural investigations by Collison, Elizabeth Jane
1 
 
 
 
 
Effects of neonicotinoid pesticide exposure on bee health: 
Molecular, physiological and behavioural investigations 
 
 
 
 
 
Submitted by Elizabeth Jane Collison to the University of Exeter 
as a thesis for the degree of 
Doctor of Philosophy in Biological Sciences 
In June 2015 
 
 
 
This thesis is available for Library use on the understanding that it is copyright 
material and that no quotation from the thesis may be published without proper 
acknowledgement. 
 
I certify that all material in this thesis which is not my own work has been 
identified and that no material has previously been submitted and approved for 
the award of a degree by this or any other University. 
 
 
 
Signature: ………………………………………………………….. 
 
2 
 
  
3 
 
Abstract 
Neonicotinoid exposure has been recognised as potentially impacting upon bee 
health, but whether realistic exposure scenarios are driving declines in bee 
health is not known. This thesis contributes new insights and perspectives to 
this research field investigating the use of molecular, physiological and 
behavioural endpoints as potential ecotoxicological markers for pesticide risk 
assessment. The thesis presents experimental data for dietary exposures of the 
European honey bee, Apis mellifera, and the buff-tailed bumble bee, Bombus 
terrestris, to one of two neonicotinoid pesticides, imidacloprid and 
thiamethoxam. 
The first part of this thesis explores impacts of chronic dietary exposures to 
neonicotinoid pesticides on bee immunocompetence- the ability to mount an 
immune response- using an artificial challenge to invoke an immune response 
in adult workers. Levels of phenoloxidase, an enzyme involved in melanisation 
and part of the bee’s defence system, were largely constitutive and resilient to 
exposure in honey bees and bumble bees. In honey bees, transient 
transcriptional changes in antimicrobial effector genes were observed following 
neonicotinoid exposure, but the physiological antimicrobial response was 
unaffected. In bumble bees, the induced antimicrobial response was impaired 
following neonicotinoid exposure, but only when exposed to concentrations 
likely higher than realistic environmental exposure scenarios. 
The next phase of this thesis investigates whether transcriptional, physiological 
and behavioural endpoints associated with the functioning of the honey bee 
hypopharyngeal gland were altered by imidacloprid exposure. Imidacloprid 
exposure led to transcriptional changes in foraging genes (associated with the 
control of temporal polyethism) and major royal jelly proteins (fed to developing 
larvae by nurse workers) and enzymatic changes in glucose oxidase (an 
enzyme involved in social immunity), which I hypothesise are linked with 
hypopharyngeal gland development. Despite these laboratory observations, no 
behavioural effects were observed in a field setting, monitored using Radio 
Frequency Identification transponders. 
Lastly, using RNA-Sequencing to investigate changes across the honey bee 
transcriptome, this thesis identified a suite of genes that were differentially 
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expressed in adult workers in response to immune challenge and/or dietary 
neonicotinoid exposure. Wounding and bacterial-like infection led to 
upregulation of known immune genes, including a peptidoglycan recognition 
protein and antimicrobial effectors. Chronic exposure to thiamethoxam and 
imidacloprid led to downregulation of genes associated with several metabolic 
pathways, such as oxidative phosphorylation, pyruvate- and purine- metabolic 
pathways, as well as ribosomal activity. Some of these genes identified provide 
candidates for further study to elucidate functional effects mechanisms and 
better understand health outcomes, as well as potential new biomarkers for use 
in pesticide risk assessment. 
This thesis presents novel findings and offers opportunities for future research 
that will be of interest to a wide audience, including risk assessors and policy 
makers, as well as the broader biological community, including ecotoxicologists, 
insect physiologists and molecular biologists. 
  
5 
 
Table of Contents 
Abstract .............................................................................................................. 3 
Acknowledgements ............................................................................................ 9 
List of tables ..................................................................................................... 13 
List of figures .................................................................................................... 15 
Author’s declaration .......................................................................................... 23 
Abbreviations .................................................................................................... 24 
1. General Introduction ..................................................................................... 28 
1.1. Biology of bees ....................................................................................... 29 
1.1.1. The honey bee, Apis mellifera ......................................................... 29 
1.1.2. The bumble bee, Bombus terrestris ................................................. 31 
1.2. Bees as providers of ecosystem services .............................................. 33 
1.3. Risk assessment of plant protection products on bees .......................... 34 
1.4. Interactive effects of pesticide exposure and pathogen infection on bee 
health – a critical analysis ............................................................................. 35 
1.4.1. Abstract ............................................................................................ 35 
1.4.2. Introduction ...................................................................................... 35 
1.4.3. Interactive effects of pesticide exposure and pathogen infection on 
bee health .................................................................................................. 44 
1.4.4. Conclusions ..................................................................................... 60 
1.5. Thesis aims ............................................................................................ 64 
1.6. References ............................................................................................. 66 
2. Methods development and assay validations ............................................... 82 
2.1. Method of immune elicitation ................................................................. 83 
2.2. Measurement of phenoloxidase activity ................................................. 83 
2.2.1. Thorax homogenisation ................................................................... 84 
2.2.2. Neat haemolymph collection ............................................................ 85 
2.2.3. Perfusion bleed approach ................................................................ 85 
2.3. Measurement of antimicrobial activity .................................................... 88 
2.3.1. Measurement of antimicrobial activity in honey bees ....................... 89 
2.3.2. Measurement of antimicrobial activity in bumble bees ..................... 92 
2.4. Measurement of glucose oxidase activity ............................................... 93 
2.5. Gene expression assays using qPCR .................................................... 96 
2.5.1. Primer design and optimisation ........................................................ 96 
2.5.2. Preparation of standard PCR (calibration) curves ............................ 97 
2.5.3. Selection of reference genes for normalisation .............................. 102 
2.6. References ........................................................................................... 110 
6 
 
3. Resilience of honey bee immunocompetence to chronic neonicotinoid 
exposure......................................................................................................... 115 
3.1. Abstract ................................................................................................ 115 
3.2. Introduction .......................................................................................... 116 
3.3. Methods ............................................................................................... 118 
3.3.1. Honey bee provenance and husbandry ......................................... 119 
3.3.2. Neonicotinoid exposure ................................................................. 120 
3.3.3. Immune challenge .......................................................................... 120 
3.3.4. Measurement of gene expression .................................................. 121 
3.3.5. Measurement of antimicrobial activity ............................................ 124 
3.3.6. Measurement of phenoloxidase activity ......................................... 124 
3.3.7. Data analysis ................................................................................. 125 
3.4. Results ................................................................................................. 126 
3.4.1. Antimicrobial effector gene expression and enzymatic activity ...... 126 
3.4.2. Phenoloxidase gene expression and enzymatic activity ................ 130 
3.4.3. Sucrose consumption .................................................................... 132 
3.5. Discussion ............................................................................................ 132 
3.5.1. Conclusions ................................................................................... 136 
3.5.2. Implications .................................................................................... 136 
3.6. Acknowledgements .............................................................................. 137 
3.7. References ........................................................................................... 138 
3.8. Supporting information ......................................................................... 143 
4. The immune response of the bumble bee (Bombus terrestris L.) is resilient to 
dietary imidacloprid in field realistic exposures............................................... 147 
4.1. Abstract ................................................................................................ 147 
4.2. Introduction .......................................................................................... 148 
4.3. Materials and methods ......................................................................... 150 
4.3.1. Bumble bee provenance and husbandry ....................................... 152 
4.3.2. Neonicotinoid exposure ................................................................. 152 
4.3.3. Immune challenge .......................................................................... 153 
4.4.4. Measurement of PO activity ........................................................... 153 
4.4.5. Measurement of AMP activity ........................................................ 154 
4.4.6. Data analysis ................................................................................. 155 
4.4. Results ................................................................................................. 157 
4.4.1. Treatment effects on feeding rates ................................................ 157 
4.4.2. Time course of immune response to the simulated pathogen infection 
(TC experiment) ....................................................................................... 158 
4.4.3. Dose response effects (DR experiment) ........................................ 160 
4.5. Discussion ............................................................................................ 161 
7 
 
4.5.1. Evaluation of the threat posed by dietary neonicotinoids to bee health
 ................................................................................................................. 163 
4.5.2. Implications for regulatory risk assessment ................................... 165 
4.6. References ........................................................................................... 165 
5. Disruption of hypopharyngeal gland function in honey bees exposed to a 
dietary neonicotinoid (imidacloprid) ................................................................ 172 
5.1. Abstract ................................................................................................ 172 
5.2. Introduction .......................................................................................... 173 
5.2.1. The role of HPG development in worker temporal polyethism ....... 174 
5.2.2. Secretory role of HPGs in nutrition: Major royal jelly proteins ........ 175 
5.2.3. Secretory role of HPGs in social immunity: Glucose oxidase ........ 176 
5.3. Materials and Methods ......................................................................... 177 
5.3.1. Honey bee provenance and husbandry – general protocol ............ 177 
5.3.2. Neonicotinoid exposure – general protocol .................................... 178 
5.3.3. The role of HPG development in worker temporal polyethism ....... 178 
5.3.4. Secretory role of HPGs in nutrition: MRJPs ................................... 184 
5.3.5. Secretory role of HPGs in social immunity: GOX ........................... 185 
5.4. Results ................................................................................................. 187 
5.4.1. Effect of imidacloprid on general health indicators during laboratory 
exposures ................................................................................................ 187 
5.4.2. The role of HPG development in worker temporal polyethism ....... 187 
5.4.3. Secretory role of HPGs in nutrition: MRJPs ................................... 194 
5.4.4. Secretory role of HPGs in social immunity: GOX ........................... 194 
5.5. Discussion ............................................................................................ 196 
5.6. Acknowledgements .............................................................................. 202 
5.7. References ........................................................................................... 203 
6. Transcriptome sequencing analysis of the honey bee following exposure to 
immune and chemical stressors ..................................................................... 209 
6.1. Abstract ................................................................................................ 209 
6.2. Introduction .......................................................................................... 210 
6.3. Materials and Methods ......................................................................... 211 
6.3.1. Honey bee provenance and husbandry ......................................... 212 
6.3.2. Neonicotinoid exposure ................................................................. 212 
6.3.3. Immune challenge .......................................................................... 213 
6.3.4. RNA Extraction, Library Preparation, and Sequencing .................. 213 
6.3.5. Validation of RNA-Seq data with qPCR ......................................... 214 
6.4. Data analysis........................................................................................ 215 
6.4.1. Data processing for read counts .................................................... 215 
6.4.2. Statistical analysis for identification of differentially expressed genes
 ................................................................................................................. 217 
8 
 
6.4.3. Functional analysis of differentially expressed genes .................... 218 
6.5. Results ................................................................................................. 220 
6.5.1. Transcriptional response to immune challenge without neonicotinoid 
exposure .................................................................................................. 220 
6.5.2. Transcriptional response to immune challenge with neonicotinoid 
exposure .................................................................................................. 224 
6.5.3. Transcriptional response to pesticide exposure without immune 
challenge ................................................................................................. 227 
6.5.4. Transcriptional response to pesticide exposure with immune 
challenge ................................................................................................. 229 
6.6. Discussion ............................................................................................ 230 
6.7. Acknowledgements .............................................................................. 234 
6.8. References ........................................................................................... 235 
6.9. Supporting information ......................................................................... 241 
7. General Discussion .................................................................................... 245 
7.1. Introduction and overview of main findings .......................................... 245 
7.2. Implications for pesticide risk assessment schemes ............................ 246 
7.3. Pesticide effects on insect immunity .................................................... 248 
7.4. Questions raised .................................................................................. 251 
7.4.1. Does field relevant neonicotinoid exposure affect bee nursing roles 
and larval development? .......................................................................... 251 
7.4.2. Does neonicotinoid exposure impair the immune response to natural 
pathogen infections and parasitic attack? ................................................ 252 
7.5. References ........................................................................................... 254 
 
  
9 
 
Acknowledgements 
I would not have completed this thesis without the support of countless people 
and whilst compliments are not my strong point, I am truly truly grateful! 
Thank you to James Cresswell, Charles Tyler and Helen Thompson for giving 
me the opportunity to embark on this adventure, and welcoming me to both 
Exeter and York so warmly (and Helen, thanks for letting me stay!). Charles, 
thank you for stepping up in the changing circumstances despite your already 
huge workload- you really kept the project together with such enthusiasm and 
encouragement and your contribution to this thesis is invaluable. James, I’m so 
glad you’ve been able to finish this with me, and thank you for returning to the 
project with the excitement you always had. Huge thanks must go also to Hez 
Hird for joining the supervisory team with little notice (or choice!) and driving the 
project in new exciting directions- I did not expect to become a molecular 
biologist but I’ve enjoyed the learning curve far more than I could have 
imagined. 
Sooo many people have helped with the experimental work of the project, and 
I’m sorry I can’t mention you all, but the contributions of work experience 
students, interns, apprentices and staff are not underestimated, whether you’ve 
labelled tubes, made cages, weighed feeders, supplied bees or lent me your 
stapler. 
Special thanks to the CCSS bee crowd for your (mostly) good company in the 
lab, and to Ross for letting me beat you at go-karting. 
To the NBU massive, thanks for (kind of) accepting my hatred of tea, for 
introducing me to the pudding scoring system, and for general lunchtime and 
pub time mayhem. You made my arrival to Yorkshire an easy transition to the 
North, and have since made things twice as hard- but I wouldn’t have had it any 
other way. As much as it hurts me to do so, superior reference must be given to 
Mr Ben Jones. I genuinely would not have completed the majority of this thesis 
without your help through the notorious assay development, the lengthy 
experimental design discussions and your enthusiasm to drive me mad. I 
hugely respect your efforts to complete your PhD whilst working full time- that’s 
10 
 
more than the average UK male could do- and I wish you all the best in 
reaching the Dr Jones dream. 
Toby Hodges Stamper, thank you thank you thank you for your bioinformatics 
expertise. I actually enjoyed the challenge and more importantly made a good 
friend in the process. Your patience and encouragement to teach even us 
beginners will be missed by future Fera students, but will no doubt get you far in 
life. 
Edward Haynes, where do I start? If I say that I’m crying writing this, I think it 
says it all. The last few years have been without a doubt the hardest of my life 
so far and you’ve been there through the highest of the highs and the lowest of 
the lows. What may have only seemed like a trivial weekend coffee (/hot 
chocolate), or afternoon tea (/water), seriously got me through some rough 
patches and for that I owe you big time. Maybe I’ll buy you an otter T-shirt. 
To my trusty sidekick, Rachel Yale, it’s been an absolute pleasure to share the 
PhD rollercoaster with you. From lessons in the phonetic alphabet and 
wheelbarrows in the corridor, to road trips, cycle trips, cake trips and emergency 
shelter trips- it’s been a blast and I look forward to many more adventures of Dr 
Yale and Dr Collison. 
York City Rowing Club has played a bigger part in this thesis than maybe you’d 
expect. In its own insane way, the Purple Army has kept me sane and given me 
maximum motivation not to quit because I simply didn’t want to leave York. You 
took away my weekend lie-ins and my evenings on the sofa, but in return gave 
me hours on the Ouse to switch off from bees and hours on the erg to 
experience non-PhD-related agony. My second home has remained 
consistently a place of friendship, laughter and all round oarsomeness, which 
has been such an important constant away from the challenges of work. 
Saving the best til last, huge appreciation goes to the Collison clan. Pip, you 
remain my source of positive thinking, ambition and competitiveness, despite 
your own struggles, and seeing you overcome your own challenges has made 
my drive to succeed stronger. Mum and Dad, you have supported me from the 
beginning, through tears at Junior School entrance exams through to Oxford 
graduation, and beyond into the PhD world. You’ve been at the end of the 
phone pretty much every night, you’ve made my bed a few times when I’ve just 
11 
 
had to come home, and you’ve ferried me to the station to let me flee when I’ve 
had enough of you within two days. Thanks for always encouraging me to aim 
high and I look forward to joining the Dr Collison gang. 
  
12 
 
  
13 
 
List of tables 
Table 1.1. (Page 40) Summary of major pathogens and parasites of honey bees 
(Apis spp.) and bumble bees (Bombus spp.). 
Table 1.2. (Page 57) Summary of effects of pesticide exposure on expression of 
immune-related genes. 
Table 2.1. (Page 108) Summary of pairwise variations between normalisation 
factors with the sequential addition of a reference gene, based on methods of 
Vandesompele et al. (2002). *** = significant effect of inclusion of gene (i.e. V > 
0.15). 
Table 3.1. (Page 119) Overview of the test substances, sampling time course 
and endpoints measured in each of six experiments. Each experiment was 
performed with newly emerged honey bees from a single colony, but each 
experiment used a different colony. 
Table 3.2. (Page 123) Oligonucleotide primers used in qPCR assays. 
Table 5.1. (Page 179) Oligonucleotide primers used in qPCR assays in 
experiment L102-N. 
Table 6.1. (Page 223) Summary of the top five upregulated and top five 
downregulated genes in the control-fed Ringers vs LPS injection contrast 8 h 
PIC. 
Table 6.2. (Page 226) Description of the five genes that were upregulated in 
LPS-injected bees compared to Ringers- injected bees in all three pesticide 
groups (i.e. the five genes that overlap in Figure 6.2.) 
Table 6.3. (Page 228) KEGG pathways associated with DEGs in the Control-
Thiamethoxam contrast (naïve bees only, 24 h sample set). 
 
 
 
 
14 
 
 
 
  
15 
 
List of figures 
Figure 1.1. (Page 38) (A) Frequency of publications on each topic published 
each year as a percentage of the total number published in the last 20 years 
(1993–2013). (B) Cumulative number of publications on bees and pesticides in 
the last 20 years (1993–2013). In both cases, data are based on a Web of 
Science key word search in December 2013 using the key words ‘bee’ and 
those described in the key to each plot. 
Figure 1.2. (Page 45) Hypothetical survival curve showing an interaction 
between stressors. 
Figure 1.3. (Page 50) Scatterplots of observed effects of neonicotinoids and 
fipronil on (A) bee pathogen load, (B) bee immunity and (C) bee mortality, 
based on data from Alaux et al. (2010), Aufauvre et al. (2012), Di Prisco et al. 
(2013), Doublet et al. (2015), Gregorc et al. (2012), Pettis et al. (2012), 
Retschnig et al. (2014) and Vidau et al. (2011). The observed effects at each 
pesticide concentration are based on the significance levels as defined within 
each publication. Different shapes used for each data point are used to show 
the different pesticide/pathogen combinations and/or endpoints used in each 
publication. The upper range of pesticide concentrations expected in nectar in 
the field, as shown by the vertical dashed lines, are approximations based on 
residue analysis from previous studies: fipronil (1 ppb) (Chauzat et al., 2011), 
clothianidin (5 ppb) (Cutler & Scott-Dupree, 2007; Pohorecka et al., 2012), 
imidacloprid (10 ppb) (Blacquiere et al., 2012; Pohorecka et al., 2012), 
thiacloprid (100 ppb) (Skerl et al., 2009; Pohorecka et al., 2012). AMP, 
antimicrobial peptides; BCQV, Black Queen Cell Virus; DWV, Deformed Wing 
Virus; GOX, glucose oxidase; PPOact, prophenoloxidase-activating enzyme, 
PO, phenoloxidase; THC, total haemocyte count. 
Figure 1.4. (Page 53) Schematic of the honey bee immune response, including 
identification of those components shown to be affected by pesticides in other 
insect species and/or specifically in honey bees. AmPPO, Apis mellifera 
prophenoloxidase gene; Imd, immune deficiency; JAK/STAT, Janus kinase/ 
Signal transduction and transcription; JNK, c-Jun N-terminal kinases; LLR, 
leucine-rich repeats; PPOact, prophenoloxidase-activating enzyme; RNAi, 
Ribonucleic acid interference. 
16 
 
Figure 2.1. (Page 87) Measurement of phenoloxidase activity. A. Comparison of 
neat haemolymph and perfusion bleed sampling collection methods for both the 
PO and total proPO/PO assays (Mean ± SE). B. Photograph of the dilution 
series plate following spectrophotometry. C. Dilution series measuring PO 
activity of a single sample (Mean of four replicates ± SE). D. Dilution series 
measuring total proPO/PO activity of a single sample (Mean of four replicates ± 
SE). Trend lines show linear lines of best fit.  
Figure 2.2. (Page 92) Dilution series measuring antimicrobial activity of a 
lysozyme standard from chicken egg white against the clearance of M. 
lysodeikticus (Mean of two replicates ± SE). Trend line shows line of best fit. 
Figure 2.3. (Page 93) Left: Dilution series measuring antimicrobial activity of an 
antibiotic standard against the inhibition of M. luteus. (Mean of two replicates ± 
SE). Trend line shows line of best fit. Right: Photograph of a growth inhibition 
plate, demonstrating zones of inhibition of varying diameter. 
Figure 2.4. (Page 95) Dilution series measuring GOX activity of a single sample 
(Mean of two replicates ± SE). Trend line shows line of best fit. 
Figure 2.5. (Pages 98-101) Calibration curves for each qPCR assay. Trend 
lines show lines of best fit. 
Figure 2.6. (Page 107) Gene stability values of each of the 15 genes in the 
qPCR study of Chapter 3, analysed using the GeNorm algorithm (black circles) 
and NormFinder algorithm (white squares). Genes are ordered along the x-axis 
from highest to lowest stability values from the GeNorm output, from least to 
most stable left to right. Whilst the NormFinder output showed a very similar 
trend (as shown by the shapes of the two curves), note that the order of stability 
was not identical between the two algorithms. 
Figure 2.7. (Page 109) Gene stability values of each of the 9 genes in the qPCR 
study of Chapter 5, analysed using the GeNorm algorithm. Genes are ordered 
along the x-axis from highest to lowest stability values from the GeNorm output, 
from least to most stable left to right. 
Figure 3.1. (Page 118) Schematic of overall experimental setup. Note, this 
overall setup was achieved in a series of individual experiments, as outlined in 
Table 3.1. For each pesticide exposure (top white boxes), bees received one of 
17 
 
three immune challenges (middle grey boxes). For each pesticide/immune 
combination, samples were collected across either a short time course or long 
time course (depending on the individual experiments). * Sampling at 2 and 4 h 
post immune challenge (PIC) was taken only in the qPCR experiments. 
Samples were then analysed to measure one of three immune endpoints 
(bottom grey ellipses). 
Figure 3.2. (Page 128) Antimicrobial response to artificial immune challenge 
over time in control-fed (black) and imidacloprid-exposed (white/grey) bees. Top 
plots: Physiological AMP activity (as measured by a lytic clearance assay). 
Bottom plots: Expression of the AMP gene, abaecin. Note other AMP genes 
(see text 3.4.1.; supporting information) showed a similar temporal pattern. 
Plots on the left hand side show responses for a period of 2-48 hours post 
injection and plots on the right hand side for the responses of 1-7 days post 
injection. In all plots, symbols indicate sample means and error bars depict 1 
SE. 
Figure 3.3. (Page 129) Antimicrobial response to artificial immune challenge 
over time in control-fed (black) and thiamethoxam-exposed (white/grey) bees. 
Top plots: Physiological AMP activity (as measured by a lytic clearance assay). 
Bottom plots: Expression of the AMP gene, hymenoptaecin. Note other AMP 
genes (see text 3.4.1.; supporting information) showed a similar temporal 
pattern. Plots on the left hand side show responses for a period of 2-48 hours 
post injection and plots on the right hand side for the responses of 1-7 days 
post injection. In all plots, symbols indicate sample means and error bars depict 
1 SE. 
Figure 3.4. (Page 131) Phenoloxidase response to artificial immune challenge 
over time in control-fed (black) and imidacloprid-exposed (white) bees. Top 
plots: Physiological activity; Left- Active (functional) PO response, Right- 
Inactive (potential) proPO response. Bottom plot: Expression of the proPO 
gene, AmPPO. 
Figure 3.5. (Page 143) Antimicrobial response to artificial immune challenge 
over time in control-fed (black) and imidacloprid-exposed (white/grey) bees. Top 
plots: Expression of the AMP gene, apidaecin. Bottom plots: Expression of the 
AMP gene, hymenoptaecin. Plots on the left hand side show responses for a 
18 
 
period of 2-48 hours post injection and plots on the right hand side for the 
responses of 1-7 days post injection. In all plots, symbols indicate sample 
means and error bars depict 1 SE. 
Figure 3.6. (Page 144) Antimicrobial response to artificial immune challenge 
over time in control-fed (black) and imidacloprid-exposed (white/grey) bees. 
Clockwise from top-left plot: Expression of the AMP genes defensin-1, defensin-
2 and lysozyme-1, for a period of 2-48 hours post injection. In all plots, symbols 
indicate sample means and error bars depict 1 SE. 
Figure 3.7. (Page 145) Antimicrobial response to artificial immune challenge 
over time in control-fed (black) and thiamethoxam-exposed (white/grey) bees. 
Top plots: Expression of the AMP gene, abaecin. Bottom plots: Expression of 
the AMP gene, apidaecin. Plots on the left hand side show responses for a 
period of 2-48 hours post injection and plots on the right hand side for the 
responses of 1-7 days post injection. In all plots, symbols indicate sample 
means and error bars depict 1 SE. 
Figure 3.8. (Page 146) Antimicrobial response to artificial immune challenge 
over time in control-fed (black) and thiamethoxam-exposed (white/grey) bees. 
Clockwise from top-left plot: Expression of the AMP genes defensin-1, defensin-
2 and lysozyme-1, for a period of 2-48 hours post injection. In all plots, symbols 
indicate sample means and error bars depict 1 SE. 
Figure 4.1. (Page 151) Schematic of time course (TC) experimental setup. For 
each pesticide exposure (top white boxes), bees received one of two immune 
challenges (middle grey boxes). For each pesticide/immune combination, 
samples were collected across a short time course. *Sampling at 0 h post 
immune challenge (PIC) was taken only from naïve samples. Samples were 
then analysed to measure one of two immune endpoints (bottom grey ellipses). 
Figure 4.2. (Page 152) Schematic of dose-response (DR) experimental setup. 
For each pesticide exposure (top white boxes), bees received an immune 
challenge via injection with LPS molecules. *Additionally in the control, 2.6 ppb 
and 102 ppb exposures, a manipulation-control group, denoted ‘naïve’, were 
ice-immobilised but received no further immune challenge. Samples were 
19 
 
collected at 48 h post immune challenge (PIC) and subsequently analysed to 
measure antimicrobial activity. 
Figure 4.3. (Page 157) Effects of dietary imidacloprid (x-axis, µgL-1) on daily 
consumption of feeder sucrose (y-axis, g bee-1 day-1). A. Daily sucrose 
consumption for the four days prior to injection treatment in Expt TC. B. Daily 
sucrose consumption for the 48 h PIC in Expt TC. In both panels, symbols 
indicate sample means and error bars depict 1 SE. Some data points are 
adjusted slightly on the x-axis to reveal error bars (for exact imidacloprid 
concentrations see text). Squares indicate LPS-injected bees and circles 
indicate naïve manipulation controls. 
Figure 4.4. (Page 158) Measures of phenoloxidase activity (y-axis, Vmax) over 
time (x-axis, h PIC) in individual bumble bee workers. A. Total proPO/PO 
activity (‘immune potential’); and B. Functional PO activity. Squares indicate 
LPS-injected bees and circles indicate naïve manipulation controls. Only data 
for control sucrose (open symbols) and 102 ppb imidacloprid (closed symbols) 
presented. n = 4 to 6 bees per treatment/time point combination. In both panels, 
symbols indicate sample means and error bars depict 1 SE. Some data points 
are adjusted slightly on the x-axis to reveal error bars (for exact times PIC see 
text). 
Figure 4.5. (Page 159) AMP activity (y-axis, inhibition zone) over time (x-axis, h 
PIC) in individual bumble bee workers. Squares indicate LPS-injected bees and 
circles indicate naïve manipulation controls (naïve individuals showed no AMP 
activity in all cases). Symbols show mean activity in individual bees pooled from 
all three imidacloprid treatments and error bars depict 1 SE. n = 7 or 8 bees per 
injection/time combination. 
Figure 4.6. (Page 161) Effects of dietary imidacloprid (x-axis, µgL-1) on AMP 
activity (y-axis, inhibition zone) in individual bumble bee workers 48 h PIC 
following LPS injection. Data for naïve manipulation controls are not shown, as 
typically no AMP activity was detectable. Symbols indicate sample means and 
error bars depict 1 SE. n = 5 bees per treatment. Some data points are adjusted 
slightly on the x-axis to reveal error bars (for exact imidacloprid concentrations 
see text. Open symbol indicates control sucrose and black closed symbol 
indicates 102 ppb). Dashed horizontal line indicates mean for control sucrose. 
20 
 
Figure 5.1. (Page 182) (a) Honey bee with RFID tag secured to thorax. (b) RFID 
reader on hive (arrow shows entrance). (c) Yellow queen cages placed between 
frames to introduce tagged bees. (d) Schematic of setup of Experiment F10-B. 
Figure 5.2. (Page 183) Proportion of the 800 tagged young bees that were ever 
recorded, and to make a return trip to the colony. NB. 50 control and 50 
imidacloprid (IMI)-exposed bees were initially tagged in each colony/cohort. 
Figure 5.3. (Page 188) A) Enzymatic GOX activity; B-H) Relative gene 
expression in honey bee workers exposed to 125 µgL-1 (102 ppb) imidacloprid 
for 5-20 days post emergence (experiment L102-N). The mean fold-change in 
expression was calculated for each pesticide/age compared to the mean 
expression of the control-fed/5-day-old group. Data presented as Mean ± SE (n 
= 4). 
Figure 5.4. (Page 191) A) Mean ± SE number of days for tagged bees to first 
record to leave the colony following their introduction to the colony at 6 days 
old. B) Mean ± SE number of trips recorded by each bee. C) Mean ± SE 
duration of trips recorded by each bee. Numbers in each bar represent the 
number of bees recorded in each cohort (n). * Asterisks show significant 
differences between control and imidacloprid groups. 
Figure 5.5. (Page 193) Cumulative number of trips recorded in each cohort over 
the 6+ weeks of the study. 
Figure 5.6. (Page 195) Enzymatic activity of GOX measured 0-48 hours PIC, 
following exposure to 125 µgL-1 (102 ppb) imidacloprid (IMI) (experiment L102-
GOX). Data presented as Mean ± SE (n = 3). 
Figure 5.7. (Page 196) Enzymatic activity of GOX measured 24 hours PIC, 
following exposure to 0.08 - 125 µgL-1 (0.1 – 102 ppb) imidacloprid (IMI) 
(experiment L0.1-102-GOX). Data presented as Mean ± SE (n = 3), and linear lines 
of best fit. 
Figure 6.1. (Page 222) Top: Number of DEGs between pairwise comparisons of 
injection treatment in control-fed bees, 8 and 24 h PIC. e.g. the Naïve vs 
Ringers comparison refers to no. of genes up- or down- regulated in Ringers-
injected samples compared to naïve samples. Black bars = Upregulated genes, 
White bars = Downregulated genes. Bottom: Venn diagram to show the number 
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of DEGs in the 8 h samples that overlap among the injection treatment 
comparisons. Bar chart to show the magnitude of expression between the three 
injection contrasts for each of the five DEGs that were shared between these 
contrasts in control-fed bees 8 hours PIC. Log2 fold-change mean ± SE. 
Figure 6.2. (Page 225) Top: Number of genes up- or down- regulated in LPS-
injected samples compared to Ringers-injected samples 8 hours PIC in each 
pesticide group. Venn diagram shows the number of these DEGs that overlap 
among these contrasts in each pesticide treatment. Bottom: Bar chart to show 
the magnitude of expression following LPS injection compared to Ringers 
injection in each pesticide treatment, for each of the five DEGs that were shared 
between these contrasts. Log2 fold-change mean ± SE. 
Figure 6.3. (Page 226) Relative expression of ALDH1L2 gene in response to 
immune challenge over a period of 2 - 48 h PIC. Mean ± SE fold-changes are 
shown relative to expression in control-fed, naïve (unchallenged) bees at the 0 
h time point. Left plot shows expression profile for control and imidacloprid-
exposed bees. Right plot shows expression profile for control and 
thiamethoxam-exposed bees. 
Figure 6.4. (Page 230) Number of up- or down-regulated genes in (left) 
thiamethoxam-exposed bees; and (right) in imidacloprid-exposed bees, for each 
injection treatment and time PIC. 
Figure 6.5. (Page 241) Schematic of experimental design. For each pesticide 
exposure (top white boxes), bees received one of three immune challenges 
(middle grey boxes). For each pesticide/immune combination, samples were 
collected at either 8 or 24 h PIC. 
Figure 6.6. (Page 242) Percentage breakdown of raw sequencing reads 
following trimming and alignment pipeline. A. Pie chart depicting average of all 
reads across the 45 samples. B. Bar chart depicting breakdown for each 
sample in turn. 
Figure 6.7. (Page 243) Pie chart representing the data distribution of Apis 
mellifera sequences following the functional analysis pipelines i) (Top chart) 
using a 1:1 homology TBLASTX against Drosophila melanogaster and 
annotation using GOrilla (Eden et al., 2009); and ii) (Bottom chart) using a 
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BLASTX against the NCBI non-redundant coding sequence database and 
annotation using Blast2GO. 
Figure 6.8. (Page 244) Summary of GO terms enriched across the 163 DEGs in 
the Naïve 24 h Control vs Thiamethoxam subset, at an FDR of 0.05. 
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µgL-1 - Micrograms per litre 
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AMP - Antimicrobial peptide 
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ANCOVA - Analysis of Covariance 
ANOVA - Analysis of Variance 
BLAST - Basic Local Alignment Search Tool 
BLASTX - BLAST search of a protein database using a translated nucleotide 
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BQCV - Black queen cell virus 
CCSS - Centre for Chemical Safety and Stewardship 
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CRD- Chemicals Regulation Directorate 
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Dscam - Down syndrome cell adhesion molecule 
DWV - Deformed wing virus 
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g - Grams 
GO - Gene ontology 
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Log - Base-10 logarithm 
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mgml-1 - Milligrams per millilitre 
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MRJP - Major royal jelly protein 
mRNA - Messenger ribonucleic acid  
MTU - Molecular Technology Unit 
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NCBI - National Center for Biotechnology Information 
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PIC - Post immune challenge 
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SE - Standard error 
TBLASTX - BLAST search of a translated nucleotide database using a 
translated nucleotide query 
Tak1 - TGFbeta Activated Kinase 1 
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1. General Introduction 
Bees have long been of ecological, economic and cultural importance, and their 
value to both natural ecosystems and human societies remains just as vital 
today. However, there is widespread concern over declines in wild bee 
populations and losses of managed colonies. Anthropogenic activities are likely 
impacting on bee health, including habitat loss and fragmentation, the 
introduction of alien species (including plants, animals and microorganisms), the 
spread of pathogens and parasites, and pesticide application. The application of 
one particular class of pesticides, the neonicotinoids, has increased rapidly in 
the UK since introduction to the agrochemical market in the 1990s. These 
neonicotinoid pesticides have been of particular recent concern to bee health 
due to the potential exposure of bees through residues in nectar and pollen of 
flowering plants, but whether realistic exposure scenarios are driving declines in 
bee health remains unknown. Increasing debate over the impacts of pesticide 
exposure on bee health has questioned whether the current risk assessment 
schemes for plant protection products are appropriate. 
Managed honey bees and wild bumble bee species are amongst the most 
important insect pollinators in the UK, contributing to the pollination of both wild 
flowering plants and commercial agricultural and horticultural crops. This 
chapter introduces these key pollinators and reviews our current understanding 
of the impacts of neonicotinoid exposure and other threats on bee health. It 
highlights key knowledge gaps in this research field and puts in context the 
aims and objectives of this thesis, which are summarised at the end of the 
chapter. 
I first provide an overview of the biology of honey bees and bumble bees, 
focusing on the study species of this thesis, and recognise their importance as 
ecosystem service providers. I then introduce the current system in the UK for 
the risk assessment of plant protection products on bees. This thesis primarily 
focuses on the role of pathogenic infection and pesticide exposure as threats to 
bee health, and these are discussed in context in a separate paper within this 
introductory chapter, which has been accepted for publication. 
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1.1. Biology of bees 
Here I briefly review bee natural history to highlight that there are many levels of 
organisation and potential targets for effects of pesticide exposure and therefore 
many ecotoxicological endpoints for study. 
Today there are approximately 25,000 known bee species (of which 253 are 
known from the UK) (Goulson, 2010). The earliest bees probably diverged from 
the predatory sphecoid wasps during the Cretaceous period, 100-130 million 
years ago, diversifying away from a diet of insect prey to specialise on nectar 
and pollen (Winston, 1987). The appearance of the first bees coincided with the 
appearance of flowering plants (angiosperms) as the dominant vegetation. The 
earliest bees were almost certainly solitary species, but sociality amongst the 
bees probably evolved around 80 million years ago (Winston, 1987). 
1.1.1. The honey bee, Apis mellifera 
The Western or European honey bee, Apis mellifera L., most likely originated in 
eastern tropical Africa during the Tertiary period, before spreading to Northern 
Europe and Asia (Winston, 1987, Whitfield et al., 2006). Although non-native to 
the Americas, it was first imported to North America by European colonists in 
the 17th century and its movement for beekeeping has resulted in a now 
worldwide distribution. Its vast geographic range has led to geographic 
differentiation into  as many as 28 subspecies (races) (Engel, 1999), each with 
distinctive adaptations to different climates, habitats and flora. Although cross-
fertile, these races show various local adaptations including brood cycles 
synchronised with localised floral phenology (Hepburn, 1998), enhanced 
foraging behaviours in desert areas (Alqarni, 2006) and migratory swarming in 
Africa (Nuru et al., 2002). Nevertheless, beekeeping has changed the range of 
these races too, and there is considerable hybridisation of races and selective 
breeding for certain traits. 
The honey bee has a complex social organisation, in which approximately 
60,000 individuals comprise a single colony. The colony has a perennial life 
cycle, which is briefly outlined here. There is typically a single queen in the 
colony, who is the only female to lay eggs. She will lay throughout the spring 
and summer (as many as 1500 eggs a day in peak production), only ceasing 
laying in late autumn and over winter, and she may live for several years (with 
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an average productive life span of 2-3 years). The majority of eggs will be 
fertilised by releasing several sperm from the spermatheca as she lays, 
developing into female workers (or potentially new queens). Each egg is laid 
one per cell of a wax brood comb, using its yolk as a food source as it develops. 
Larvae develop after three days and are fed by nurse worker bees with royal 
jelly, honey and pollen (bee bread), before the cells are capped with wax 
(typically after about six days for worker larvae). Within these capped cells, 
larvae develop into pupae, and after about 12 days newly developed adult bees 
emerge by chewing their way out. Unfertilised eggs are typically laid in larger 
cells and develop into haploid male drones (the largest individuals in the 
colony). Drones are normally fed by the workers, although they can also feed 
themselves from sources within the hive, but they do not forage for their own 
nectar or pollen. They are generally only found in late spring and summer, and 
may number several hundred in the colony during this time. Although not all 
drones will fertilise a virgin queen, this is their sole function (after which they die 
instantly). Virgin queens will attract drones during mating flights by releasing 
pheromones and may mate with 7-15 drones. New (virgin) queens are raised by 
workers i) to supersede the mother queen if she begins to fail and decreases 
production of her ‘queen substance’ pheromone, ii) as an ‘emergency’ if the 
mother queen is killed or lost from the colony, and iii) in preparation for 
swarming. In the latter case, eggs are raised in larger ‘queen’ cells in gaps in 
the wax brood comb, or along the bottom of the comb frames. Supersedure and 
emergency queens are typically raised by modifying worker cells so that they 
hang vertically from the comb surface. Caste development of fertilised eggs is 
thought to depend on the nutrition supplied to the larvae by the nurse workers 
(Kamakura, 2011). 
Whilst honey bee and bumble bee colonies both consist of three castes of bees 
(queen, worker and drone), honey bees also show a further level of caste 
differentiation known as temporal polyethism. Female workers within the honey 
bee colony may specialise on different sets of tasks, and these tasks may 
change as an individual worker ages. In this way, younger workers may typically 
perform tasks within the hive, acting as nurses in brood care duties, whilst older 
workers may typically perform tasks outside the hive, acting as foragers and in 
colony defence duties (Calderone, 1998, Johnson, 2010). 
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 1.1.2. The bumble bee, Bombus terrestris 
Classified within the same subfamily as the honey bees (Apinae), the bumble 
bees comprise a separate genus (Bombus). The first bumble bees most likely 
originated 30-40 million years ago, in the mountains of central Asia, coinciding 
with a period of cooler temperatures that would have favoured the adaptation of 
larger, furrier bees (Goulson, 2010). Today, there are about 250 bumble bee 
species (Williams, 1998). Their natural distribution spans Europe, Asia, North 
and South America, and otherwise their distribution in the southern hemisphere 
(including Australia, New Zealand) results only from recent deliberate 
introductions by humans (e.g. Hopkins, 1914). 
27 bumble bee species are found naturally in the UK, and amongst the most 
common of these is the buff-tailed bumble bee, Bombus terrestris L., which is 
widely distributed across England, Wales, Northern Ireland and southern and 
central Scotland (BWARS, 2014). It is also widespread in Europe, and middle 
and northern latitudes of Asia, and is the most widely used bumble bee species 
for commercial glasshouse pollination (Velthius & Van Doom, 2006). 
Like most bumble bee species, B. terrestris colonies have an annual cycle, and 
at their largest may comprise up to 350 individuals (Goulson, 2010). They are 
often described as ‘primitively eusocial’, as their social organisation is simpler 
than that of the honey bee. Young mated queens at the end of the colony cycle 
are the only individuals to overwinter, hibernating until the following spring when 
they found a new colony. Queens emerge from hibernation in spring (typically 
March in the UK, depending on weather conditions) and search for suitable nest 
sites in cavities such as deserted small rodent nests, dead logs, dead tussocks 
of grass or the base of thick hedges. On finding a suitable nest site, the queen 
will exude wax and use this wax to form a honey pot, into which she 
regurgitates nectar to form a store of honey. She will also forage to collect 
pollen and return this to the nest where she will moisten it with nectar to form a 
ball of ‘bee bread’. Feeding on pollen stimulates the queen’s ovaries to produce 
eggs, and she will lay these in batches of about 4-16 on the ball of bee bread, 
then covering them in a layer of wax. The queen will brood these eggs at 30 °C, 
feeding on the honey pot close by, and leaving the eggs for only short periods if 
she needs to leave the nest to forage for more nectar and pollen. Eggs hatch 
after 4-5 days, and the larvae will feed on the bee bread pollen, pupating after 
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three weeks and these pupae then emerging as adult workers another two 
weeks later. These workers may spend their first few days as adults producing 
wax to build new egg cells, and then they begin to forage. By collecting pollen 
and returning it to the nest, this enables the queen to spend almost all her time 
in the nest, laying eggs to increase the colony size. When the new queen mated 
prior to hibernation in the autumn of the previous year, she stored the sperm of 
her mate in the spermatheca. Throughout the laying season, the queen lays 
fertilised eggs by releasing sperm from the spermatheca, in turn producing 
female workers. It is only at the end of the colony life cycle (in late spring/early 
summer) that the queen lays unfertilised eggs which develop into males. At this 
stage she will not lay any more eggs that will develop into female workers, but 
will only lay a few fertilised eggs to develop into new queens. The development 
of queens from these fertilised eggs is stimulated by the loss of production of a 
pheromone by the queen. The developing larvae and pupae will feed 
considerably more than developing workers, and consequently will be larger in 
size. At this late stage of the colony cycle, some remaining workers may also 
produce unfertilised eggs, developing into males.  Males feed on honey stores 
in the nest for a few days when they first emerge as adults and then 
permanently leave the nest, foraging for themselves and flying in circuits 
depositing a sex-pheromone on objects such as tree trunks and rocks to attract 
new queens for mating. New queens emerge about a week later than the new 
males, and unlike these males they will return to the nest to shelter (although 
they do forage for themselves). When ready to mate, she will leave the nest and 
use the pheromone cues of the male to find a suitable mate, usually only mating 
with a single male whilst resting on the ground or vegetation. Whilst the mother 
queen, workers and drones all die in autumn, the newly mated queens stock 
their honey stomach (by feeding on nectar) and build their fat bodies (by feeding 
on pollen and nectar) before finding a suitable hibernation site in the ground to 
spend the winter. 
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1.2. Bees as providers of ecosystem services 
Many wild plant communities and agricultural and horticultural crops rely on 
animal pollinators (Wilcock and Neiland, 2002, Kearns et al., 1998), including 
several species of honey bees, bumble bees, stingless bees and solitary bees 
(Klein et al., 2007). Natural pollination services as a whole have been estimated 
at £430 million a year in the UK (UK National Ecosystem Assessment, 2011), 
whilst wild bees have been valued at over $3 billion a year to US crop 
production, contributing over $750 million to soybean production alone (Losey 
and Vaughan, 2006). Where wild bee populations do not visit agricultural fields, 
managed populations of A. mellifera provide essential pollination services, 
increasing the edible yield of 40 % of the world’s 115 leading crop species 
(Pesticide Action Network, 2008). In the UK alone, honey bee pollination 
services are estimated at a monetary value of £200 million a year (National 
Audit Office, 2009), and estimates for the role of honey bees in US crop 
production are as high as $15 billion annually (Morse and Calderone, 2000). 
Bumble bees are also reared commercially for the pollination of greenhouse 
crops, such as tomatoes, peppers and strawberries (Velthuis and van Doorn, 
2006). Whilst precise figures are unknown, global trade in bumble bee colonies 
has been estimated at over one million nests per year (Goulson, 2010), and 
Japan alone imports about 40,000 bumble bee colonies annually (Asada and 
Ono, 2000). Furthermore, the importance of pollinators for the maintenance of 
natural plant diversity should not be underestimated. For example, in a study in 
Britain and the Netherlands, Biesmeijer et al. (2006) found a parallel decline 
between pollinators and outcrossing insect-pollinated plants relative to other 
plant species. Increased bee diversity is associated with increased pollination 
success (Klein et al., 2003). These figures briefly highlight the importance of 
both honey bees and bumble bees to the pollination of worldwide crops and 
human food production, and the success of wild flowering plants. This 
demonstrates the need to understand declines in bee health to minimise the 
long term consequences of bee population declines to ecological, agricultural 
and horticultural systems. 
 
  
34 
 
1.3. Risk assessment of plant protection products on bees 
Here I give a brief synopsis of the current procedures for the authorisation of 
plant protection products (PPPs) in the UK and Europe. This introduction serves 
to put into context the study of pesticide effects on non-target organisms, 
including beneficial pollinators such as bees, and the application of these 
scientific studies in the ecotoxicological risk assessment of PPPs. 
As an EU Member State, the UK must authorise the placing of commercial 
PPPs on the market, as well as their use and control within the European 
community, under Regulation (EC) No 1107/2009 of the European Parliament. 
This is regulated nationally in the UK by the Chemicals Regulation Directorate 
(CRD), and internationally by the European Food Safety Authority (EFSA). The 
Regulation sets out an approval criteria for active substances and PPPs 
containing these actives, which must be met prior to the authorisation of a 
product to meet specific protection goals that are set out with the aim that any 
effects of PPP exposure are within a defined level of ‘acceptable harm’. 
Amongst these criteria includes an assessment of the risks of exposure and the 
effects of this exposure on bees, following a set of test guidelines based on 
scientific opinion (e.g. OECD, 1998). Given the scientific and public concern 
that bee health may be at particular threat from pesticide exposure, a new 
guidance document was published by EFSA in 2013, following a review of the 
scientific opinion on the risk assessment of PPPs on bees by EFSA in 2012. To 
summarise, this new guidance document proposed several new areas of 
assessment to be completed as part of a bee risk assessment, including a 
requirement to assess risks to bumble bees and solitary bees as well as honey 
bees, a requirement to include chronic oral, larval, accumulation potential and 
hypopharyngeal gland assessments in the lower tier screening assessment, 
and a requirement to assess the exposure from water consumption (such as 
guttation fluid, surface water and puddles) and the risk from metabolites. 
Several other recommendations were included in this guidance, including a 
priority for research to determine the most appropriate sublethal endpoints for 
use in future risk assessment, and the development of ecotoxicological 
biomarkers to enable prediction of potential sublethal effects (e.g. Badiou-
Beneteau et al., 2012, Carvalho et al., 2013). 
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1.4. Interactive effects of pesticide exposure and pathogen infection on bee 
health – a critical analysis 
Further introduction and background to support the aims of this thesis are 
discussed in the paper presented below, which was written by the primary 
author and formed a significant part of the research for this thesis. This paper 
was accepted for publication in Biological Reviews in June 2015 (Collison et 
al.,2015). 
 
1.4.1. Abstract 
Bees are fundamentally important for pollination services and declines in 
populations could have significant economic and environmental implications. 
Pesticide exposure and pathogen infection are recognised as potential 
stressors impacting upon bee populations and recently there has been a surge 
in research on pesticide–disease interactions to reflect environmentally realistic 
scenarios better. We critically analyse the findings on pesticide–disease 
interactions, including effects on the survival, pathogen loads and immunity of 
bees, and assess the suitability of various endpoints to inform our mechanistic 
understanding of these interactions. We show that pesticide exposure and 
pathogen infection have not yet been found to interact to affect worker survival 
under field-realistic scenarios. Colony-level implications of pesticide effects on 
Nosema infections, viral loads and honey bee immunity remain unclear as these 
effects have been observed in a laboratory setting only using a small range of 
pesticide exposures, generally exceeding those likely to occur in the natural 
environment, and assessing a highly selected series of immune-related 
endpoints. Future research priorities include the need for a better understanding 
of pesticide effects on the antimicrobial peptide (AMP) component of an 
individual’s immune response and on social defence behaviours. Interactions 
between pesticide exposure and bacterial and fungal infections have yet to be 
addressed. The paucity of studies in non-Apis bee species is a further major 
knowledge gap. 
1.4.2. Introduction 
There is widespread concern over losses of managed honey bees and declines 
in wild bee populations (e.g. Biesmeijer et al., 2006; Goulson et al., 2008; 
Neumann & Carreck, 2010; vanEngelsdorp et al., 2008) due mainly to the 
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potential impact on pollination of crops and wild plants (see Potts et al., 2010). 
Potential stressors impacting on bee health include habitat loss and 
fragmentation, the introduction of alien species (including plants, animals and 
microorganisms), climate change, the spread of pathogens and parasites, and 
pesticide application (Potts et al., 2010). To manage bee declines better, it is 
important to understand how these multiple stressors could impact bee health, 
and whether the importance of different stressors varies with bee species, 
geographic location and time. Over the past 30 years there has been a steady 
accumulation of studies investigating the individual stressors that could cause 
bee declines, but investigation of different stressors in combination has only 
recently gained momentum (Figure 1.1.). The study of stressors in combination 
is important because this approach more likely reflects the complexity of 
realistic ecological scenarios and may reveal otherwise unforeseen sublethal 
effects and synergies among stressors. Combinations of stressors that have 
been studied have included infection with multiple pathogens (Martin et al., 
2012; Yang & Cox-Foster, 2005) and exposure to chemical (pesticide) mixtures 
(Johnson et al., 2013; Johnson et al., 2009). Here, we focus on the effects of 
pesticide exposure in combination with pathogen infection. In a Web of Science 
search of the literature (conducted in 2014) using the key words ‘disease’, 
‘pesticides’ and ‘bees’, only 20 of the 196 papers identified were on non-Apis 
bee species [16 on bumble bees (Bombus spp.) and four on solitary bees (e.g. 
Andrena, Megachile and Osmia spp.]. Our review is therefore necessarily 
focused primarily on honey bees (Apis spp.), but we also include studies of non-
Apis bee species where they are available.  
The effect of a stressor can be acutely lethal (increasing the rate of mortality) or 
sublethal, modifying performance, for example in aspects of growth, fecundity, 
immunity, longevity or behaviour (Desneux et al., 2007). There is an increasing 
body of evidence that some pesticide applications have sublethal effects that 
may impact on bee health, including inhibiting colony growth and queen 
production (Whitehorn et al., 2012), altering foraging behaviour (Decourtye et 
al., 2004; Mommaerts et al., 2010; Schneider et al., 2012), impairing learning 
ability (Decourtye et al., 2004) and reducing fecundity (Laycock et al., 2012; 
Mommaerts et al., 2010; Tasei et al., 2000). Whilst sublethal effects may not 
cause immediate population declines through increased bee mortality rates, 
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they may decrease the long-term survival and growth of colonies and thereby 
affect the success of bee populations. In this review we focus both on the lethal 
effects of simultaneous pesticide exposure and pathogen infection, and 
sublethal effects of pesticide exposure on the ability of bees to defend against 
pathogenic or parasitic attack, or ‘immunocompetence’. Previous published 
reviews highlight a lack of studies investigating the effect of interactions 
between pesticide and disease exposure in bees (James & Xu, 2012). In 
response, there has been a recent proliferation in the investigation of pesticide–
pathogen interactions to address this knowledge gap, with 25% of the total 
number of publications on the topic over the last 20 years published in 2013 
alone (Figure 1.1.A).  
This review aims to provide a synthesis and critical analysis of findings 
regarding pesticide–disease interactions in bees to identify trends and 
discrepancies in the data and to highlight gaps in our understanding. It is hoped 
that this will focus future research, contributing to our understanding of the 
underlying mechanisms driving pesticide–disease interactions, and be of value 
in the assessment of potential sublethal ecotoxicological endpoints for risk 
assessment. We first provide a brief overview of the pathogens and pesticides 
of most current concern for bees to set the required context for our analysis on 
the effects of pesticide–pathogen interactions on bee health. 
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Figure 1.1. (A) Frequency of publications on each topic published each year as 
a percentage of the total number published in the last 20 years (1993–2013). 
(B) Cumulative number of publications on bees and pesticides in the last 20 
years (1993–2013). In both cases, data are based on a Web of Science key 
word search in December 2013 using the key words ‘bee’ and those described 
in the key to each plot. 
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1.4.2.1. Bee pathogens and parasites 
Honey bees and bumble bees are susceptible to a wide range of pathogens and 
parasites, which can infect all stages of the bee life cycle. Severe infections can 
kill or weaken the colony in wild bumble bees (e.g. Schmid-Hempel & Schmid-
Hempel, 1988) and domesticated honey bees (e.g. Genersch, 2010) causing 
significant economic impact to beekeepers (e.g. Botias et al., 2013; Zaghloul et 
al., 2005). The most common of these pathogens and parasites and their 
modes of action are summarised in Table 1.1., and they include bacterial, 
fungal and viral pathogens (with examples that include Paenibacillus larvae, 
Ascophaera apis and Deformed Wing Virus, respectively), microsporidia 
pathogens (most notably Nosema spp.), and ectoparasitic mites, the main 
example being the Varroa mite (Varroa destructor). 
Varroa destructor has spread rapidly amongst honey bee populations across 
the world, and now has a near-global distribution (with the notable exception of 
Australia) (Oldroyd, 1999). Coupled with its close-association with the 
transmission of viruses, Varroa destructor is often considered the most 
important pest of Apis mellifera and has been linked to the loss of millions of 
colonies worldwide (Martin, 2001; Martin et al., 2012). 
Two bacteria, Paenibacillus larvae and Melissococcus plutonius, are the 
infective agents behind American and European foulbrood disease, 
respectively. These are the only formalised bacterial diseases of honey bee 
larvae, but are found worldwide and considered among the primary threats to 
honey bee colony losses (Evans & Schwarz, 2011). 
Whilst Nosema spp. are typically ubiquitous in honey bee colonies, its role in 
recent colony losses remains unclear, and its impact may result from 
interactions with other stressors, rather than as a sole key factor (see review by 
Evans & Schwarz, 2011). 
However, in contrast to their relative prevalence and impact in honey bee 
colonies, amongst the most important pathogens and parasites of bumble bees 
are the trypanosome protozoa, parasitic flies and tracheal mites (Shykoff & 
Schmid-Hempel, 1991; Schmid-Hempel & Schmid-Hempel, 1998; Whitehorn et 
al., 2011). 
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Table 1.1. Summary of major pathogens and parasites of honey bees (Apis 
spp.) and bumble bees (Bombus spp.). 
 
Species 
(common name) 
Taxonomic 
affiliation 
Mode of action 
Affects 
Apis 
Affects 
Bombus 
References 
Varroa destructor 
(Varroa) 
Mite (Acari: 
Arachnida) 
Ectoparasite of pupae and 
adults. Strong associations 
with the transmission of 
several bee viruses 
  Martin (2001), 
Sammataro et al. 
(2000) 
(Nosema spp.), 
including N. apis, 
N. ceranae and 
N. bombi 
Microsporidian 
Germinates in bee gut, 
leading to dysentery. Use 
host resources and 
suppress immune response 
  Coffey (2007), Otti & Schmid-Hempel (2007) 
Melissococcus 
plutonius 
(European 
Foulbrood, EFB) 
Bacterium 
Multiplies in the larval gut, 
generally not lethal but 
stresses the colony 
  Forsgren (2010) 
Paenibacillus 
larvae (American 
Foulbrood, AFB) 
Bacterium 
Multiplies in the larval gut, 
often leading to death of 
developing larvae 
  Hansen & Brodsgaard (1999) 
Ascophaera apis 
(Chalkbrood) 
Fungus 
Infects the larval gut, 
leading to death of 
developing larvae 
  Aronstein & Murray (2010) 
Several viruses, 
including 
Deformed Wing 
Virus (DWV), 
Black Queen Cell 
Virus (BQCV) 
and Acute Bee 
Paralysis Virus 
(ABPV) 
Virus 
Intracellular parasites, 
affecting various life 
stages. Often lead to 
deformities in developing 
bees, such as deformed 
wings 
  
Graystock et al. 
(2013), Martin et al. 
(2012) 
(Crithidia spp), 
including C. 
bombi, C. 
expoeki, C. 
mellificae 
Trypanosome 
protozoa 
Gut parasite, transmitted 
via contaminated faeces   
Brown et al. (2003), 
Ravoet et al. (2013), 
Shykoff & Schmid-
Hempel (1991), 
Whitehorn et al. (2011) 
Locustacarus 
buchneri 
Mite (Acari: 
Arachnida) 
Tracheal mite, overwinters 
in hibernating queens   
Otterstatter & Whidden 
(2004), Whitehorn et 
al. (2011) 
Conopid and 
phorid flies 
Fly (Diptera) 
Parasite, laying eggs in bee 
abdomen   
Core et al. (2012), 
Schmid-Hempel & 
Schmid-Hempel (1988) 
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1.4.2.2. Pesticides of current concern in bee research  
1.4.2.2.1. Chemicals and mode of toxicity 
Crops are protected from insect pests by the application of insecticides and 
three classes dominate current usage: organophosphates, pyrethroids and 
neonicotinoids (Koehler & Triebskorn, 2013). These three classes are all 
neurotoxic to insects, causing neurons to excite, with organophosphates 
inhibiting acetylcholinesterase, pyrethroids prolonging the opening of voltage-
gated sodium channels, and neonicotinoids acting as nicotinic acetylcholine 
receptor (nAChR) agonists (reviewed by Belzunces et al., 2012). Over the last 
5–10 years there has been a considerable increase in the number of 
publications investigating effects of these pesticides on wildlife (Koehler & 
Triebskorn, 2013). In line with this, the number of studies investigating effects of 
the three main insecticide classes (organophosphates, pyrethroids and 
neonicotinoids) specifically on bees has also increased with the greatest 
attention on the neonicotinoids. For example, in a Web of Science search of the 
literature (conducted in 2014) using the key words ‘bees’ and 
‘organophosphates’, ‘pyrethroids’ or ‘neonicotinoids’, three, 12 and six 
publications were identified between 2006 and 2009 for organophosphates, 
pyrethroids and neonicotinoids, respectively, whilst 11, 22 and 66 were 
identified between 2010 and 2013 (Figure 1.1.B). Fungicides are also widely 
used and may be harmful to bees, mainly by their interactions with other 
pesticides, for example by inhibiting the metabolism, detoxification and 
excretion of insecticides (e.g. Johnson et al., 2013; Pilling et al., 1995; Schmuck 
et al., 2003). 
 
1.4.2.2.2. Modes of exposure 
Pyrethroids, organophosphates and fungicides are usually applied to crops via 
sprays, so bees can be exposed by direct contact either during application or 
from residues present on plant surfaces, which can also be ingested in nectar 
and pollen. Neonicotinoids are applied as sprays, as well as via soil and topical 
plant treatments (e.g. leaf or root dipping), but most commonly they are applied 
as seed dressings. Irrespective of the mode of delivery, neonicotinoids are 
taken up by the plant and circulated systemically to the leaves, shoots and 
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flowers as they grow. In this way target insects, including wireworms, cutworms, 
aphids and leafhoppers, are exposed to the insecticide in their diet as they feed 
on the plant tissue, including seeds, roots, stems and sap. Beneficial pollinating 
insects, including honey bees and bumble bees, consume neonicotinoids at 
trace levels in the nectar and pollen of the treated crop plants (e.g. Pohorecka 
et al., 2012). Managed honey bee colonies are also exposed to acaricide 
pesticides, which are frequently applied directly to the hives by beekeepers to 
control for mite infestations. Acaricide treatments include plant-derived products 
(e.g. thymol), organic acids (e.g. formic acid) and synthetic pesticides, including 
formamidine, pyrazole, organophosphates and pyrethroid insecticides (Johnson 
et al., 2010), some of which are considered in this review. 
 
1.4.2.2.3. Spatial extent of exposure and evidence of contamination 
levels 
Here, we evaluate the spatial extent of pesticide application and bee exposure 
principally in the context of a European (and specifically UK) landscape, but we 
also include comparisons on usage with other countries. We note also that 
other developed countries generally follow similar agricultural practices. A 
quarter of the UK land area is arable (WorldBank, 2014), and 85% of this is 
sprayed with pesticides (Twining & Simpson, 2009). A small proportion (3.3%) 
of UK agricultural land (pasture and arable) is classified under organic 
management (DEFRA, 2013), similarly to that occurring in other developed 
European nations including France (3.6% in 2012) and Germany (5.8% in 2012) 
(Eurostat, 2015). Organic management does not however exclude this land 
from the use of pesticides as definitions of ‘organic’ vary, and most allow use of 
‘organic insecticides’ which may pose risk to bees. The top pesticide classes, 
ranked on their 2012 usage on UK arable land (Garthwaite et al., 2013), are: 
fungicides (50% of treated pesticide area) > pyrethroids (6.3%) > neonicotinoids 
(1.7%) > carbamates (0.7%) > organophosphates (0.2%). By contrast, a 
tentative ranking based on the residues detected in honey bee colonies at given 
sites in North America (Mullin et al., 2010; Wu et al., 2012) and France 
(Chauzat et al., 2011; Lambert et al., 2013) shows: acaricide insecticides 
(pyrethroids and organophosphates) > fungicides > organophosphates > 
pyrethroids > carbamates and neonicotinoids. It is a shortcoming that the 
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application and residue data are collated from different geographical regions, 
but this tentative evaluation shows that the ranking of spatial exposure is not 
represented consistently in residues detected in honey bee colonies. The top-
ranked pesticides detected as residues in colonies were typically acaricide 
insecticides and fungicides, consistent with the frequent direct application of 
acaricides to hives to control mites and the dominance of fungicides in UK 
pesticide usage. Pyrethroid residues were typically found in < 15% of hive 
samples, but nevertheless cypermethrin was amongst the top ten residues 
found in French wax samples, and deltamethrin in honey and bee samples 
(Chauzat et al., 2011). Despite their relatively minor share of the market, 
organophosphate residues, including chlorpyrifos, triphenylphosphate and 
azinphos-methyl, were more commonly found in hive samples than pyrethroids, 
neonicotinoids and carbamates. Overall neonicotinoid residues were found in < 
1–5 % of samples analysed from across the USA and France, with the 
exception of one study in which imidacloprid and its metabolite 6-chloronicotinic 
acid were found in 20–40% of honey and pollen samples (Chauzat et al., 2011). 
Although both the use of neonicotinoids and the amounts of neonicotinoid 
residues found in apiaries are relatively low compared to the other major 
pesticide classes, their effects on bees have recently received greater relative 
interest (Figure 1.1.B), perhaps due to the very significant increase in their use 
since their introduction in the 1990s and their systemic nature. In the UK, the 
use of neonicotinoids has risen from a national application rate of 3 tonnes per 
year in 1994 to nearly 80 tonnes in 2011 (reviewed by Goulson, 2013). In 2008, 
neonicotinoids represented 24% of the global agrochemical market and they are 
registered for use in 120 countries (Jeschke et al., 2011). Growing concern over 
the sublethal effects of neonicotinoids on pollinator populations led the 
European Commission (2013) to introduce a two-year restriction on the use of 
three neonicotinoid pesticides (imidacloprid, clothianidin and thiamethoxam) on 
bee-attractive crops in Europe until further research can clarify their effects on 
pollinators. 
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1.4.3. Interactive effects of pesticide exposure and pathogen infection on 
bee health 
Here we address the following three key research questions that relate to the 
interactions of pesticides and pathogen infections on bee health: (1) do 
pesticide exposure and pathogen infection increase pathogen load? (2) Do 
pesticide exposure and pathogen infection reduce bee immunocompetence? (3) 
Do pesticide exposure and pathogen infection interact to reduce bee survival? 
Each question focuses on a different endpoint of biological interest, the 
underlying biological mechanisms and/or the ecological relevance of pesticide–
pathogen interactions. With respect to each question, we assess evidence in 
support or otherwise, and briefly outline the suitability of each endpoint to inform 
our understanding of pesticide–pathogen interactions. 
In our review, we use the term ‘interaction’ between two or more stressors to 
indicate a combined effect on bee survival that is greater than the sum of the 
effects of each stressor alone (Figure 1.2.), i.e. a ‘more-than-additive’ statistical 
effect. In the context of pesticide–pathogen interactions, we avoid the use of 
‘synergism’ and ‘antagonism’ because these terms bring interpretive 
complications. The terms ‘synergistic/antagonistic’ are widely used to describe 
any statistical departure from additivity, but in toxicology they specifically denote 
an interaction between two or more chemical stressors (IUPAC, 2015) through 
a common biological mechanism (Solomon et al., 2008), and they should be 
avoided in a toxicological context when either the underlying biological 
mechanisms are unknown (Kupper & Hogan, 1978) or when the two stressors 
are known to cause their effects through independent biological mechanisms 
(Blot & Day, 1979). Because we refer to both a chemical and non-chemical 
(pathogenic) stressor and our understanding of the biological basis of the 
impact of multiple stressors is incomplete, we have chosen to refer to statistical 
non-additivity between stressors by the term ‘interaction’ because it refers to 
solely an observable pattern that is mechanistically neutral and we restrict it to 
signify exclusively a positive interaction increasing bee mortality, as depicted in 
Figure 1.2. 
Most studies on pathogen load and immunocompetence have investigated 
possible mechanisms that could underlie pesticide–pathogen interactions on 
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bee survival and they have not directly investigated interactions between these 
stressors. Any toxicant that increases bee pathogen load or reduces bee 
immunocompetence is analogous to a potentiation because the toxicant 
exposure alone cannot affect pathogen load or immunocompetence in the 
absence of the pathogen. However, the term potentiation has been previously 
used restrictively to refer to toxicant–toxicant interactions (IUPAC, 2015), and it 
seems both anomalous and misleading to extend it to pathogen–toxicant 
interactions. Here we address whether a combined pesticide exposure and 
pathogen infection increases pathogen load and/or reduces 
immunocompetence as possible mechanisms leading to more-than-additive 
effects on bee survival, but avoid specifically referring to each mechanism itself 
as an interaction or potentiation. 
 
 
Figure 1.2. Hypothetical survival curve showing an interaction between 
stressors. 
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1.4.3.1. Do pesticide exposure and pathogen infection increase pathogen 
load? 
To date, this question has been investigated in the context of one of two 
pathogenic infections known to infect honey bees naturally (Nosema and viral 
infection), and one pathogen (Crithidia bombi) that naturally infects bumble 
bees, and we discuss each below. 
Most work in this area has used a model system of honey bees infected with the 
microsporidian pathogen Nosema spp. Adult workers can be infected with 
Nosema spores by ingestion relatively easily in the laboratory. Nosema spore 
count in individual honey bees has been used as an endpoint in several studies 
to represent a measure of the proliferation of Nosema infection within the host. 
The studies conducted to date show both variable and contrasting effects of 
pesticide exposure on the Nosema spore count and the effects of pesticide 
exposure on Nosema load remain unclear (Figure 1.3.A). For example, 
thiacloprid exposure has been shown to increase Nosema spore count, whilst 
fipronil exposure reduces Nosema spore count (Vidau et al., 2011). The latter 
study revealed contrasting effects on Nosema spore count despite using 
concentrations of each pesticide equivalent to approximately 1/100 of the lethal 
dose, 50% (LD50). Altering the timing of fipronil exposure and Nosema infection 
also influenced the effects observed on Nosema spore counts (Aufauvre et al., 
2012). In another study, several pollen diets from honey bee colonies were 
analysed for mixtures of pesticide residues and a ‘relative risk’ of Nosema 
infection was calculated based on relative Nosema loads in bees infected after 
consuming pollen contaminated with a specific pesticide in the laboratory. 
Whilst all of the neonicotinoids and organophosphates identified were 
associated with a reduced risk of Nosema infection, two acaricides, one 
herbicide, two cyclodiene insecticides, one pyrethroid insecticide and two 
fungicides were associated with a significantly increased Nosema load (Pettis et 
al., 2013). By contrast, a field study investigating five acaricide treatments found 
no effect of these on Nosema ceranae load (tested using a quantitative 
polymerase chain reaction (qPCR) approach) (Boncristiani et al., 2012). 
Honeybee colonies placed in close proximity to neonicotinoid-treated oilseed 
rape (Brassica napus L.) in the field did not show significantly altered levels of 
Nosema infection compared to colonies placed at other sites (Pohorecka et al., 
47 
 
2012). However, in this work, no true controls were available as even the 
colonies that were situated in areas away from treated oilseed rape were also 
found to contain neonicotinoid residues. 
Overall, there is no clear dose-dependent relationship between Nosema spore 
count and pesticide concentration based on the limited number of pesticides 
and concentrations tested (Figure 1.3.A; e.g. Pettis et al., 2012; Retschnig et 
al., 2014). In the only study attempting a laboratory–field comparison, honey 
bees originating from the same parent colonies showed context-dependent 
effects of imidacloprid exposure on Nosema spore counts (Pettis et al., 2012). 
Individual worker honey bees whose colonies had experienced imidacloprid 
exposure accumulated significantly increased spore counts after being fed 
syrup with pathogen spores in the laboratory. However, among the subset of 
experimental colonies that contracted Nosema under field conditions, average 
spore counts were, by contrast, inversely related to imidacloprid dosing (4.3, 2.9 
and 0.5 million spores per bee in control, 5 ppb imidacloprid-, and 20 ppb 
imidacloprid-dosed colonies, respectively; Pettis et al., 2012). Furthermore, 
whilst it is easy to infect individual honey bees with Nosema spores, spore loads 
seem particularly variable even within treatments. Several studies have found 
low levels of spores within control groups (e.g. Alaux et al., 2010) and in some 
cases, experimental inoculation has not resulted in an increase in the proportion 
of bees infected compared to those naturally infected (Wu et al., 2012). 
With no clear patterns across the data collectively, we argue that the use of 
spore counts has not provided a reliable measure of pesticide effects on honey 
bee colony health, nor has it yet proven to be a useful indicator of the 
mechanisms involved in any interactions between pesticide exposure and 
Nosema infection on bee survival. 
Compared to Nosema, viral pathogens in honey bees may present a more 
tractable system. Quantitation of viral load is conveniently performed using 
molecular techniques, typically qPCR. To date, the effect of pesticide exposure 
on viral load has been investigated in relation to both acaricides and the 
neonicotinoid insecticides. 
Acaricides are typically used to control Varroa mites that are an important pest 
of honey bee colonies on a global scale (with the notable exception of 
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Australia). The close association between viral infection and parasitism by the 
Varroa mite may be related to mites acting as vectors for viral transmission, as 
well as Varroa-mediated suppression of the immune response (Yang & Cox-
Foster, 2005). Hence, acaricide exposure aims to reduce the viral load of 
Varroa-associated viruses indirectly by reducing the load of Varroa mites. The 
pyrethroid acaricide tau-fluvalinate reduces Varroa numbers in honey bee 
colonies in the field, but it leads to increased loads of Deformed Wing Virus 
(DWV) and, to a lesser extent, Black Queen Cell Virus (BQCV) and Sacbrood 
virus (SBV) (Locke et al., 2012). However, loads of BQCV and SBV were highly 
variable over time, with and without acaricide treatments, making it difficult to 
draw firm conclusions about these infections. In a field experiment, five different 
acaricide treatments (applied in the absence of Varroa) had no effects on the 
loads of the pathogens tested, including DWV, BQCV and SBV (Boncristiani et 
al., 2012). Hence, the effect of acaricide exposure on viral load remains 
uncertain. 
Across the few studies to investigate the effect of neonicotinoid exposure on 
viral load, exposures at a concentration ≥ 1 ppb generally led to increased viral 
loads in honey bees (Figure 1.3.A; Di Prisco et al., 2013; Doublet et al., 2015). 
Whilst the studies of acaricides were performed on colonies under field 
conditions, the effect of neonicotinoid exposure on viral load has been 
investigated only in a laboratory setting in the absence of Varroa mites, allowing 
for differentiation between effects of parasitism by Varroa and pesticide 
exposure. Given that there is a positive correlation between Varroa and viral 
loads (Francis et al., 2013) and Varroa is endemic to honey bee populations in 
many parts of the world, further work is needed to investigate the combined 
effects of neonicotinoid exposure and parasitism by Varroa on viral loads in a 
field setting, as well as to understand how changes in viral load affect colony 
health. 
Pesticide exposure has not been observed to increase pathogenic infection in 
bumble bees, but this has been investigated only in relation to laboratory 
infection with the trypanosome gut parasite Crithidia bombi. Susceptibility of 
worker bumble bees to C. bombi and the intensity of C. bombi infection within 
individual bees was not affected by exposure to the neonicotinoids 
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thiamethoxam and clothianidin or the pyrethroid λ-cyhalothrin (Baron et al., 
2014; Fauser-Misslin et al., 2014). 
  
50 
 
 
Figure 1.3. See legend overleaf. 
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Figure 1.3. (previous page). Scatterplots of observed effects of neonicotinoids 
and fipronil on (A) bee pathogen load, (B) bee immunity and (C) bee mortality, 
based on data from Alaux et al. (2010), Aufauvre et al. (2012), Di Prisco et al. 
(2013), Doublet et al. (2015), Gregorc et al. (2012), Pettis et al. (2012), 
Retschnig et al. (2014) and Vidau et al. (2011). The observed effects at each 
pesticide concentration are based on the significance levels as defined within 
each publication. Different shapes used for each data point are used to show 
the different pesticide/pathogen combinations and/or endpoints used in each 
publication. The upper range of pesticide concentrations expected in nectar in 
the field, as shown by the vertical dashed lines, are approximations based on 
residue analysis from previous studies: fipronil (1 ppb) (Chauzat et al., 2011), 
clothianidin (5 ppb) (Cutler & Scott-Dupree, 2007; Pohorecka et al., 2012), 
imidacloprid (10 ppb) (Blacquiere et al., 2012; Pohorecka et al., 2012), 
thiacloprid (100 ppb) (Skerl et al., 2009; Pohorecka et al., 2012). AMP, 
antimicrobial peptides; BCQV, Black Queen Cell Virus; DWV, Deformed Wing 
Virus; GOX, glucose oxidase; PPOact, prophenoloxidase-activating enzyme, 
PO, phenoloxidase; THC, total haemocyte count. 
 
 
 
1.4.3.2. Do pesticide exposure and pathogenic infection reduce bee 
immunocompetence? 
Immunocompetence is the ability to mount an immune response (Wilson-Rich et 
al., 2009). If pesticide exposure leads to reduced immunocompetence, this 
could lead to increased susceptibility to pathogenic infection, potentially 
impacting on individual and colony survival. The individual bee’s immune 
response is comprised of cellular responses such as phagocytosis and 
encapsulation, and humoral responses via both the prophenoloxidase cascade 
(leading to melanisation) and antimicrobial effectors (Figure 1.4.). Whilst not an 
immune response per se, individual bees may also respond to pathogenic or 
parasitic attack through changes in their behaviour, for example, by grooming 
themselves to remove ectoparasitic mites (Danka & Villa, 2003). In addition to 
these individual responses, social immunity in eusocial bee species such as 
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honey bees also plays a key role in defence against pathogens and parasites. 
These social defences may explain the dearth of individual immune genes 
found in the honey bee compared to other insects, such as fruit flies and 
mosquitoes (Evans et al., 2006). For example, gland secretions, such as 
glucose oxidase, are thought to act as a form of social immunity by sterilising 
colony honey supplies (White et al., 1963). Social behaviours, such as 
grooming of colony members, also play an important role in the defence of 
honey bee colonies against pathogenic and parasitic attack (see review by 
Cremer et al., 2007). 
Here, we assess whether these various components of the bee immune 
response are responsive to pesticide exposure as measured by enzymatic 
(physiological) and/or transcriptomic (molecular) endpoints. This assessment 
solely addresses honey bee immunocompetence as there has been no reported 
investigation of non-Apis species. 
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Figure 1.4. Schematic of the honey bee immune response, including 
identification of those components shown to be affected by pesticides in other 
insect species and/or specifically in honey bees. AmPPO, Apis mellifera 
prophenoloxidase gene; Imd, immune deficiency; JAK/STAT, Janus kinase/ 
Signal transduction and transcription; JNK, c-Jun N-terminal kinases; LLR, 
leucine-rich repeats; PPOact, prophenoloxidase-activating enzyme; RNAi, 
Ribonucleic acid interference. 
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1.4.3.2.1. Individual immunity 
Haemocytes provide the cellular defence and are involved in the recognition of 
foreign surfaces, phagocytosis of small microbial targets, and the nodulation 
and encapsulation of larger bacteria and parasites. Production of haemocytes is 
often coupled with melanin production, catalysed by phenoloxidase enzymes, to 
seal wounding sites and suffocate or starve parasites by blocking nutrient 
absorption (reviewed by Gillespie et al., 1997; Kanost & Gorman, 2008). As yet, 
pesticide exposure has not reportedly affected the cellular and 
prophenoloxidase components of the bee immune response at a physiological 
level (Alaux et al., 2010). The expression of several gene candidates involved in 
the functioning of honey bee haemocytes and/or the phenoloxidase cascade 
has been altered by pesticide exposure (Table 1.2.), but typically in the absence 
of pathogenic infection and the biological and ecological relevance of these 
transcriptional changes remains unclear. Several pesticides, such as insect 
growth regulators, have been observed to affect components of the cellular 
immune response and prophenoloxidase cascade in other insect species, such 
as moths (James & Xu, 2012; Figure 1.4.), but bees are not at current risk of 
exposure to many of these pesticide types. Further research is needed to 
understand whether the effects observed in the expression of some immune 
genes in bees (Table 1.2.) relate to changes in haemocyte function and have 
significance for the phenoloxidase system of the immune response. 
The second major component of the individual immune response involves the 
induction of antimicrobial peptides (AMPs). Several AMP genes have been 
observed to increase in expression following challenges with bacteria (Evans, 
2004, 2006), fungi (Bull et al., 2012; Evans, 2006) and microsporidia (Antunez 
et al., 2009) and increased AMP protein levels have been observed when bees 
were artificially infected with bacteria (e.g. Gatschenberger et al., 2012; 
Laughton et al., 2011; Randolt et al., 2008). In bumble bees, AMP genes were 
also upregulated following challenge with trypanosomal gut parasites (Riddell et 
al., 2009; Riddell et al., 2011). AMPs are synthesised primarily by the fat body, 
and also by haemocytes, the Malpighian tubules and midgut (Gillespie et al., 
1997), which are also major sites of pesticide detoxification (e.g. Hodgson, 
1983; Mao et al., 2011). Potentially, there may be trade-offs in the allocation of 
resources for pesticide detoxification and the AMP immune response when 
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bees are simultaneously exposed to a pesticide and pathogenic infection. 
Additionally, exposure to imidacloprid has been found to degenerate the honey 
bee Malpighian tubules (Rossi et al., 2013), which may compromise AMP 
production. However, there has been no previous investigation of the effects of 
pesticide exposure on AMP activity in any insect species at a physiological 
level. Furthermore, most studies have observed no changes in honey bee AMP 
gene expression following pesticide exposure (e.g. Figure 1.3.B; Table 1.2.), in 
a wide range of contexts including field studies with five different acaricide 
treatments (Boncristiani et al., 2012), laboratory studies in larvae exposed to 
acaricides, fungicides or neonicotinoids (Gregorc et al., 2012), and in adult 
workers topically exposed to the organophosphate chloropyrifos (Di Prisco et 
al., 2013). Despite these findings, there is some evidence to support the 
hypothesis that pesticide exposure alters the AMP component of the honey bee 
immune response at a molecular level (Figure 1.3.B; Table 1.2.). Dietary 
exposure to the neonicotinoid, imidacloprid, led to increased transcription of the 
gene coding for the AMP abaecin in larvae (Derecka et al., 2013), whilst topical 
exposure to another neonicotinoid, clothianidin, led to reduced transcription of 
the gene coding for the AMP apidaecin in adult workers (Di Prisco et al., 2013). 
Furthermore, exposure to the pyrethroid acaricide flumethrin led to increased 
expression of the AMP hymenoptaecin in nurse bees (Garrido et al., 2013). The 
few studies to observe pesticide effects on AMP gene expression however, did 
not include exposure to a natural pathogenic infection. Furthermore, those 
studies typically only tested and/or observed effects in a single AMP gene, but 
nine antimicrobial effector genes have been identified in the honey bee (Evans 
et al., 2006). There are therefore insufficient data to assess whether AMP gene 
expression in general is affected in a dose-dependent manner, or indeed 
whether the observed effects are repeatable (Figure 1.3.B). Furthermore, it 
remains unclear whether expression of a single AMP gene provides a relevant 
representation of the antimicrobial effector repertoire as a whole, and/or 
whether specific AMPs have greater biological relevance to colony strength 
than others. For example, colonies with larvae exhibiting higher transcript levels 
of the AMP abaecin were found to have lower infection with the natural bacterial 
pathogen, Paenibacillus larvae, but this correlation with lower infection rates 
was not observed for the AMP defensin (Evans & Pettis, 2005). More studies 
comparing molecular changes with protein levels at the individual and colony 
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level are needed to demonstrate the biological relevance of changes in AMP 
levels to colony strength and, ultimately, population survival.  
Various other proteins are integral to the individual immune response to specific 
pathogens and they too could provide potential insights into the mechanistic 
understanding of pesticide–disease interactions. For example, recognition of 
pathogen surface molecules is a fundamental step in combating pathogens, 
leading to activation or upregulation of immune effector proteins (Evans et al., 
2006; Figure 1.4.). β-glucan recognition proteins (βGRPs), galectins and 
fibrinogen-related proteins, Toll and Toll-like receptor (TLR) genes and 
peptidoglycan recognition proteins (PGRPs) have all been identified in the 
honey bee genome (Evans et al., 2006). The expression of a peptidoglycan 
recognition protein (PGRP-LC) has been observed to increase following 
neonicotinoid exposure (Derecka et al., 2013; Table 1.2.), and this component 
of immunocompetence also may warrant further investigation. 
Overall, there is some evidence that genes associated with individual immunity 
are differentially expressed following pesticide exposure, but the functional 
significance of these changes remains unclear. Furthermore, there has been a 
lack of investigation of the effects of pesticide exposure on individual immunity 
in the presence of pathogenic infection, so the combined effects of these two 
stressors on individual immunity is not well understood. 
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Table 1.2. Summary of effects of pesticide exposure on expression of immune-
related genes. 
 
Gene Expected role of gene Pesticide(s) 
Observed 
effect on 
gene 
expressio
n 
Reference 
PPOact 
Involved in phenoloxidase 
cascade/melanisation 
Imidacloprid, myclobutanil, chlorothalonil ↑ 
Gregorc et al. 
(2012) 
Chlorpyrifos, amitraz, fluvalinate, coumaphos, 
glyphosate, simazine 
---- 
Dscam 
Haemocyte-specific loss of 
Dscam impairs 
phagocytosis of bacteria in 
fruit flies (Watson et al., 
2005) * 
Thymol, tau-fluvalinate ↓ 
Boncristiani et al. 
(2012) 
Imidacloprid, myclobutanil, chlorothalonil, chlorpyrifos, 
amitraz, fluvalinate, coumaphos, glyphosate, simazine, 
formic acid 
---- 
Boncristiani et al. 
(2012), Gregorc et 
al. (2012) 
Basket 
Involved in JNK pathway 
[feedback to melanisation 
and antimicrobial effectors 
(Evans et al., 2006)] 
Thymol, tau-fluvalinate ↓ 
Boncristiani et al. 
(2012) 
Imidacloprid, myclobutanil, chlorothalonil, chlorpyrifos, 
amitraz, fluvalinate, coumaphos, glyphosate, simazine, 
formic acid 
---- 
Boncristiani et al. 
(2012), Gregorc et 
al. (2012) 
Vitellogenin 
Many functions, including as 
a zinc carrier to maintain 
haemocyte function 
(Amdam et al., 2004) and in 
reducing oxidative stress 
(Seehuus et al., 2006) 
Thymol, tau-fluvalinate ↓ 
Boncristiani et al. 
(2012) 
Imidacloprid, myclobutanil, chlorothalonil, chlorpyrifos, 
amitraz, fluvalinate, coumaphos, glyphosate, simazine, 
formic acid, flumethrin 
---- 
Boncristiani et al. 
(2012), Garrido et 
al. (2013), Gregorc 
et al. (2012) 
Hymenoptaecin Antimicrobial effector 
Flumethrin (pyrethroid acaricide) ↑ 
Garrido et al. 
(2013) 
Imidacloprid, myclobutanil, chlorothalonil, chlorpyrifos, 
amitraz, fluvalinate, coumaphos, glyphosate, simazine, 
flumethrin 
---- 
Garrido et al. 
(2013), Gregorc et 
al. (2012) 
Abaecin Antimicrobial effector 
Imidacloprid (neonicotinoid insecticide) ↑ 
Derecka et al. 
(2013) 
Imidacloprid, myclobutanil, chlorothalonil, chlorpyrifos, 
amitraz, fluvalinate, coumaphos, glyphosate, simazine, 
flumethrin 
---- 
Garrido et al. 
(2013), Gregorc et 
al. (2012) 
Apidaecin Antimicrobial effector 
Clothianidin (neonicotinoid insecticide) ↓ 
Di Prisco et al. 
(2013) 
Imidacloprid, myclobutanil, chlorothalonil, chlorpyrifos, 
amitraz, fluvalinate, coumaphos, glyphosate, simazine 
---- 
Di Prisco et al. 
(2013), Gregorc et 
al. (2012) 
PGRP-LC 
Peptidoglycan recognition 
protein 
Imidacloprid (neonicotinoid insecticide) ↑ 
Derecka et al. 
(2013) 
Imidacloprid, myclobutanil, chlorothalonil, chlorpyrifos, 
amitraz, fluvalinate, coumaphos, glyphosate, simazine 
---- 
Gregorc et al. 
(2012) 
Defensin2 Antimicrobial effector 
Imidacloprid, myclobutanil, chlorothalonil, chlorpyrifos, 
amitraz, fluvalinate, coumaphos, glyphosate, simazine, 
formic acid, flumethrin 
---- 
Boncristiani et al. 
(2012), Garrido et 
al. (2013), Gregorc 
et al. (2012) 
Cactus 
IkB transcription factor 
 
Imidacloprid, myclobutanil, chlorothalonil, chlorpyrifos, 
amitraz, fluvalinate, coumaphos, glyphosate, simazine, 
formic acid 
---- 
Boncristiani et al. 
(2012), Gregorc et 
al. (2012) 
Tab; Domeless 
Tab Tak1- binding protein; 
Domeless JAK/STAT 
signalling pathway 
Thymol, tau-fluvalinate, coumaphos, formic acid, 
amitraz 
---- 
Boncristiani et al. 
(2012) 
Other immune 
genes, including 
Eater, 
Defensin1, 
Dorsal-1, 
Hopscotch, 
PGRPSC 
Involved in several immune 
pathways 
Imidacloprid, myclobutanil, chlorothalonil, chlorpyrifos, 
amitraz, fluvalinate, coumaphos, glyphosate, simazine 
---- 
Gregorc et al. 
(2012) 
 
*But note, bacterial infection previously not shown to affect Dscam expression 
in honey bees (Evans et al., 2006). 
↑= increase in expression. ↓=decrease in expression. ---- = no effect on 
expression. Significance values associated with these effects are defined in the 
appropriate references. 
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Dscam, Down syndrome cell adhesion molecule; IkB, I kappa B; JAK/STAT, 
Janus kinase/ Signal transduction and transcription; JNK, c-Jun N-terminal 
kinases; PGRP-LC, peptidoglycan recognition protein LC; PGRPSC, 
peptidoglycan recognition protein SC; PPOact, prophenoloxidase-activating 
enzyme; Tak1, TGFbeta Activated Kinase 1. 
 
 
1.4.3.2.2. Social immunity 
Glucose oxidase is secreted from the honey bee hypopharyngeal gland (Ohashi 
et al., 1999), and is involved in the conversion of nectar to honey, catalysing the 
production of gluconic acid and hydrogen peroxide. Together, gluconic acid and 
hydrogen peroxide give honey antimicrobial properties, so sterilising brood food 
and colony honey supplies, and acting as a form of social immunity (White et 
al., 1963). Environmentally realistic concentrations of imidacloprid have been 
found to affect the development of the honey bee hypopharyngeal gland 
(Heylen et al., 2011; Skerl & Gregorc, 2010; Hatjina et al., 2013). However, only 
a single study to date has considered the effects of pesticide exposure on 
honey bee social immunity using the level of glucose oxidase activity as an 
endpoint. In that study, imidacloprid exposure reduced glucose oxidase activity 
when coupled with Nosema infection (Alaux et al., 2010). Further work is 
needed to elucidate the link between the effects of pesticide exposure on 
hypopharyngeal gland development and gland secretions, including glucose 
oxidase, and the consequences of these effects for colony health. 
 
1.4.3.2.3. Behavioural defences as a form of individual and social 
immunity 
Given that behavioural defences have received significant attention in the 
literature for their role in honey bee defence against disease, it also seems 
relevant here briefly to assess the effect of pesticide exposure on behavioural 
endpoints relevant to social immunity. In termites and beetle larvae, exposure to 
imidacloprid is known to reduce grooming behaviours, leading to increased 
susceptibility to infection and parasitism (Boucias et al., 1996; Koppenhofer et 
al., 2000; Neves & Alves, 2000). Honey bees groom both themselves (Danka & 
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Villa, 2003) and other colony members (Khongphinitbunjong et al., 2012) to 
remove mites, as well as perform other social defence behaviours such as the 
uncapping and removal of infected pupae and adult corpses (e.g. Ibrahim & 
Spivak, 2006; Trumbo et al., 1997) and the collection of antimicrobial plant 
resins to form propolis for nest building (Simone et al., 2009). Neonicotinoid 
exposure has been shown to affect foraging behaviour of honey bees in a dose-
dependent manner when exposed as single oral treatments (Bortolotti et al., 
2003; Henry et al., 2012; Schneider et al., 2012; Yang et al., 2008). However, 
there has been no previous investigation of effects of pesticide exposure on 
social defence behaviours in honey bees or other bee species. Social defence 
behaviours are ecologically relevant at the colony level because colonies bred 
for hygienic behaviour have demonstrated resistance to American Foulbrood 
and greater honey production than non-hygienic colonies (Spivak & Reuter, 
2001). We therefore argue that it seems appropriate to prioritise further 
investigation of pesticide effects on social defence behaviours that are known to 
alter colony functioning. Established behavioural assays could be easily 
adapted to provide a simple, cost-effective and biologically relevant endpoint for 
future investigations. 
 
1.4.3.2.4. Summary 
Pesticide exposure and pathogenic infection, when investigated separately, 
may alter expression of genes associated with the individual immune response, 
but there is no evidence that pesticide exposure reduces immunocompetence 
following natural pathogen infection in the context of honey bee individual 
immunity at a physiological level, or individual or social defence behaviours. 
Pesticide exposure coupled with pathogenic infection has been shown to 
reduce social immunity in the laboratory, but the ecological relevance of this 
finding to honey bee colonies remains unclear. 
 
1.4.3.3. Do pesticide exposure and pathogenic infection interact to 
reduce bee survival? 
To date, this question has been investigated in the context of one of two 
pathogenic infections known naturally to infect honey bees (Nosema and viral 
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infection), and one pathogen (C. bombi) that naturally infects bumble bees; we 
discuss each below. 
The available laboratory data show that Nosema infection interacts with 
exposure to a sublethal concentration of phenylpyrazole (fipronil) or 
neonicotinoid (imidacloprid or thiacloprid) to reduce honey bee worker survival 
(Figure 1.3.C; Alaux et al., 2010; Aufauvre et al., 2012; Doublet et al., 2015; 
Retschnig et al., 2014; Vidau et al., 2011). However, the interaction has only 
been observed in laboratory studies in which pesticide exposures far exceed 
environmentally realistic scenarios in the field, with the exception of the two 
studies on fipronil (Aufauvre et al., 2012; Vidau et al., 2011; Figure 1.3.C). Two 
field experiments using field-realistic exposures have, by contrast, found no 
interaction (Pettis et al., 2012; Wu et al., 2012). 
Additive effects reducing honey bee survival have been observed in the 
laboratory between pesticide exposure and viral infection, including between the 
pyrethroid cypermethrin and Chronic Paralysis Virus (CPV) (Bendahou et al., 
1997), and the neonicotinoid thiacloprid and BQCV (Doublet et al., 2015), but 
no interaction has been observed (Figure 1.3.C). 
An artificial challenge with Escherichia coli lipopolysaccharides (LPS) interacted 
with oral exposure to the natural plant toxin nicotine to reduce honey bee 
survival (Koehler et al., 2012). Nicotine and the neonicotinoid pesticides have a 
similar mode of action on the insect nicotinic acetylcholine receptors and LPS 
has been used in several studies to elicit a bacterial-like immune response (e.g. 
Laughton et al., 2011). We hypothesise that neonicotinoid exposure in 
combination with natural bacterial infections could lead to similar effects on 
honey bee survival, but this has not been tested yet. 
Lastly, there was no observed interaction between neonicotinoid exposure and 
C. bombi infection on the production of bumble bee workers, gynes and males. 
However, queen longevity was lower when bumble bee colonies were exposed 
in the laboratory to both neonicotinoid exposure and C. bombi infection (Fauser-
Misslin et al., 2014). 
 
1.4.4. Conclusions 
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(1) We demonstrate that through a combination of laboratory and field studies 
understanding is progressing on the extent to which bee populations are 
impacted in realistic scenarios of pesticide exposure and natural pathogenic 
infection. Laboratory studies are serving to isolate the possible underlying 
mechanisms of effects and to establish the direction of future work by 
elucidating potential pesticides and pathogens of concern to bee health and 
recognising informative endpoints. Laboratory studies allow also the opportunity 
to test pesticide effects against true no-pesticide controls, which is often not 
possible in field experiments due to the increasingly ubiquitous nature of 
residues in field colonies, as highlighted by Pohorecka et al. (2012). Field trials, 
however, establish ecological relevance for the laboratory-based findings, and 
we argue that field studies should increase if we are to close some of the very 
significant knowledge gaps in this research area. 
(2) Effects of pesticide exposure and pathogenic infection on bee health vary 
among studies (Figure 1.3.), often making it difficult to draw conclusions on 
interactive or dose-dependent effects. Whilst some of this variation may result 
from different exposure and infection regimes, differences in the developmental 
stages of insects studied, and differences in approaches adopted, we also show 
that some endpoints, namely Nosema and viral pathogen loads, appear to be 
inherently variable. It is possible that both genetic and seasonal variation in the 
experimental bees may account for some of the differences seen among 
studies and in their susceptibility to pesticide exposure and pathogen infection. 
However, it remains unclear whether the variation within and among studies is 
methodological or inherent. The methodologies have not been explicitly 
contrasted herein, but features we suspect could lead to variation include the 
mode and timing of pesticide exposure and pathogenic infection, such as 
contact versus oral exposures/infections and the initial levels of infection 
administered. Similarly, it was not possible herein explicitly to contrast the 
genetic background of bees within each study, which could have a bearing on 
the results reported. In the studies reviewed investigating Nosema pathogen 
load various different honey bee races were used, including A. mellifera carnica, 
A. mellifera ligustica, A. mellifera mellifera and Buckfast hybrids (Alaux et al., 
2010; Doublet et al., 2015; Vidau et al., 2011). To understand better the extent 
of methodological and/or natural variation in some of the endpoints, future 
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studies may benefit from an increasingly standardised approach. A recent 
publication (Dietemann et al., 2013) contains specific chapters for toxicology 
studies (Medrzycki et al., 2013), molecular studies (Evans et al., 2013) and 
study of specific honey bee pathogens (e.g. Fries et al., 2013) and this may 
help to standardise approaches in honey bee research methods. 
Standardisation of terms to describe the interactions between pesticide 
exposure and pathogen infection on bee health will harmonise interpretations of 
the same interactions, such as additive versus more-than-additive effects. 
(3) Some areas for understanding pesticide–pathogen interaction in bees have 
received relatively little attention. Further investigation of pesticide effects on 
bee social defence behaviours and the antimicrobial peptide (AMP) component 
of the individual immune response are important, as these endpoints in 
particular have shown the potential to respond to pesticide exposure and to 
impact bee health at the colony level. We would also encourage further 
investigation to elucidate colony-level effects on social immunity due to 
pesticide-induced changes in hypopharyngeal gland development. 
(4) To date, there has been no investigation of interactions between pesticide 
exposure and infection with bacterial or fungal pathogens, despite their 
prevalence amongst the most common causal agents of bee disease (Table 
1.1.), and we highlight this as a knowledge gap worthy of future investigation. 
Upregulation of AMPs is thought to be important in response to bacterial 
infection (Evans et al., 2006; Korner & Schmid-Hempel, 2004), so we propose 
that our mechanistic understanding of any potential interactions between 
pesticide exposure and bacterial infection could benefit from the integrated 
investigation of the AMP component of the immune response. Furthermore, the 
most prevalent bacterial and fungal infections, including foulbrood and 
chalkbrood diseases, are symptomatic in honey bee larvae (Table 1.1.), so 
investigations on larval survival, pathogen load and immunocompetence may 
provide useful insights. 
(5) Our review highlights the lack of assessment of non-Apis bee species. Other 
bee species have considerable roles in providing pollination services and 
increased bee diversity is associated with increased pollination success (Klein 
et al., 2003). In fact, native bee species alone are capable of pollinating 
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intensively farmed crops in the absence of managed honey bees (Winfree et al., 
2007). Consideration of Bombus and other wild bee species in the investigation 
of interactions between pesticide exposure and pathogenic infection would be 
extremely valuable because susceptibility to specific pathogens and parasites, 
and risk of exposure and sensitivity to specific pesticides, differs among species 
(Cresswell et al., 2012). 
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1.5. Thesis aims 
Having identified several knowledge gaps in our understanding of pesticide 
exposure as a potential stressor impacting upon bee health, the central aim of 
this thesis is to investigate sublethal effects of neonicotinoid exposure on honey 
bees and bumble bees, and to establish the relevance of different sublethal 
endpoints as appropriate ecotoxicological markers for risk assessment. In 
particular, this thesis focuses on the study of neonicotinoid exposure in 
combination with immune stressors, as a combination of stressors more likely 
reflects realistic ecological scenarios. This thesis addresses the following 
specific aims: 
1) To establish whether exposure to two neonicotinoids, imidacloprid and 
thiamethoxam, impacts on immune-related gene expression and enzymatic 
activity in adult workers of the honey bee, Apis mellifera. This work will 
investigate effects on two key components of the insect immune response, the 
phenoloxidase cascade and antimicrobial effectors. It will better our 
understanding of the relationships between the temporal dynamics of 
transcriptional and physiological changes in the immune response, providing a 
foundation to understanding the potential regulatory value of gene expression 
bioassays as indicators of pesticide effects on honey bee health. 
2) To establish whether exposure to the neonicotinoid, imidacloprid,  
impacts on the immune response of adult workers of the bumble bee, Bombus 
terrestris. This work will investigate effects on two key components of the insect 
immune response, the phenoloxidase cascade and antimicrobial effectors, 
providing new insights into the value of these physiological endpoints in the 
pesticide risk assessment of sublethal effects on non-Apis species. 
3) To establish whether exposure to the neonicotinoid, imidacloprid, 
impacts on gene expression, enzymatic activity and flight behaviour associated 
with the development of the hypopharyngeal glands and their roles in temporal 
polyethism, nutrition and social immunity in the honey bee, Apis mellifera. This 
work aims also to improve our understanding of the social immune response to 
infection, and investigates a novel approach using Radio Frequency 
Identification (RFID) technology to monitor life-long behaviours of honey bees 
following chronic pesticide exposures. 
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4) To identify the genes that are differentially expressed across the 
transcriptome of adult workers of the honey bee, Apis mellifera, following 
immune challenge, neonicotinoid exposure or a combination of both stressors. 
This work will investigate effects of two neonicotinoids, imidacloprid and 
thiamethoxam, and aims to elucidate potential functions and molecular 
pathways that are altered by immune and chemical stressors, and reveal 
candidate genes of potential value as biomarkers for risk assessment. 
 
Collectively, this work uses an artificial immune challenge via an injection with 
lipopolysaccharides (LPS) from E.coli to aim to mimic a bacterial-like infection. 
This approach standardises the invoking of an immune response across 
individual bees and excludes the dynamic behaviour of a real pathogen. The 
data presented in this thesis therefore does not aim to unfold exact biological 
mechanisms associated with specific natural infections, but rather provides an 
understanding of the general dynamics of pesticide-pathogen interactions using 
a well-established method for insect immune studies. 
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2. Methods development and assay validations 
A variety of physiological and molecular assays have been used in the study of 
bees as informative endpoints for bee health (e.g. Laughton and Siva-Jothy, 
2011, Alaux et al., 2010, Evans, 2006). Subsequent work described in this 
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thesis aimed to use a selection of assays to measure relative physiological 
activity and gene expression in bees in response to immune and chemical 
stressors, to investigate different components of bee physiology and behaviour 
and assess their suitability as appropriate ecotoxicological markers for risk 
assessment. Here I describe in detail and critically discuss the development, 
optimisation and validation of these assays, which formed a significant part of 
the research for this thesis, to provide relevant context for understanding their 
application to the hypotheses addressed and to help support a critical 
evaluation of the data obtained and interpretation of those data. 
2.1. Method of immune elicitation 
An artificial immune challenge via an injection with lipopolysaccharides (LPS) 
from Escherichia coli was used as an immune elicitor, as described later in the 
relevant methods sections of the thesis. This approach was adopted to 
standardise the stimulus used to invoke a response in individual bees and to 
minimise the treatment variation inherent in using a real pathogen, which can be 
logistically difficult to control. Nevertheless, this artificial immune elicitor has 
relevance to the modes of action of the major pathogens and parasites of the 
two model bee species used. For example, the injection procedure involves a 
wounding of the bee’s pleural membrane, which is comparable to the wounding 
likely to occur during the parasitism of honey bees by, for example, Varroa 
mites and the parasitism of bumble bees by, for example, conopid flies. These 
wounding events during parasitic attack are unlikely to be sterile, and therefore 
exposure to pathogens, such as bacteria, is likely. Furthermore, two bacterial 
infections, Paenibacillus larvae and Melissococcus plutonius, are considered 
major threats to honey bee colony losses (see Chapter 1). 
2.2. Measurement of phenoloxidase activity 
Measurement of the phenoloxidase system of the honey bee immune response 
has previously been described using a spectrophotometry assay (Laughton and 
Siva-Jothy, 2011). This measures the conversion of a colourless test substrate, 
L-Dopa (3,4-dihydroxy-L-phenylalanine) to dopachrome (red-brown in colour), 
which is catalysed by the phenoloxidase (PO) enzymes contained in a 
haemolymph sample. This PO is present in insect haemolymph as an inactive 
precursor enzyme, prophenoloxidase (proPO), and the combination of proPO 
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and PO in a sample can be measured by first activating any proPO in the 
sample to PO, using a chemical activator, α-chymotrypsin (Laughton and Siva-
Jothy, 2011). However, inherent difficulties are thought to arise in quantification 
of haemolymph enzyme activity since methods of haemolymph collection often 
involve wounding of the individual, which itself can activate or upregulate 
enzyme activity. Several methods have been used in the literature to collect 
haemolymph samples for PO analysis in bumble bees and honey bees, 
including homogenisation of the thorax in a buffer solution (Korner and Schmid-
Hempel, 2004), collection of neat haemolymph (Korner and Schmid-Hempel, 
2004) and a perfusion bleed in which a buffer is flushed through the thorax and 
abdomen (Laughton et al., 2011). Here, pilot studies were set up to compare 
the measurement of proPO and PO in samples collected using different 
methods. This aimed, firstly, to establish the most suitable method to minimise 
activation of proPO during sample collection, and secondly, to establish whether 
a method of haemolymph collection could be used to measure both PO activity 
and antimicrobial activity (see section 2.2.) from the same individual bee. The 
different sampling methods could not be performed on the same individual 
bees, but by collecting samples from different bees using the different 
techniques we aimed to identify any obvious differences in the suitability of each 
technique, despite likely variation in the PO activity of individual bees. 
Phenoloxidase (PO) and total potential phenoloxidase response (total 
proPO/PO) could be measured for each individual bee. Three collection 
methods were investigated. First, the thorax was homogenised by hand in a 
buffer solution. Second, neat haemolymph was collected with a pipette by 
cutting a small slit in the abdominal tergites and placing gentle pressure to the 
thorax to release a bubble of haemolymph through this slit. Third, a perfusion 
bleed method was adopted, whereby a microsyringe and needle were used to 
insert a buffer solution between the head and thorax, and this solution was 
flushed through the body and collected along with the haemolymph. 
2.2.1. Thorax homogenisation 
There was a trend towards higher measures of PO activity in samples collected 
using a thorax homogenisation approach compared with collection of neat 
haemolymph or via a perfusion bleed. It is possible that this resulted from the 
presence of cuticular PO, since PO also has an important role in melanin 
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biosynthesis used in cuticle hardening (sclerotization) and pigmentation of the 
insect exoskeleton (Sugumaran, 2002). To avoid this potential source of PO 
activity in an assay intended to inform on immune function, the use of a thorax 
homogenisation method was ruled out. 
2.2.2. Neat haemolymph collection 
In neat haemolymph samples, similar levels of total proPO/PO and PO activity 
were measured (Figure 2.1.A.). This was contrary to expectation that measures 
of total proPO/PO activity would be considerably higher than those of PO only, 
as the former would include measurement of inactive proPO titres, as was 
indeed found in samples collected using the thorax homogenisation or perfusion 
bleed approaches. It is assumed that the much higher activity measured in the 
PO assay following neat haemolymph collection reflects a significant activation 
of proPO titres during the wounding caused by the process of neat haemolymph 
collection. Here it is likely that most of the proPO was activated to PO, and 
hence the two assays were essentially measuring the same overall total 
proPO/PO response (the collection technique itself acting as an equivalent 
proPO activator to the addition of α-chymotrypsin).  
2.2.3. Perfusion bleed approach 
Activity was higher in the total proPO/PO assay compared to PO alone, 
demonstrating that there was significant titre of proPO in the sample not 
activated to PO during the sample collection. Despite the much lower Vmax 
values in the PO assay, these were significantly greater than those observed in 
control wells in which samples were replaced by a buffer solution. It is 
recognised that even these (lower) PO titres could result from proPO activation 
during sample collection, but this is a limitation of any collection method that 
cannot be fully excluded. Nevertheless, this thesis aims only to compare relative 
activity levels between samples, not directly quantify natural PO titres. Hence, 
any observed differences in PO between experimental treatments can be 
assumed to be true differences as the level of proPO activation during sample 
collection should be consistent across samples. 
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It was concluded that the results of this pilot work, in conjunction with the 
standardised protocol outlined by Laughton and Siva-Jothy (2011), provided 
sufficient evidence that the perfusion bleed approach would be the most 
appropriate collection method for measurement of PO activity in bees. Perfusion 
bleeds allowed distinction between the measurement of PO titres only and total 
proPO/PO titres, and reduced the risk of measuring cuticular PO, that in turn, 
could lead to overestimation of the PO component of the immune response. 
To validate the assay as an appropriate measure of relative differences in PO 
activity between samples, a two-fold dilution series of a single pooled 
haemolymph sample was prepared in sodium cacodylate (NaCac) buffer, and 
PO and total proPO/PO subsequently measured. Each measure was taken 
using four technical replicates (to confirm the repeatability of the method). As 
expected, there was a significant linear relationship between the sample input 
and both the measured PO activity (Figure 2.1.C; Linear regression: R2 = 0.991, 
P < 0.001) and the measured total proPO/PO activity (Figure 2.1.D; Linear 
regression: R2 = 0.996, P < 0.001). This was also evident visually from the 
respective colour changes of each dilution, with the most concentrated samples 
leading to a greater conversion of the colourless L-Dopa substrate to the dark 
red dopachrome (Figure 2.1.B). From this pilot work, it was concluded that the 
protocols used were appropriate and they were adopted for future work to 
investigate the phenoloxidase activity in bees subjected to immune and 
chemical stressors, as described later in this thesis. 
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Figure 2.1. Measurement of phenoloxidase activity. A. Comparison of neat 
haemolymph and perfusion bleed sampling collection methods for both the PO 
and total proPO/PO assays (Mean ± SE). B. Photograph of the dilution series 
plate following spectrophotometry. C. Dilution series measuring PO activity of a 
single sample (Mean of four replicates ± SE). D. Dilution series measuring total 
proPO/PO activity of a single sample (Mean of four replicates ± SE). Trend lines 
show linear lines of best fit.  
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2.3. Measurement of antimicrobial activity 
Antimicrobial peptide (AMP) activity has previously been quantified using an 
established assay, measuring the inhibition of bacterial or fungal growth on an 
agar plate containing wells of haemolymph samples (e.g. Moret and Schmid-
Hempel, 2000, Rees et al., 1997, Mallon et al., 2003, Gatschenberger et al., 
2012). In each case, these growth inhibition assays assume a concentration 
related increase in inhibition with higher levels of antimicrobial activity. The 
sensitivity of antimicrobial activity assays, however, may be highly dependent 
on both the growth medium and the bacterial strains used (Casteels et al., 
1990, Taormina et al., 2001) and previous studies have used several bacterial 
species to measure AMP activity in bumble bees and honey bees. These 
bacterial species have been typically used as they can be readily cultured in the 
laboratory and they are sensitive to bee antimicrobial proteins, and they include 
Arthrobacter globiformis  (Moret and Schmid-Hempel, 2000, Korner and 
Schmid-Hempel, 2004, Mallon et al., 2003, Laughton et al., 2011), Escherichia 
coli (Rees et al., 1997, Gatschenberger et al., 2012, Randolt et al., 2008), 
Micrococcus flavus (Randolt et al., 2008, Gatschenberger et al., 2012), 
Micrococcus luteus (Rees et al., 1997) and Staphylococcus aureus (Stow et al., 
2007, McCleskey and Melampy, 1939). For work measuring antimicrobial 
responses in bees in this thesis, we aimed to adopt previously described 
protocols to ensure a reliable culture of bacterial strains that are sensitive to bee 
antimicrobial activity. Given that pilot work described earlier concluded that 
perfusion bleeds were the most appropriate technique of haemolymph collection 
for measuring PO activity, in some further pilot work we investigated whether 
perfusion bleed samples could also be used to measure AMP activity. If this 
were the case, this would allow direct comparison of phenoloxidase and 
antimicrobial activity from individual bees. Further work also tested alternative 
sample collection methods, as previously described in the literature for AMP 
measurement, including thorax homogenisation and neat haemolymph 
collection. All of this methods development work used samples from bees 
collected 24-72 hours post injection with an artificial immune challenge with 
bacterial lipopolysaccharides (LPS);  it is well recognised that minimal 
antimicrobial activity is typically observed in the absence of an immune 
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challenge and this LPS approach is well documented in the literature (e.g. 
Laughton et al., 2011). 
2.3.1. Measurement of antimicrobial activity in honey bees 
2.3.1.1. Bacterial growth inhibition assays 
Despite following protocols previously described in the literature, whether using 
neat haemolymph, homogenised thoraces or perfusion bleeds, I did not find that 
honey bee samples inhibited the growth of A. globiformis, E.coli, or S.aureus. A 
few small zones of inhibition were seen against M.luteus growth using neat 
haemolymph samples, but these were seen in a very few samples, and this 
showed that the assay had too low a sensitivity to be reliable or informative. 
Expecting that the abdomen may contain more antimicrobial peptides, given 
that the fat body and midgut are the principle sites of AMP synthesis (Gillespie 
et al., 1997), samples collected via an homogenisation of the abdomen were 
also tested, but again no inhibition was observed. Despite the lack of inhibition, 
the majority of neat haemolymph samples were observed to darken the 
surrounding agar, demonstrating a melanisation response to the bacteria (as 
associated with the phenoloxidase cascade). This melanisation was not thought 
to affect the capability of any antimicrobial peptides to inhibit the bacterial 
growth; previous studies that have observed inhibition and also melanisation 
found no effect of melanin presence on the inhibition assay (Haine, unpublished 
data, cited in Laughton et al., 2011). Nevertheless, here melanisation confirmed 
that the haemolymph samples were diffusing into the inoculated agar. 
Difficulty in the setup of inhibition assays to measure antimicrobial activity has 
been recognised widely previously by other research groups. Haine et al. (2008) 
reported that attempts to measure antimicrobial activity in mealworm beetle 
haemolymph failed with use of E.coli or Bacillus subtilus. Others have also 
found difficulties in repeatedly measuring antimicrobial activity in bees against 
A.globiformis (A. Laughton, S. Rustage personal communication). In my pilot 
work I found no inhibition despite efforts to increase the sensitivity of the live 
bacterial cultures to enhance antimicrobial activity, using low nutrient agar and 
low concentrations of bacterial inoculants. 
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2.3.1.2. Lytic clearance assays 
As an alternative to an inhibition assay against the growth of a live bacterial 
culture, studies of antimicrobial activity in other insects have used a clearance 
assay against a turbid suspension of lyophilised bacterial cells (e.g. Cytrynska 
et al., 2007, Cotter et al., 2008, Kurtz et al., 2000). In this case, these lytic 
clearance assays assume a concentration related increase in clearance with 
higher levels of antimicrobial activity, as antimicrobial proteins in the 
haemolymph sample lyse the peptidoglycan bacterial cell walls (an antimicrobial 
action typical of lysozymes (Gillespie et al., 1997)). Lyophilised M.luteus cells 
(Micrococcus lysodeikticus) are typically used for this assay. Whilst this has not 
been documented previously for bees, in our trials a few observations of 
inhibition against live M.luteus with honey bee neat haemolymph provided some 
support for testing the potential of this alternative assay. Here a pilot study, 
following the protocols of Cotter et al. (2008) and Kurtz et al. (2000) aimed to 
test whether honey bee antimicrobial activity could be measured using a lytic 
clearance assay.  
Firstly, agar plates were set up containing a suspension of 5 mgml-1 M. 
lysodeikticus and neat haemolymph samples from LPS-injected honey bees 
were found to give very faint zones of clearance (~3 mm diameter). Much 
clearer and larger zones were observed using lysozyme standards from chicken 
egg white. In an attempt to increase the sensitivity of the assay, a series of agar 
plates were set up containing a suspension of M. lysodeikticus across a dilution 
series from 5-0.05 mgml-1, and haemolymph samples were added to each plate. 
Across this dilution series, weaker suspensions of lyophilised cells successfully 
allowed for observation of clearer and larger clearance zones from aliquots of 
the same haemolymph sample. It was concluded that using a suspension of M. 
lysodeikticus in an agar assay at a concentration of 0.2 mgml-1 was the most 
appropriate concentration for reliable measurement of antimicrobial activity from 
honey bee neat haemolymph samples. 
To identify whether clearer or larger zones of clearance could be measured if 
the samples were left in wells of the agar plate for a longer time period, zones 
were measured 24, 48, 72 and 96 hours after the setup of the clearance assay, 
with measurements made blind to the previous day’s results. There was a 
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significant difference in the presence of zones across the four time 
measurements, with a general trend that more zones were observed when the 
assay was left for a longer period of time (Friedman rank sum test: χ2df=3 = 10.3, 
P = 0.017). Nevertheless, of the samples from which zones were consistently 
measured at all four recording points, there was no significant difference in the 
diameter of these zones when measured at each point in time (Repeated 
measures ANOVA: F3,348 = 2.45, P = 0.063). A few plates were observed to 
have very small colonies of bacterial growth by 96 hours post setup, possibly 
due to the viability of some lyophilised bacterial cells (Antheuni, 1973) or other 
contamination. It was concluded that future use of the assay would measure 
lytic zones at 72 hours post injection, to allow for a sufficient length of time for 
even weak samples to clear the lyophilised cells, whilst minimising the risk of 
contamination by bacterial growth on the plates. 
Lastly, lytic zones of clearance were not observed using perfusion bleed 
samples. From this we concluded that for appropriate measurement of both 
phenoloxidase activity and antimicrobial activity separate individual bees were 
required for each measurement (using perfusion bleeds and neat haemolymph, 
respectively). 
To validate the lytic clearance assay as an appropriate measure of relative 
differences in antimicrobial activity between samples, a dilution series of a 
standard lysozyme solution was measured. Each measure was taken using two 
technical replicates to confirm the repeatability of the method. As expected, 
there was a significant relationship between log lysozyme concentration and the 
diameter of clearance zone measured against the M. lysodeikticus suspension 
(Figure 2.2.). It was concluded that the protocols used were appropriate for 
future work to investigate the antimicrobial activity in honey bees subjected to 
immune and chemical stressors, as described later in this thesis. 
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Figure 2.2. Dilution series measuring antimicrobial activity of a lysozyme 
standard from chicken egg white against the clearance of M. lysodeikticus 
(Mean of two replicates ± SE). Trend line shows line of best fit. 
 
2.3.2. Measurement of antimicrobial activity in bumble bees 
2.3.2.1. Bacterial growth inhibition assays 
Testing whether bumble bee neat haemolymph samples inhibited the growth of 
live bacterial cultures, I found small zones of inhibition (< 3 mm) of A.globiformis 
growth from LPS-injected bumble bees, but no inhibition of E.coli, or S.aureus. 
Furthermore, much clearer larger inhibition zones were observed using an 
inhibition assay with M.luteus (typically zones up to 8 mm diameter in samples 
collected 24 hours post LPS injection; Figure 2.3.). It was concluded that using 
a growth inhibition assay against M.luteus was appropriate for reliable 
measurement of antimicrobial activity from bumble bee neat haemolymph 
samples. 
To validate the growth inhibition assay as an appropriate measure of relative 
differences in antimicrobial activity between samples, a dilution series of a 
standard antibiotic (ceftazidime) solution was measured. Each measure was 
taken using two technical replicates to confirm the repeatability of the method. 
As expected, there was a significant relationship between log ceftazidime 
concentration and the diameter of inhibition zone measured against growth of 
M.luteus (Figure 2.3.; Linear regression: R2=0.989, P<0.001). It was concluded 
that the protocols used were appropriate for future work to investigate the 
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antimicrobial activity in bumble bees subjected to immune and chemical 
stressors, as described later in this thesis. 
It is unclear as to why the best methods differed between honey bees and 
bumble bees, but it is likely that the repertoire of antimicrobial peptides differs 
between the species and hence the inhibitory action of these antimicrobial 
peptides on the growth of the test bacteria also differs. 
  
 
Figure 2.3. Left: Dilution series measuring antimicrobial activity of an antibiotic 
standard against the inhibition of M. luteus. (Mean of two replicates ± SE). 
Trend line shows line of best fit. Right: Photograph of a growth inhibition plate, 
demonstrating zones of inhibition of varying diameter. 
 
2.4. Measurement of glucose oxidase activity 
Glucose oxidase (GOX) activity has previously been quantified using a 
spectrophotometry assay (White et al., 1963, Alaux et al., 2010). This involves 
GOX catalysing the conversion of β-D-glucose in the reaction mixture to 
gluconic acid and hydrogen peroxide. This hydrogen peroxide subsequently 
reacts with a colourless substrate, o-dianisidine, in the presence of a 
peroxidase enzyme, to oxidise the substrate to a coloured product. Hence the 
greater the colour change the greater the initial concentration of GOX in the 
sample. Since GOX is secreted from the hypopharyngeal glands in the honey 
bee head, activity can be measured most easily from a homogenised head 
sample. My approach was to use methods previously described in the literature 
to measure glucose oxidase activity, replicating the protocol of Alaux et al. 
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(2010) as far as possible and given the laboratory facilities available to me. For 
this assay, I used a saturated solution of o-dianisidine, as the described 
concentration of 3 mM (= 0.7 mgml-1) was not found to be soluble in water at 
room temperature. All bee heads were homogenised in 200 µl PBS, centrifuged 
and the supernatant used in the assay. This volume of buffer presented the 
minimum volume that could be used (to maximise the concentration of GOX in 
the sample) since testing smaller volumes it was difficult to homogenise the 
head and subsequently collect enough debris-free supernatant for analysis of 
up to three replicates of each sample. Initial pilots allowed reactions to proceed 
for a three hour period in the spectrophotometer. Reaction curves typically 
demonstrated that the linear phase of the reaction was recorded within the first 
80 minutes, with the slope of change in absorbance over time plateauing by 90-
100 minutes. Since I was interested in the maximum linear phase of the 
reaction, it was concluded that allowing each reaction to proceed for 105 
minutes (1 hour 45 minutes) would be sufficient to measure this phase of all 
reactions. This is in line with the protocol of Alaux et al., in which reactions were 
measured for 1 hour 30 minutes. 
To validate the assay as an appropriate measure of relative differences in 
glucose oxidase activity between samples, a dilution series of a single pooled 
sample of homogenised bee heads was prepared in PBS, and GOX activity 
subsequently measured. Each measure was taken using two technical 
replicates to confirm the repeatability of the method. There was a significant 
linear relationship between the log sample input and GOX activity (Figure 2.4.; 
Linear regression: R2 = 0.989, P < 0.001), demonstrating, as expected, that a 
greater Vmax value corresponded to greater GOX activity. It was concluded that 
the protocols used were appropriate for future work to investigate the glucose 
oxidase activity in bees subjected to immune and chemical stressors, as 
described later in this thesis. 
 
95 
 
 
Figure 2.4. Dilution series measuring GOX activity of a single sample (Mean of 
two replicates ± SE). Trend line shows line of best fit. 
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2.5. Gene expression assays using qPCR 
2.5.1. Primer design and optimisation 
Real-time quantitative PCR (qPCR) is a well-established research tool allowing 
a relatively cheap, quick and reliable method to study differential gene 
expression of specific genes of interest. For the majority of work presented in 
this thesis, honey bee genes were selected for investigation based on a priori 
knowledge of their candidate function and their regulation in response to 
immune or chemical stressors in previous studies. In these cases, primer sets 
applied in previous qPCR studies were used here, and they are described in the 
appropriate methods sections. 
An optimisation study was carried out to investigate the most appropriate 
concentrations of forward and reverse primers to maximise the yield of amplified 
DNA for the GOX gene. Based on the manufacturer’s recommendations for 
primer concentration optimisation using the SYBR Green PCR Master Mix, an 
optimisation matrix was used to test nine conditions, with each combination of 
three primer concentrations: 100 nM, 300 nM and 900 nM. For all conditions 
tested, threshold cycle (Ct) values were undetermined for controls with no 
template included, confirming the absence of nonspecific amplification. An 
optimum mastermix containing both primers at a concentration of 900nM was 
found, providing greater amplification than any other conditions tested. In 
contrast, primer concentrations of 100 nM, consistent with those used by Yang 
and Cox-Foster (2005), were found to be the least efficient, giving the highest 
threshold cycle and hence the lowest amplification of all conditions tested. It 
was concluded that all future work would use both forward and reverse primers 
at a concentration of 900 nM in the GOX qPCR assay. 
A new qPCR assay was established to measure expression of the honey bee 
ALDH1L2 gene. ALDH1L2 primers were designed using the Primer 3 software 
(Untergasser et al., 2012). Primer concentration was optimised, as for the GOX 
assay, using an optimisation matrix for each combination of three primer 
concentrations: 100 nM, 300 nM and 900 nM. For all conditions tested, 
threshold cycle (Ct) values were undetermined for controls with no template 
included, and an optimum mastermix containing both primers at a concentration 
of 900 nM was found. Details of the ALDH1L2 primers are described below: 
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Forward primer: GGGCCACAGAACCATAAAGC; Length 20 bases; Tm 59.18 
°C, GC content 55 %. No internal secondary structure. 
Reverse primer: CGCCACGTTCCACAAATTTC; Length 20 bases; Tm 58.60 °C, 
GC content 50 %. No internal secondary structure. 
Product size: 58 bases 
 
2.5.2. Preparation of standard PCR (calibration) curves 
To validate each PCR assay and to prepare standard curves for later calibration 
of input quantities, a dilution series of a single pooled cDNA sample was 
prepared and the Ct values measured by qPCR for each gene assay. Thirteen 
dilutions were chosen with the aim that expression levels of subsequent 
samples would fall within the limits of the standard curve. An arbitrary input 
quantity was assigned to each dilution, which was relative to the dilution 
concentration. This input quantity was transformed by log10, and then plotted 
against the Ct value and the slope, intercept and R
2 value calculated (Figure 
2.5.). The PCR efficiency, E, of each primer set was also calculated using the 
formula E = 10-1/slope – 1 and PCR efficiency was typically within the 
recommended 90 - 110 %. 
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Figure 2.5 (NB. continued overleaf). Calibration curves for each qPCR assay. 
Trend lines show lines of best fit. 
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Figure 2.5 (NB. continued overleaf). Calibration curves for each qPCR assay. 
Trend lines show lines of best fit. 
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Figure 2.5 (NB. continued overleaf). Calibration curves for each qPCR assay. 
Trend lines show lines of best fit. 
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Figure 2.5. Calibration curves for each qPCR assay. Trend lines show lines of 
best fit. 
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2.5.3. Selection of reference genes for normalisation 
To reliably compare gene expression levels between samples it is essential to 
normalise the data to appropriate reference genes to control for variations 
between samples, such as the amount of starting material and differences in 
overall transcriptional activity. Reference genes should show similar levels of 
expression throughout an organism’s development and should not vary in 
response to experimental treatments. Several reference genes have been 
validated as suitable for use in normalisation of qPCR data in honey bees 
(Lourenco et al., 2008). Nevertheless, in any given study it is appropriate to 
validate the reference genes to confirm their presumed stability of expression 
within the experimental treatments of the study (Andersen et al., 2004). Genes 
tested in each of the studies in this thesis were evaluated to identify those most 
stably expressed across the experimental treatments. Furthermore, it has been 
recognised that geometric averaging of multiple reference genes may provide a 
more reliable normalisation factor than a single gene (Vandesompele et al., 
2002) and hence combinations of reference genes were evaluated to select the 
most suitable combination as a normalisation factor. 
Data were analysed using two established approaches for reference gene 
selection. Firstly, the methods of Vandesompele et al. (2002) were followed to 
calculate a gene stability measure (M). Whilst further discussion of this 
approach will refer to the ‘GeNorm’ algorithm, I did not have access to the 
GeNorm software itself, and hence the analysis was performed manually on 
Excel following the GeNorm protocol described in Vandesompele et al. (2002) 
and outlined here. Secondly, NormFinder software (NormFinder Excel Add-In 
v0.953) (Andersen et al., 2004) was used to calculate an alternative measure of 
gene stability. Since different selection methods use different criteria it is 
recognised that the selection of reference genes may depend on the method 
used. Nevertheless, it is expected that best candidate reference genes will be 
appropriately identified in both established methods, as previous comparisons 
analysing samples using more than one method have found similar measures of 
gene expression stability between selection methods (Lourenco et al., 2008). 
The two approaches were included in the validation as a comparison of the two 
methods to select appropriate reference genes and the results of both methods 
were taken into consideration in the final selection of reference genes. 
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2.5.3.1. GeNorm algorithm (Vandesompele et al., 2002) 
For each assay, the input quantities of all experimental samples (transformed 
from Ct values using the relative standard curve method) were placed in order 
of highest to lowest input quantity. Each sample input quantity was then divided 
by the highest input quantity to give a value between 0 and 1. This ratio will be 
referred to as the ‘expression value’. For each gene, the expression ratio was 
calculated systematically compared to all other genes (for example, for every 
sample the abaecin expression value was divided by the actin expression value, 
by the ef1-α expression value and so on for all genes). The GeNorm approach 
relies on the principle that two ideal reference genes will show identical 
expression ratios across all samples. Each expression ratio was then 
transformed using the natural logarithm (LN) (to give a symmetrical distribution 
of the data around zero so that a given ratio and inverse ratio have equal 
absolute values, but opposite signs). For each gene, the pairwise variation in 
expression ratio, V, was then calculated as the standard deviation of the LN-
transformed expression ratios of each sample. In this way, the pairwise 
variation V is independent of differences in abundance between genes and 
equally affected by outlying or extreme ratios caused by up- or down- regulation 
or low or high overall expression. By calculating the average pairwise variation 
across the candidate reference gene combinations, this gives a gene stability 
measure, M, whereby the gene with the highest M value is the least stably 
expressed. The least stably expressed gene was eliminated as a candidate 
reference gene and the analysis repeated, now excluding this gene. Stepwise 
analyses were performed, each time eliminating the least stable gene until left 
with a combination of the two most stably expressed genes across the samples.  
2.5.3.2. NormFinder algorithm (Andersen et al., 2004) 
As with the GeNorm approach, the expression value was calculated as the ratio 
of the highest input quantity to the sample input value, and this expression 
value was used as the input data for the NormFinder software. Like GeNorm, 
the NormFinder algorithm estimates the overall variation in expression of each 
candidate reference gene, but in addition NormFinder estimates the variation in 
expression between the treatment groups in the sample set. Using both the 
intra- and inter-group variation, a stability value is calculated, with lower stability 
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values representing more stably expressed genes. To enable the NormFinder 
software to generate this stability value, each combination of injection 
treatment, pesticide treatment and sampling time point was first identified as a 
separate treatment group in the input data. 
2.5.3.3. Results and Discussion 
This work initially used the dataset from the qPCR work outlined in Chapter 3. 
The results of the two analyses are summarised in Figure 2.6. Both methods 
found actin to be the most stably expressed gene. Actin has previously been 
validated as a suitable reference gene for normalisation in honey bee gene 
expression studies (Lourenco et al., 2008). Lourenco et al. (2008) also validated 
three other reference genes in the honey bee (ribosomal protein 49, elongation 
factor 1-alpha, tbp-association factor), of which elongation factor 1-alpha (ef1-α) 
was included as a candidate reference gene also in this study. The NormFinder 
algorithm found ef1-α to be the third most stably expressed gene, whilst it was 
the fifth most stably expressed in the GeNorm output. However, there was little 
difference in stability value between actin and ef1-α in both outputs, as depicted 
by the relatively flat line between the two genes in Figure 2.6. These results 
support those of Lourenco et al. (2008) that actin and ef1-α have a generally 
uniform expression across honey bee samples and hence are suitable 
reference genes. Of the genes tested in this study, the three P450 detoxification 
enzymes (6AS10, 6AQ1 and 6BD1) also showed low variation in expression 
between samples. In particular, 6AQ1 was the third most stably expressed gene 
according to the GeNorm algorithm and the second most stably expressed 
according to NormFinder. Similarly, 6AS10 was the second most stably 
expressed according to GeNorm and the fourth most stably expressed 
according to NormFinder. 6BD1 seemed to be less suitable based on the 
NormFinder results. Based on these findings, four genes (actin, ef1-α, 6AS10 
and 6AQ1) were considered as the most suitable candidate reference genes for 
normalisation of the data set. 
In a further stage of analysis, combinations of multiple reference genes were 
evaluated to determine a suitable number of genes and the most suitable 
combination of genes for geometric averaging. The use of more than one 
reference gene is considered to be a more accurate and reliable approach to 
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normalisation than using a single gene and the minimum number of genes to 
use in this average may depend on the variation within the sample set. A 
geometric mean is favoured to an arithmetic mean as it is expected to better 
control for possible outliers and differences in transcript levels between different 
genes (Vandesompele et al., 2002). 
Firstly, the NormFinder software identified defensin-1 and actin as the best 
combination of two genes (note, defensin-1 was ranked as the fifth most stably 
expressed gene according to NormFinder). In contrast, defensin-1 was found to 
be less stable according to GeNorm (Figure 2.6). It is recognised that the 
validity of the NormFinder approach requires firstly that the sample set contains 
at least 8 samples per treatment group, and furthermore the candidate genes in 
the analysis should have no prior expectation of differences between treatments 
(Andersen et al., 2004). Here, the sample set only allowed 3 samples per 
treatment group, and all the genes tested were included in the analysis, 
although not all were expected to show uniform expression. Despite the lack of 
conformity to the specified requirements, the NormFinder results generally 
support those of GeNorm, and reflect prior expectations, such as the high 
stability of actin and ef1-α (Lourenco et al., 2008). However, defensin-1 was 
initially included in the study for its hypothesised upregulation in response to 
injection treatment (for example, bacterial infection has previously been found to 
affect its expression (Evans, 2006)). Given this hypothesis and given that the 
accuracy of the analysis may be limited by the number of samples per treatment 
group, it seemed appropriate to take a cautious approach and avoid the use of 
defensin-1 within the normalisation factor of this study. 
Secondly, using the GeNorm methods of Vandesompele et al. (2002), 
normalisation factors were calculated for different combinations of the four most 
stable genes identified above (actin, ef1-α, 6AS10 and 6AQ1). Using a 
systematic approach to include one to four reference genes, the pairwise 
variation, V, was calculated between normalisation factors with the sequential 
addition of a reference gene. A large variation, defined by a cut off value of 
0.15, reflects that inclusion of an additional gene has a significant effect and 
hence this additional gene should be included in the normalisation factor to 
improve its reliability. Results of this analysis are summarised in Table 2.1. 
Since actin was the most stable gene according to both GeNorm and 
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NormFinder, the effect of a second gene in addition to actin was tested. 
Addition of any of the three genes significantly affected the pairwise variation, 
demonstrating that use of at least two genes in the normalisation factor was 
more appropriate than use of actin as a single reference gene. Overall, addition 
of a third gene was also shown to improve the normalisation factor compared to 
two genes. This supports the recommendation by Vandesompele et al. (2002) 
that a minimum of three reference genes should be used in the calculation of a 
normalisation factor. Addition of a fourth gene (in the case of all combinations 
analysed) was found to have no significant effect on the normalisation factor. 
On consideration of the different combinations tested, overall the addition of 
6AQ1 as a third reference gene did not have a significant effect on the 
normalisation factor compared to using only two genes. It was concluded that a 
geometric average of three reference genes (actin, 6AS10 and ef1-α) would be 
used as the normalisation factor in this sample set. This final conclusion was 
made given that i) actin and 6AS10 were the most stable genes according to 
GeNorm, ii) ef1-α was more stable than 6AS10 according to NormFinder, iii) 
ef1-α has previously been validated as a suitable reference gene in honey bees 
(Lourenco et al., 2008), and iv) the addition of ef1-α as a third gene overall was 
shown to have a significant effect on the normalisation factor (Table 2.1.). 
Based on the data presented above, and that of Lourenco et al. (2008), actin 
and ef1-α were selected as appropriate candidate reference genes in a second 
gene expression study outlined in Chapter 5. Here, only two genes were used 
for normalisation due to the relatively few genes investigated in the study. Using 
the GeNorm algorithm (as above), the stability of these two genes was 
confirmed across the sample set, confirming their suitability as reference genes 
in this study (Figure 2.7.). 
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Figure 2.6. Gene stability values of each of the 15 genes in the qPCR study of 
Chapter 3, analysed using the GeNorm algorithm (black circles) and 
NormFinder algorithm (white squares). Genes are ordered along the x-axis from 
highest to lowest stability values from the GeNorm output, from least to most 
stable left to right. Whilst the NormFinder output showed a very similar trend (as 
shown by the shapes of the two curves), note that the order of stability was not 
identical between the two algorithms. 
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Table 2.1. Summary of pairwise variations between normalisation factors with 
the sequential addition of a reference gene, based on methods of 
Vandesompele et al. (2002). *** = significant effect of inclusion of gene (i.e. V > 
0.15) 
Normalisation factor 
A 
Normalisation factor 
A+1 
Pairwise 
variation, 
V 
Equivalent of 
sequential ranking in 
algorithm: 
Actin Actin + 6AS10 0.24*** GeNorm 
Actin Actin + 6AQ1 0.27*** NormFinder 
Actin Actin + Ef1-α 0.30*** na 
Actin + 6AS10 
Actin + 6AS10 + 
6AQ1 0.15 GeNorm 
Actin + 6AQ1 
Actin + 6AQ1 + Ef1-
α 0.16*** NormFinder 
Actin + 6AQ1 
Actin + 6AQ1 + 
6AS10 0.14 na 
Actin + 6AS10 
Actin + 6AS10 + Ef1-
α 0.18*** na 
Actin + Ef1-α 
Actin + Ef1-α + 
6AS10 0.16*** na 
Actin + Ef1-α 
Actin + Ef1-α + 
6AQ1 0.15 na 
Actin + 6AS10 + 
6AQ1 
Actin + 6AS10 + 
6AQ1 + Ef1-α 0.12 na 
Actin + 6AS10 + 
6AQ1 
Actin + 6AS10 + 
6AQ1 +6BD1 0.12 GeNorm 
Actin + 6AQ1 + Ef1-
α 
Actin + 6AQ1 + Ef1-
α + 6AS10 0.11 NormFinder 
Actin + 6AS10 + 
Ef1-α 
Actin + 6AQ1 + Ef1-
α + 6AS10 0.10  na 
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Figure 2.7. Gene stability values of each of the 9 genes in the qPCR study of 
Chapter 5, analysed using the GeNorm algorithm. Genes are ordered along the 
x-axis from highest to lowest stability values from the GeNorm output, from least 
to most stable left to right. 
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3. Resilience of honey bee immunocompetence to chronic 
neonicotinoid exposure 
3.1. Abstract 
Honey bees are of global economic and ecological importance due to their role 
in the pollination of crops and wild flowering plants. Concern over declines in 
bee health and colony losses has been associated with exposure to multiple 
stressors, including to neonicotinoid pesticides and pathogenic infection. Recent 
studies have found that neonicotinoid exposure alters the expression of 
immune-related genes, but the biological relevance of these transcriptional 
changes on the physiological immune functioning of individual bees has not 
been established. Here we show that chronic oral exposure to either 102 ppb 
imidacloprid or 10 ppb thiamethoxam caused transcriptional changes in 
antimicrobial effector genes, but the physiological antimicrobial response, 
measured by a lytic clearance assay, was unaffected, suggesting no functional 
adverse outcome. Levels of an enzyme involved in melanisation in the immune 
response, phenoloxidase, were largely constitutive and resilient to neonicotinoid 
exposure. This work suggests that transcriptional responses in a series of 
immune-related genes do not necessarily translate into functionally significant 
impacts on bee health and our data indicate a need for caution in their use as 
biomarkers in pesticide risk assessment.  
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3.2. Introduction 
Currently, there is widespread concern over losses of managed honey bees and 
declines in wild bee populations (e.g. vanEngelsdorp et al., 2008, Neumann and 
Carreck, 2010, Goulson et al., 2008, Biesmeijer et al., 2006) due to the potential 
impact on the pollination of crops and wild flowering plants (Potts et al., 2010). 
Multiple stressors are likely contributing to declines in bee health, including 
habitat loss and fragmentation, the introduction of alien species (including 
plants, animals and microorganisms), climate change, the spread of pathogens 
and parasites, and pesticide application (Potts et al., 2010). Recent studies 
therefore have begun to investigate the biological mechanisms underlying 
interactions between multiple stressors, and there is evidence that exposure to 
neonicotinoid pesticides can impair the honey bee immune response, which 
could increase susceptibility to pathogenic infection and parasitic attack (e.g. 
Alaux et al., 2010). The immune response in individual honey bees consists 
primarily of cellular responses, such as phagocytosis and encapsulation, and 
humoral responses via the prophenoloxidase cascade (leading to melanisation) 
and antimicrobial effectors (Evans et al., 2006). Expression of some genes 
related to these immune processes alters following neonicotinoid exposure 
(Derecka et al., 2013, Di Prisco et al., 2013, Gregorc et al., 2012), although not 
all these studies used environmentally relevant exposure scenarios. It is unclear 
whether transcriptional changes in genes of immune function in individual bees 
are indicative of a threat to the viability of the colony as a whole. One previous 
study found no effect of exposure to one neonicotinoid, imidacloprid, on the 
cellular and phenoloxidase (PO) components of the bee immune response at a 
physiological level (Alaux et al., 2010), but it is unclear whether this result 
applies to all compounds in the neonicotinoid family and to other immune 
responses. For example, as yet there has been no investigation of neonicotinoid 
effects on antimicrobial peptide (AMP) enzyme activity, which means that it 
remains unclear whether neonicotinoid-induced suppression of AMP gene 
expression has functional significance by resulting in reduced protein levels. To 
broaden our understanding of the biological relevance of transcriptional 
changes in immune-related genes, we therefore carried out a series of 
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laboratory exposure experiments investigating relationships between changes 
in gene expression and measures of physiological honey bee immunity.  
In our investigation, we aimed to establish whether exposure to neonicotinoids, 
including environmentally relevant exposure regimes, altered immune-related 
gene expression and whether these changes impacted on enzyme activity. Our 
study aimed to provide a foundation for understanding the potential regulatory 
value of gene expression bioassays as indicators of pesticide effects on bee 
health. Bees were exposed to thiamethoxam at 10 parts per billion (ppb), 
representative of field relevant residues in nectar (e.g mean ±SD residues in 
squash of 11±6 ppb; Stoner and Eitzer, 2012), and to imidacloprid at 102 ppb, 
which is at least ten-fold higher than typical residues in most crop systems 
(typically 1-10 ppb; Blacquiere et al., 2012), although residues as high as 101 
ppb have been found in pollen from transplant-dripped pumpkin crops (Dively 
and Kamel, 2012). The study was designed as a factorial experiment in which 
only one dose of each compound was tested. This approach aimed to elucidate 
possible toxicological effects of pesticide exposure to test the biological 
relevance of immune endpoints, which could inform the direction of future work, 
and so we did not aim to establish dose-dependent effects or threshold levels to 
test for ecological relevance. 
In our study, an artificial immune challenge via an injection with 
lipopolysaccharides (LPS) from Escherichia coli was used to mimic a bacterial-
like infection and elicit an immune response. This approach was adopted to 
standardise the stimulus used to invoke a response in individual bees and to 
minimise the treatment variation inherent in using a real pathogen, which can be 
logistically difficult to control. The present study therefore does not aim to 
investigate the biological mechanisms associated with any specific natural 
infection, but instead seeks to better understand fundamental relationships 
between the temporal dynamics of transcriptional and physiological changes 
using a well-established method for insect immune studies. 
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3.3. Methods 
We exposed newly emerged workers to either undosed control or neonicotinoid-
spiked sucrose feeders and imposed an immune challenge after five days of 
experimental feeding. While maintaining bees on the same dietary treatment, 
we collected samples for various immune-related assays over the remainder of 
the experimental period. In separate experiments, sample collection followed 
either a short time course of between 2 and 48 hours post immune challenge 
(PIC), or a longer time course of between 24 and 168 hours (1-7 days) PIC 
(Figure 3.1.; Table 3.1.). 
 
Figure 3.1. Schematic of overall experimental setup. Note, this overall setup 
was achieved in a series of individual experiments, as outlined in Table 3.1. For 
each pesticide exposure (top white boxes), bees received one of three immune 
challenges (middle grey boxes). For each pesticide/immune combination, 
samples were collected across either a short time course or long time course 
(depending on the individual experiments). *Sampling at 2 and 4 h post immune 
challenge (PIC) was taken only in the qPCR experiments. Samples were then 
analysed to measure one of three immune endpoints (bottom grey ellipses). 
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Table 3.1. Overview of the test substances, sampling time course and 
endpoints measured in each of six experiments. Each experiment was 
performed with newly emerged honey bees from a single colony, but each 
experiment used a different colony. 
 
 
3.3.1. Honey bee provenance and husbandry 
All honey bees were from Apis mellifera L. colonies of British hybrid bees 
maintained on the home apiary at the Food and Environment Research Agency, 
Sand Hutton, York, UK. Brood frames were collected from colonies between 
April and September of any given year (2013, 2014) and placed in an 
environmental chamber (34 °C, 60 % relative humidity, constant darkness; 
Sanyo Versatile Environmental Test Chamber). Workers were collected from 
these frames as they emerged and batches of 10 workers were housed in 
modified plastic cages (FK-RD8 clear PET containers; Ambican UK Ltd). Each 
cage allowed ad libitum access to a sucrose solution (50 % w/v) through a 
modified 1.5 ml microcentrifuge tube. Cages were maintained in the 
environmental chamber throughout the experimental period (34 °C, 60 % 
relative humidity, constant darkness). Six separate experiments were set up 
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between August 2013 and June 2014, each using workers derived from a single 
honey bee colony (Table 3.1.).  
3.3.2. Neonicotinoid exposure 
All studies used chronic dietary exposures to sublethal concentrations of 
neonicotinoid comprising either imidacloprid or thiamethoxam. Stock solutions 
of neonicotinoids were made up in acetone, and used to create the appropriate 
concentrations. In the imidacloprid studies, sucrose was spiked with 125 µgL-1 
(= 102 ppb) imidacloprid (Fluka Analytical 37894, Sigma-Aldrich, UK). In the 
thiamethoxam studies, treated sucrose was spiked with 12 µgL-1 (= 10 ppb) 
thiamethoxam (Fluka Analytical 37924, Sigma-Aldrich, UK). All cages allowed 
ad libitum access to the sucrose feeder throughout the experiment and no other 
food was provided. Control sucrose contained a relevant volume of acetone 
equivalent to the solvent in the neonicotinoid treatments. To quantify feeding 
rates, the feeder of each cage was weighed every other day and corrected for 
evaporation using reference feeders kept in empty cages. To quantify mortality 
rates, dead bees were recorded and removed every other day. 
3.3.3. Immune challenge 
To immobilise workers for injection treatments, individual cages in which honey 
bees were housed were placed in a freezer (-20 °C) for approximately two to 
five minutes until bees were torpid. All injections were performed using a fine 
needle on a Hamilton syringe with a repeating dispenser. Honey bees were 
injected with 2 µl of solution through the pleural membrane between the tergites 
(dorsal side) of the abdomen. Bees received one of three injection treatments, 
with all workers within a cage subjected to the same treatment. In the ‘naïve’ 
treatment, bees were ice-immobilised but received no further treatment, which 
served as the unchallenged control. The ‘Ringers’ treatment group were 
injected with Insect Ringers solution (1:1:1 156 mM NaCl : 3 mM KCl : 2 mM 
CaCl2) to control for any effects of the injection process itself. The ‘LPS’ 
treatment group were injected with 0.5 mgml-1 LPS (Sigma L2755- 
Lipopolysaccharides from Escherichia coli 0128:B12, Sigma-Aldrich, UK) 
dissolved in Insect Ringers solution. This LPS concentration has been widely 
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used previously to elicit an immune response in honey bees without any acute 
effects on survival (e.g. Alaux et al., 2012, Koehler et al., 2012, Laughton et al., 
2011). 
 
There were no evident effects of pesticide or injection treatments on honey bee 
behaviour and activity. No treatment affected mortality, with the exception that 
Ringers injection increased mortality in Experiment 5 (Kruskal-Wallis: χ22df = 
7.57, P = 0.023). In the short time course experiments 2-7 % of bees died, 
whilst 8-21 % of bees died in the longer time course experiments. The low 
mortality across treatments confirmed that the pesticide concentrations and 
immune challenges used were sublethal to worker honey bees. 
3.3.4. Measurement of gene expression 
At appropriate time points, bees were placed directly into a freezer at -80 °C 
and stored until RNA extraction. Total RNA was extracted from homogenates of 
six bees (entire bodies) from a single cage. For each feeding/injection treatment 
combination and time point, separate homogenates from three cages were used 
as biological replicates for real-time quantitative PCR (qPCR) analysis. Pooling 
of six bees per replicate homogenate served to minimise between-bee variation 
in gene expression profiles. Total RNA was extracted using the mirVana miRNA 
Isolation Kit (Ambion AM1561; Life technologies, UK). RNA quantity of each 
sample was measured using a Nanodrop 1000 spectrophotometer (Thermo 
Fisher Scientific, UK) and samples were subsequently standardised to 2 µg for 
cDNA synthesis. cDNA was synthesised using the High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems 4368814; Life technologies, UK) 
and a C1000 Thermal Cycler (Bio-Rad Laboratories, UK) under the following 
cycling conditions: 10 minutes at 25 °C, 120 minutes at 37 °C, 5 minutes at 85 
°C, stored at 4 °C. 
qPCR was performed using the SYBR Green PCR Master Mix (Applied 
Biosystems 4309155, Life technologies, UK). Oligonucleotide primers, used to 
amplify genes (Table 3.2.), were used at a concentration of 1400 nM. Each 
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sample was run in duplicate, with treatments randomly assigned across plates. 
The PCR reactions were carried out on 96-well plates in a ViiA 7 Real-Time 
PCR System (Applied Biosystems; Life technologies, UK) under standard 
cycling conditions (1 cycle of 2 minutes at 50 °C, 1 cycle of 10 minutes at 95 °C 
and 40 cycles of 15 seconds at 95 °C and 1 minute at 60 °C). 
The threshold cycle (Ct) value for each sample was calculated using the 
arithmetic mean of the two replicates. Ct values were used only if the standard 
deviation of the two replicates was ≤ 0.5. If the standard deviation exceeded 
0.5, the assay was repeated for the given sample. Ct values were transformed 
into input quantity values using the relative standard curve method (Larionov et 
al., 2005). Input quantities were normalised using the geometric mean of Actin, 
Ef1-α and 6AS10 as the normalisation factor. These genes were identified as 
the most stably expressed genes using two established approaches for 
reference gene selection: GeNorm (Vandesompele et al., 2002); NormFinder 
(Andersen et al., 2004) (see chapter 2.4.3.). Normalised input quantities were 
used for statistical analysis. The mean fold-change in expression was 
calculated for each injection/pesticide/time point compared to the mean 
expression of the control-fed/naïve/zero-hours-exposure group. 
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Table 3.2. Oligonucleotide primers used in qPCR assays. 
Gene Gene category/ 
pathway 
Forward primer (5’ → 3’) Reverse primer (5’ → 3’) Reference 
Abaecin Antimicrobial 
peptide 
CAGCATTCGCATACGTACCA 
 
GACCAGGAAACGTTGGAAAC Morimoto et 
al. (2011) 
Apidaecin  Antimicrobial 
peptide 
TAGTCGCGGTATTTGGGAAT 
 
TTTCACGTGCTTCATATTCTTC
A 
Evans et al. 
(2006) 
Defensin-1 Antimicrobial 
peptide 
TGCGCTGCTAACTGTCTCAG AATGGCACTTAACCGAAACG Evans et al. 
(2006) 
Defensin-2 Antimicrobial 
peptide 
GCAACTACCGCCTTTACGTC GGGTAACGTGCGACGTTTTA Evans et al. 
(2006) 
Hymenopta
ecin 
Antimicrobial 
peptide 
CGGAATTGGAACCTGAGGAT
AC 
CCTTGAATGACAATGGATCCT
CTT 
Designed in 
house 
Lysozyme-1 Antimicrobial 
peptide 
GAACACACGGTTGGTCACTG ATTTCCAACCATCGTTTTCG Evans et al. 
(2006) 
AmPPO Phenoloxidase 
immune 
cascade 
AGATGGCATGCATTTGTTGA CCACGCTCGTCTTCTTTAGG Evans et al. 
(2006) 
6AS10 P450 
detoxification- 
reference 
GGGGTACCTGGACCCAAGCC
A 
GCCAGAACACGCACGTTTCG
C 
Morimoto et 
al. (2011) 
Actin Structural 
protein- 
reference 
TGCCAACACTGTCCTTTCTG AGAATTGACCCACCAATCCA Lourenco et 
al. (2008) 
Elongation 
factor 1-
alpha (ef1-
alpha) 
Protein 
synthesis- 
reference 
GGAGATGCTGCCATCGTTAT CAGCAGCGTCCTTGAAAGTT Lourenco et 
al. (2008) 
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3.3.5. Measurement of antimicrobial activity 
Haemolymph was collected from bees that had first been immobilised on ice. A 
small slit was made in the abdominal tergites using sterile dissecting scissors 
and gentle pressure to the thorax resulted in a bubble of haemolymph exiting 
this slit. 2-10 µl of this neat haemolymph was collected with a pipette and 
immediately stored at -20 °C for later analysis. Activity was measured from six 
individual bees from a single cage, and the cage mean was used as the 
biological replicate for statistical analysis. Three cages were measured for each 
feeding/injection treatment combination and at each time point. 
Antimicrobial activity was measured using a lysozyme clearance assay (Cotter 
et al., 2008) in which antimicrobial proteins in the haemolymph lyse the 
peptidoglycan cell walls of the test bacteria to produce a clear zone in a 
bacterial suspension, which is a proxy for relative antimicrobial activity (a larger 
zone indicates greater antimicrobial activity). Phosphate buffer solution (PBS) 
containing 1% agar was inoculated with 0.2 mgml-1 lyophilised Micrococcus 
lycodeikticus (M3770; Sigma-Aldrich, UK). 8 ml of this suspension was poured 
immediately into a 9 cm-diameter petri dish and left to set. Ten wells 
(approximately 2 mm diameter) were bored on each plate. Each haemolymph 
sample was thawed on ice and a 2 µl aliquot was added per well. Plates were 
incubated at 27 °C for 72 hours, and the diameters of clearance zones were 
measured using digital callipers. 
Note, here we do not explicitly distinguish between lysozymes and other 
antimicrobial proteins, as in this context we consider lysozymes as a subgroup 
of antimicrobial proteins based on sequence similarity, which overall all play a 
role in antimicrobial activity (Gillespie et al., 1997). 
3.3.6. Measurement of phenoloxidase activity  
A perfusion-bleed method was used to collect haemolymph samples, whereby a 
microsyringe and needle were used to insert 300 µl sodium cacodylate (NaCac) 
between the head and thorax. This solution was flushed through the body and 
collected along with the haemolymph in a microcentrifuge tube, which was 
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immediately snap-frozen in liquid nitrogen to release prophenoloxidase or 
phenoloxidase enzymes from haemocytes, before being stored at -20 °C for 
later analysis. 
Spectrophotometric assays were used to measure activity of: phenoloxidase 
(PO); total prophenoloxidase and phenoloxidase (total proPO/PO) activity 
(Laughton and Siva-Jothy, 2011). Haemolymph samples were centrifuged 
(9600 RPM, 10 minutes, 4 °C) and kept on ice. For the PO assay, 5 µl of PBS 
was added to the bottom of each well in a 96-well plate. For the total proPO/PO 
assay, 5 µl of α-chymotrypsin (5 mgml-1; Sigma C4129, Sigma-Aldrich, UK) was 
added to the bottom of each well. A 10 µl aliquot of a sample (supernatant) was 
added to each well, the plate was then shaken and left at room temperature for 
five minutes to allow the α-chymotrypsin to activate any proPO in the sample. 
The plate was then placed back on ice and 175 µl L-Dopa mastermix 
[containing 20 µl L-Dopa solution (saturated 11 mgml-1, then filtered; Acros 
Organics 167530050, Fisher Scientific, UK), 20 µl PBS, 135 µl water] was 
added to each well. The plate was shaken and the reaction allowed to proceed 
at 25 °C in a spectrophotometer (ThermoMax microplate reader, Molecular 
Devices, UK). Absorbance was measured at 490 nm every 15 seconds (shaking 
the plate between reads) for 1 hour 15 minutes (= 4500 seconds). A blank was 
used containing 10 µl NaCac in place of sample, but otherwise contained the 
same reaction mixture. Each sample was measured in duplicate for each assay 
and treatments were randomly assigned across plates to minimise between 
plate variation. Softmax Pro v4.3 software (Molecular Devices, UK) was used to 
calculate enzyme activity measured as the maximum linear rate of substrate 
conversion (Vmax), using 100 Vmax points, across the 4500 s reaction period. 
Activity was measured from six individual bees from a single cage, and the cage 
mean was used as the biological replicate for statistical analysis. Three cages 
were measured for each feeding/injection treatment combination and at each 
time point. 
3.3.7. Data analysis 
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Where necessary, data were first transformed to meet the assumptions for 
parametric testing. Variation among treatments was analysed by ANOVA with 
injection treatment, pesticide treatment and time post injection as fixed effects. 
Where ANOVA results were significant, pairwise differences were tested by 
Tukey’s HSD. 
 
3.4. Results 
3.4.1. Antimicrobial effector gene expression and enzymatic activity 
In response to injection, four antimicrobial effector genes (abaecin, apidaecin 
and defensin-1 and hymenoptaecin) were significantly upregulated irrespective 
of whether the challenge contained LPS, but the challenge did not alter 
expression of defensin-2 and lysozyme-1. A similar temporal pattern of 
expression was observed for all four genes, despite between-gene differences 
in the magnitude of fold-changes in expression. Increased expression was 
typically observed as early as two hours PIC, increasing to peak expression at 
between eight and 24 hours PIC, after which the response showed a gradual 
decline over the following six days (Figures 3.2. and 3.3.; see also supporting 
information). 
Antimicrobial activity at the protein/enzyme level typically succeeded 
upregulated gene expression following immune challenge. Specifically, a peak 
in activity was typically seen between 24 and 72 hours PIC, followed by a 
gradual decline over the days following this. At both the molecular and 
protein/enzyme levels Ringers injection induced a response compared with the 
naïve-control treatment and these responses were greater for LPS injection 
compared with the Ringers injection alone (Tukey’s HSD tests: P ≤ 0.05). 
Dietary pesticide affected AMP gene expression occasionally, and activity at the 
protein/enzyme level was apparently unaffected. Specifically, imidacloprid 
caused a reduction in abaecin titres, but only in naïve-control bees, and only in 
the short time course study (Experiment 4; Figure 3.2.; Pesticide*Injection: F2,82 
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= 4.701, P = 0.012). Dietary imidacloprid exposure also reduced defensin-1 
titres over the short time course exposure (Experiment 4; Pesticide: F1,82 = 
11.223, P = 0.001), but there were no detectable effects of imidacloprid on the 
expression of hymenoptaecin, apidaecin, defensin-2 or lysozyme-1 (see 
supporting information: Figures 3.5., 3.6.). In bees exposed to thiamethoxam, 
defensin-1 expression was suppressed (Experiment 4; Pesticide: F1,81 = 18.388, 
P ≤ 0.001; supporting information: Figure 3.8.), whilst apidaecin expression was 
increased 8-24 hours PIC (Pesticide*Time interaction F5,81 = 5.867, P ≤ 0.001; 
supporting information: Figure 3.7.). This upregulation, however, was not seen 
at the equivalent 24 hour time point in the longer time course study (Experiment 
5). Thiamethoxam exposure suppressed hymenoptaecin expression only in 
bees injected with Ringers and LPS, and within the first 24 hours post injection 
only (Pesticide*Injection*Time: F10,71 = 4.298, P ≤ 0.001). Again this effect was 
not detectable at the equivalent 24 hour time point in the longer time course 
study (Figure 3.3.). The effects of thiamethoxam on abaecin expression were 
transient, and reduced titres in naïve bees only at the 4 hour sampling 
(Pesticide*Injection*Time: F10,71 = 2.664, P = 0.008). 
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Figure 3.2. Antimicrobial response to artificial immune challenge over time in 
control-fed (black) and imidacloprid-exposed (white/grey) bees. Top plots: 
Physiological AMP activity (as measured by a lytic clearance assay). Bottom 
plots: Expression of the AMP gene, abaecin. Note other AMP genes (see text 
3.4.1.; supporting information) showed a similar temporal pattern. Plots on the 
left hand side show responses for a period of 2-48 hours post injection and plots 
on the right hand side for the responses of 1-7 days post injection. In all plots, 
symbols indicate sample means and error bars depict 1 SE. 
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Figure 3.3. Antimicrobial response to artificial immune challenge over time in 
control-fed (black) and thiamethoxam-exposed (white/grey) bees. Top plots: 
Physiological AMP activity (as measured by a lytic clearance assay). Bottom 
plots: Expression of the AMP gene, hymenoptaecin. Note other AMP genes 
(see text 3.4.1.; supporting information) showed a similar temporal pattern. 
Plots on the left hand side show responses for a period of 2-48 hours post 
injection and plots on the right hand side for the responses of 1-7 days post 
injection. In all plots, symbols indicate sample means and error bars depict 1 
SE. 
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3.4.2. Phenoloxidase gene expression and enzymatic activity 
Total proPO/PO activity was higher than PO activity, confirming that the method 
of haemolymph collection itself had not lead to activation of all the proPO 
precursor enzymes. Immune challenge had no detectable effect on either 
AmPPO gene expression or total proPO/PO activity. However, LPS-injection 
increased PO activity whereas injection alone did not (Experiment 3; Injection: 
F2,53 = 5.308 P = 0.008). The phenoloxidase cascade was largely unresponsive 
to treatments, and maintained a relatively stable level of activity throughout the 
experiments indicative of a constitutive role (Figure 3.4.). The exception was for 
total proPO/PO activity that was lower in imidacloprid-exposed bees (Pesticide: 
F1,53 = 5.527, P =  0.022). 
  
131 
 
 
 
 
Figure 3.4. Phenoloxidase response to artificial immune challenge over time in 
control-fed (black) and imidacloprid-exposed (white) bees. Top plots: 
Physiological activity; Left- Active (functional) PO response, Right- Inactive 
(potential) proPO response. Bottom plot: Expression of the proPO gene, 
AmPPO.  
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3.4.3. Sucrose consumption 
Consumption of imidacloprid-spiked sucrose was significantly lower than control 
sucrose, with the exception of the PO study in which no significant differences 
were observed. In general there were no significant differences between 
consumption by bees feeding on control and thiamethoxam-spiked sucrose. 
The exception to this was for bees in Experiment 4 where there was 
significantly reduced feeding in the thiamethoxam treatment (Wilcoxon Rank 
Sum: W = 1880, P = 0.008). Even when reduced feeding was observed in 
neonicotinoid-treated bees, bees ingested significant amounts of sucrose and 
consumed realistic doses of neonicotinoid (e.g. in Experiment 4, mean daily 
sucrose consumption in the four days prior to injection treatment for control-fed 
= 46 ± 3 mg bee-1; for imidacloprid-fed = 38 ± 4 mg bee-1; for thiamethoxam-fed 
bees = 36 ± 2 mg bee-1). There was no evidence that injection treatment altered 
sucrose consumption. 
 
3.5. Discussion 
Four antimicrobial effector genes showed a clear upregulation in response to 
the artificial immune challenge. The lack of observed response of lysozyme-1 is 
consistent with most of the previous studies of bacterial infection in honey bees 
(e.g. Yang and Cox-Foster, 2005, Evans, 2006). This may reflect the 
proposition that lysozymes act by hydrolysing the peptidoglycan cell wall 
(Gillespie et al., 1997) and so are more effective against Gram-positive bacteria, 
which have a thicker peptidoglycan layer. Therefore, it is perhaps not surprising 
that lysozyme-1 was not found to be upregulated in response to the LPS 
molecules from Gram-negative E.coli in the present study. The response to 
immune challenge differed between the two defensin genes tested (defensin-1 
and defensin-2), which is consistent with previous studies (Evans, 2006) and 
known differences in the regulation of the two genes (Klaudiny et al., 2005). 
The transcriptional changes in AMP genes in response to immune challenge 
that occurred in our study have probable functional significance because they 
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were accompanied by increases in antimicrobial activity at the protein/enzyme 
level. Wounding by injection alone induced an antimicrobial response, albeit to 
a lesser extent than injection with bacterial LPS, which is consistent with 
previous studies (Evans et al., 2006, Yang and Cox-Foster, 2005, Laughton et 
al., 2011). This wound-response to injection is probably biologically relevant 
because, for example, parasitic flies cause similar puncture wounds by inserting 
their ovipositors into the honey bee abdomen (e.g. Core et al., 2012). It is likely 
this AMP response to wounding allows pre-emptive induction of the immune 
system because most natural cases of wounding will inevitably be non-sterile 
(Erler et al., 2011). 
The phenoloxidase system was largely constitutive. Expression of the AmPPO 
gene was not altered following injection and this was supported by a lack of any 
change in the total proPO/PO activity. These results are comparable with 
previous studies, in which buffer or E.coli injection induced no transcriptional 
changes in AmPPO (Evans et al., 2006), and buffer or LPS injection induced no 
physiological changes in total proPO/PO activity in adult foragers (Laughton et 
al., 2011). In other studies, however, similar challenges have led to lower 
AmPPO expression (Yang and Cox-Foster, 2005) and, in newly emerged 
workers, lower total proPO/PO activity (Laughton et al., 2011). Here, PO activity 
was significantly higher following LPS injection, but our findings remain difficult 
to interpret as there was no clear temporal pattern in the phenoloxidase 
response (Figure 3.4.). Korner and Schmid-Hempel (2004) reported a 
significant effect of LPS injection on PO activity in worker bumble bees, but they 
too recognised that the temporal dynamics of the response were complex and 
difficult to interpret. 
The effects of neonicotinoid exposure on transcriptional responses in the 
antimicrobial component of honey bee immunity were weak and inconsistent. 
Moreover, neonicotinoid exposure did not affect the physiological activity of the 
antimicrobial response, measured by a lytic clearance assay. This suggests that 
induced transcriptional changes in the individual AMP genes due to 
neonicotinoid exposure may not actually impinge on bee health. This is perhaps 
because the insecticide evokes balancing trade-offs in its effects on the 
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expression of multiple antimicrobial genes as, for example, when thiamethoxam 
was found to suppress hymenoptaecin expression but increase apidaecin 
expression. Where transcriptional changes were observed these differed 
between the two neonicotinoid compounds. Generally expression was altered in 
a greater number of genes tested following exposure to 10 ppb thiamethoxam 
than to the much higher exposure to 102 ppb imidacloprid, but even in the case 
of thiamethoxam the results were inconsistent. Nevertheless we highlight that 
effects may differ between compounds despite their similar chemical properties 
and mode of action as nicotinic acetylcholine receptor agonists. There has been 
recent interest to identify suitable molecular biomarkers for pesticide risk 
assessment on bees (EFSA, 2012). However, our findings do not support the 
use in risk assessment of the immune-related molecular biomarkers tested here 
as there is currently no evidence for the functional significance of pesticide-
induced transcriptional changes in AMP genes, principally because we have 
shown that enzymatic/protein-level components of honey bee antimicrobial 
activity are resilient to neonicotinoid exposure. The patterns of gene expression, 
however, may be useful simply as indicators of neonicotinoid exposure. 
Our results show that exposure to imidacloprid impaired the potential for 
immune response by honey bees, as measured by the precursor proPO. This 
may be important for honey bee immune functioning if exposure to imidacloprid 
disrupts the prophenoloxidase cascade, including the release of reactive 
intermediates and the melanisation response, for example impairing the ability 
to heal wounding sites and/or encapsulate bacterial and fungal spores.  
Nevertheless, levels of the active functional enzyme, PO, were not found to be 
affected by the exposure to imidacloprid. As in other studies (e.g. Laughton et 
al., 2011, Roberts and Hughes, 2014), levels of both proPO and PO were highly 
variable in time, which makes it difficult to interpret the biological significance of 
imidacloprid’s effects on total proPO/PO activity given the apparent variable 
nature of the temporal response (Figure 3.4.). The overall effects of imidacloprid 
on measures of the prophenoloxidase cascade have been sometimes 
inconsistent among studies, but this may result in part from the use of different 
proPO/PO- related endpoints. For example, in a previous study (Gregorc et al., 
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2012), transcription of the prophenoloxidase-activating gene (PPOact) was 
increased when honey bee larvae were exposed to imidacloprid, but at a 
physiological level, in contrast, PO activity was unaffected by imidacloprid 
exposure in adult workers (Alaux et al., 2010). Overall, it appears that 
phenoloxidase markers likely do not provide a reliable and informative measure 
of pesticide effects on honey bee immunity at this time due to the uncertainty in 
their interpretation and biological relevance to natural infections. For example, 
proPO activity has been observed to be negatively correlated with Nosema 
spore load, but showed no correlation with individual bee survival (Roberts and 
Hughes, 2014), and in a separate study imidacloprid exposure was found to 
reduce spore load despite no observed effect on PO activity (Alaux et al., 2010). 
Our study begins to improve our understanding of the general relationships 
between transcriptional and physiological changes that underlie immune 
responses in honey bees. It is acknowledged that this work was conducted as a 
series of separate experiments on individual honey bee colonies and our 
findings must be interpreted in the context of this experimental setup. Our work 
begins to unravel the potential for differences in the response of different 
immune endpoints to pesticide exposure, but it is unclear from our findings 
whether this could result also from between-colony variation in pesticide 
sensitivity. Further work would benefit from studies designed to directly 
compare transcriptional and physiological changes of honey bees within a 
single colony, as well as to investigate these same measures in a number of 
colonies within and between seasons to increase the power of analyses to 
extrapolate findings to honey bee colonies as a whole. Further studies should 
establish also whether the apparent resilience of the immune response is 
observed using natural honey bee pathogens. For example, several AMP genes 
have been upregulated following infection with honey bee bacterial, fungal and 
microsporidian pathogens (Evans, 2004, Evans, 2006, Antunez et al., 2009), as 
well as in bumble bees infected with trypanosomal gut parasites (Riddell et al., 
2009, Riddell et al., 2011). These may be suitable systems in which further 
investigations should measure both transcriptional and physiological 
antimicrobial responses, both in the absence and presence of pesticide 
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exposure, as it is only by understanding functional responses that we can truly 
assess impacts on bee health. 
3.5.1. Conclusions 
Whilst these findings are yet to be confirmed in field colonies, we show no 
functionally significant impacts on honey bee immunity under laboratory 
conditions for neonicotinoid exposures that are likely to exceed most field 
relevant exposures. We are tentative in generalising our findings to bees under 
field conditions, however, because our experimental exposures were conducted 
for periods of up to 11 days whereas realistic exposures may be for longer 
periods. Furthermore we are tentative in generalising our findings to honey bee 
immunity as a whole, as we only tested a subset of endpoints and there are 
many other genes and enzymes, belonging to several pathways, in the honey 
bee immune system. In summary, our experiments showed an overall clear 
temporal pattern of AMP gene expression and physiological activity in response 
to a bacterial-like infection. This costly response could impact on bee health if it 
reduces the available resources for allocation to other needs. Transient 
transcriptional changes in AMP genes following neonicotinoid exposure were 
not found to be functionally significant, providing new evidence that this 
component of honey bee immunity may be more resilient to neonicotinoid 
exposure than previously thought based on molecular studies only. Responses 
to immune challenge were less marked in the PO system than those in the AMP 
system, which is likely to indicate a constitutive role of phenoloxidases in honey 
bee immunity. Exposure to imidacloprid impaired the potential for immune 
response by honey bees, as measured by the precursor proPO, whilst 
functional levels of active PO enzyme were apparently unaffected. The 
biological significance of imidacloprid’s effects on total proPO/PO activity 
remains unclear given the apparent variable nature of the temporal response, 
but the investigation of neonicotinoid effects on the prophenoloxidase cascade 
warrants further work given its role in the encapsulation of pathogenic cells and 
melanisation of wounding sites. 
3.5.2. Implications 
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This new evidence is useful to regulators pursuing potential sublethal 
biomarkers for bee health. Based on our results, we argue that gene expression 
bioassays, for those genes studied here, may not be reliable indicators of 
pesticide effects on honey bee immune functioning at a physiological (and 
biologically relevant) level, although they may be useful in determining whether 
exposure has occurred. 
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3.8. Supporting information 
 
 
Figure 3.5. Antimicrobial response to artificial immune challenge over time in 
control-fed (black) and imidacloprid-exposed (white/grey) bees. Top plots: 
Expression of the AMP gene, apidaecin. Bottom plots: Expression of the AMP 
gene, hymenoptaecin. Plots on the left hand side show responses for a period 
of 2-48 hours post injection and plots on the right hand side for the responses of 
1-7 days post injection. In all plots, symbols indicate sample means and error 
bars depict 1 SE. 
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Figure 3.6. Antimicrobial response to artificial immune challenge over time in 
control-fed (black) and imidacloprid-exposed (white/grey) bees. Clockwise from 
top-left plot: Expression of the AMP genes defensin-1, defensin-2 and 
lysozyme-1, for a period of 2-48 hours post injection. In all plots, symbols 
indicate sample means and error bars depict 1 SE. 
  
145 
 
 
 
Figure 3.7. Antimicrobial response to artificial immune challenge over time in 
control-fed (black) and thiamethoxam-exposed (white/grey) bees. Top plots: 
Expression of the AMP gene, abaecin. Bottom plots: Expression of the AMP 
gene, apidaecin. Plots on the left hand side show responses for a period of 2-48 
hours post injection and plots on the right hand side for the responses of 1-7 
days post injection. In all plots, symbols indicate sample means and error bars 
depict 1 SE. 
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Figure 3.8. Antimicrobial response to artificial immune challenge over time in 
control-fed (black) and thiamethoxam-exposed (white/grey) bees. Clockwise 
from top-left plot: Expression of the AMP genes defensin-1, defensin-2 and 
lysozyme-1, for a period of 2-48 hours post injection. In all plots, symbols 
indicate sample means and error bars depict 1 SE. 
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4. The immune response of the bumble bee (Bombus terrestris 
L.) is resilient to dietary imidacloprid in field realistic exposures 
 
4.1. Abstract 
Multiple stressors, including pesticide application and the spread of pathogens 
and parasites, are likely contributing to declines in bee health. Recent 
recommendations for the risk assessment of plant protection products on bees 
have included the need for a better understanding of pesticide-disease 
interactions and the development of biomarkers to evaluate sublethal effects of 
pesticide exposure, such as immune system changes. Studies have begun to 
investigate the biological mechanisms underlying pesticide-disease interactions 
in honey bees, and there is some evidence that exposure to neonicotinoid 
pesticides impairs the honey bee immune response. However, there has been 
no investigation of neonicotinoid effects on the bumble bee immune response 
despite recognition that the sensitivity to neonicotinoids, and endpoints 
appropriate for risk assessment, could differ between bee species. We 
conducted a laboratory study to investigate the effects of a chronic exposure to 
a dietary neonicotinoid on the immune response of the bumble bee (Bombus 
terrestris audax). We tested whether imidacloprid exposure impaired the ability 
of workers to respond to an artificial immune challenge with bacterial 
lipopolysaccharides (LPS) by measuring two components of the insect immune 
response- phenoloxidase (PO) enzyme activity (associated with a melanisation 
response), and antimicrobial protein (AMP) activity. Neither immune challenge 
nor imidacloprid exposure was found to affect the apparently constitutive PO 
activity. Injection with LPS induced AMP activity and this was impaired in bees 
exposed to imidacloprid in sucrose solution at 125 µgL-1, but not at field relevant 
imidacloprid exposures. Our results begin to suggest that these two immune-
related endpoints will have limited use in pesticide risk assessment in bumble 
bees, but further work should investigate whether pesticide exposures impair 
the immune response to natural pathogen infections. 
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4.2. Introduction 
Many wild plant communities and agricultural and horticultural crops rely on 
animal pollinators (Wilcock and Neiland, 2002, Kearns et al., 1998), including 
honey bees, bumble bees, stingless bees and solitary bees (Klein et al., 2007). 
In recent years, there has been increasing evidence of declines in populations 
of both managed honey bees (vanEngelsdorp et al., 2008) and wild bumble 
bees (Goulson et al., 2008, Williams and Osborne, 2009). Multiple stressors, 
including pesticide exposure and the spread of pathogens and parasites, are 
likely to be contributing to global declines in bee health (Potts et al., 2010). 
Bumble bees are susceptible to a wide range of pathogens and parasites, 
including microsporidia (Otti and Schmid-Hempel, 2007), viruses (Graystock et 
al., 2013), trypanosome protozoa (Shykoff and Schmid-Hempel, 1991), mites 
(Otterstatter and Whidden, 2004) and flies (Schmid-Hempel et al., 1990). The 
ability to mount an immune response against pathogen infection and parasite 
attack, or immunocompetence, is probably important to bee health (e.g. Brown 
et al., 2003), and to the sustainability of bee populations. Recent concerns have 
focussed on the impact of neonicotinoid pesticides on bumble bee health (e.g. 
Gill et al., 2012, Whitehorn et al., 2012, Laycock et al., 2012), which has 
contributed to the introduction of a two-year restriction on the use of three 
neonicotinoid pesticides by the European Commission (2013) until further 
research clarifies their effects on pollinators. Here, we tested the hypothesis 
that neonicotinoid exposure could harm bee health by affecting 
immunocompetence, which could increase the susceptibility of bees to infection 
and augment population declines. 
Recent studies have found evidence that neonicotinoid exposure may interact 
with pathogen infection to reduce survival in worker honey bees (e.g. Vidau et 
al., 2011, Doublet et al., 2015, Retschnig et al., 2014), perhaps because 
neonicotinoids impair the honey bee immune response (e.g. Alaux et al., 2010, 
Di Prisco et al., 2013) and increase pathogen loads (e.g. Vidau et al., 2011, 
Pettis et al., 2012). However, sensitivity to neonicotinoids differs between honey 
bees (Apis spp.) and bumble bees (Bombus spp.) (Cresswell et al., 2012), and 
endpoints appropriate for pesticide risk assessment should therefore be 
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investigated carefully (European Food Safety Authority, EFSA, 2013, Thompson 
and Hunt, 1999). Despite this, only two studies to date have investigated 
neonicotinoid-pathogen interactions in bumble bees, and both were in relation 
to laboratory infection with the trypanosome gut parasite Crithidia bombi. 
Susceptibility of worker bumble bees to C. bombi and the intensity of C. bombi 
infection within individual bees were not affected by exposure to the 
neonicotinoids thiamethoxam and clothianidin (Baron et al., 2014, Fauser-
Misslin et al., 2014). However, longevity of the foundress queen was reduced 
when bumble bee colonies were challenged with both neonicotinoid exposure 
and C. bombi infection (Fauser-Misslin et al., 2014). As yet, however, there has 
been no investigation of neonicotinoid effects on the bumble bee immune 
response at a molecular or physiological level, which could reveal the 
mechanistic basis of neonicotinoid effects on bumble bee health. Investigation 
of the molecular and physiological basis is timely, however, because the recent 
guidance document on the risk assessment of plant protection products on bees 
released by EFSA (2013) recommended the development of biomarkers to 
evaluate sublethal effects of pesticide exposure, such as immune system 
changes. We therefore report a laboratory study that was performed to 
investigate the effects of a chronic oral neonicotinoid exposure on the immune 
response of the bumble bee (Bombus terrestris audax). 
The immune response in individual bumble bees is comprised primarily of 
cellular responses such as phagocytosis and encapsulation, and humoral 
responses via the phenoloxidase (PO) cascade (leading to melanisation) and 
antimicrobial protein (AMP) effectors (Hoffmann, 1995). Whilst bumble bees 
may also use some behavioural defences against parasitic attack (e.g. 
Hoffmann et al., 2008), they lack the complex social structure and many of the 
behavioural defences seen in honey bee colonies, so the innate immune 
response may be of greater importance to individual bumble bees compared to 
honey bees. Here, we tested whether imidacloprid exposure impaired the ability 
of workers to respond to an artificial immune challenge with Escherichia coli 
lipopolysaccharides (LPS) by measuring two components of the insect immune 
response: PO enzyme activity; and AMP activity. We used an artificial immune 
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challenge that mimics a bacterial-like infection, which allowed us to standardise 
the induction of an immune response across individual bees, avoiding the 
technical difficulties of controlling the titres of a live pathogen. In addition, it 
avoids the confounding responses of a live pathogen that may also respond to 
the neonicotinoid. 
PO is present in insect haemolymph as an inactive precursor enzyme, 
prophenoloxidase (proPO), which can be activated to PO for subsequent 
production of melanin to isolate pathogens from access to host resources, as 
well as production of reactive intermediates toxic to pathogens (Wilson-Rich et 
al., 2009). We measured the total level of inactive proPO and active PO as an 
indicator of the potential immune response, and the level of active PO as an 
indicator of the functional PO present in the haemolymph at the given sampling 
time.  
AMPs, including lysozymes, are typically synthesised by the fat body in 
response to detection of a pathogen within the insect haemolymph, although 
other tissues, including the Malphigian tubules and midgut may also play a role 
in AMP production (Gillespie et al., 1997). These AMPs may possess inhibitory 
properties against Gram-negative and Gram-positive bacteria and some fungi 
(Rees et al., 1997), and several bee AMP genes have been found also to be 
upregulated in response to trypanosome protozoa (Riddell et al., 2011) and 
microsporidian pathogens (Antunez et al., 2009).  
In summary, our study aimed to evaluate the effects of neonicotinoid exposure 
on bumble bee immunity, and to explore the potential value of two physiological 
immune endpoints for pesticide risk assessment in field-relevant scenarios. 
 
4.3. Materials and methods 
In two experiments, individually housed bumble bee workers were exposed to 
an imidacloprid-spiked sucrose feed or control sucrose for an initial period of 
four days. On day five, workers were injected with LPS as an artificial immune 
challenge, and then exposed continuously to the same imidacloprid or control 
151 
 
 
feeding treatment. Haemolymph samples were collected for measurement of 
immune responses at various intervals ‘post immune challenge’ (PIC) as 
described below. 
In the ‘time course’ experiment, denoted ‘TC’, we characterized the 
development of the PIC immune response to select the optimum time for testing 
pesticide impacts. Specifically, we measured PO and AMP activity at intervals 
of 8, 24 and 48 hours (h) PIC after exposing bees to imidacloprid in dietary 
sucrose at either a ‘low dose’ of 2.6 parts per billion (ppb) or a ‘high dose’ of 
102 ppb (Figure 4.1.). In the ‘dose-response’ experiment, denoted ‘DR’, we 
exposed bees to one of ten imidacloprid doses up to 102 ppb (see below), and 
subsequently measured AMP activity at 48 h PIC (Figure 4.2.). 
 
Figure 4.1. Schematic of time course (TC) experimental setup. For each 
pesticide exposure (top white boxes), bees received one of two immune 
challenges (middle grey boxes). For each pesticide/immune combination, 
samples were collected across a short time course. *Sampling at 0 h post 
immune challenge (PIC) was taken only from naïve samples. Samples were 
then analysed to measure one of two immune endpoints (bottom grey ellipses). 
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Figure 4.2. Schematic of dose-response (DR) experimental setup. For each 
pesticide exposure (top white boxes), bees received an immune challenge via 
injection with LPS molecules. *Additionally in the control, 2.6 ppb and 102 ppb 
exposures, a manipulation-control group, denoted ‘naïve’, were ice-immobilised 
but received no further immune challenge. Samples were collected at 48 h post 
immune challenge (PIC) and subsequently analysed to measure antimicrobial 
activity. 
 
4.3.1. Bumble bee provenance and husbandry 
Worker bumble bees (Bombus terrestris audax) were collected from 
domesticated colonies (Biobest Belgium N.V.) and housed in modified plastic 
cages (FK-RD8 clear PET containers; Ambican UK Ltd). Each cage allowed ad 
libitum access to a sucrose solution (50 % w/v) through a modified 
microcentrifuge tube (1.5 ml; Eppendorf UK Ltd) and was maintained in an 
environmental chamber throughout the experimental period (26 °C, 50 % 
relative humidity, constant darkness; Sanyo Versatile Environmental Test 
Chamber). 
4.3.2. Neonicotinoid exposure 
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Bees were exposed to an imidacloprid exposure between 0.1 ppb and 102 ppb 
in sucrose solution (50 % w/v). Treated sucrose was spiked with 0.08, 0.20, 
0.51, 1.28, 3.20, 8.00, 20.00, 50.00 or 125.00 µg L-1 imidacloprid (Fluka 
Analytical 37894) (≈ 0.1, 0.2, 0.4, 1.0, 2.6, 6.5, 16.3, 40.7 and 101.7 ppb 
respectively). Treatment cages allowed ad libitum access to a single level of 
spiked sucrose throughout the experimental period, during which no other food 
source was available. Control bees received sucrose containing < 0.1 % 
acetone to control for the solvent in which original pesticide stocks were 
dissolved. The feeder of each cage was weighed every other day to allow an 
estimate of the mean daily sucrose consumption per bee to be calculated 
(accounting for any evaporation using feeders kept in empty cages). 
4.3.3. Immune challenge 
Bumble bees were immobilised on ice for injection treatments, which were 
performed using a Hamilton syringe. Bumble bees were injected with 6 µl of 
solution through the pleural membrane between the sternites (ventral side) of 
the abdomen. The ‘LPS’ treatment group were injected with 0.5 mgml-1 LPS 
(Sigma L2755- Lipopolysaccharides from Escherichia coli 0128:B12) dissolved 
in Insect Ringers solution (1:1:1 156 mM NaCl : 3 mM KCl : 2 mM CaCl2). This 
LPS concentration has been widely used previously to elicit an immune 
response in bumble bees without any acute effects on survival (e.g. Korner and 
Schmid-Hempel, 2004, Moret and Schmid-Hempel, 2000). A manipulation-
control group, denoted ‘naïve’, were ice-immobilised but received no further 
treatment. 
In general < 5 % of bees died during the experimental period and these were 
distributed across imidacloprid and injection treatments, confirming that the 
pesticide concentrations and immune challenges used were sublethal to worker 
bumble bees. 
4.4.4. Measurement of PO activity  
A ‘perfusion-bleed’ method was used to collect haemolymph samples from bees 
that had first been immobilised on ice. Specifically, a small slit was made in the 
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abdominal tergites using sterile dissecting scissors. A microsyringe was used to 
insert 300 µl sodium cacodylate (NaCac) between the head and thorax and 
after this was flushed through the body it emerged through the slit in the 
abdomen, along with the haemolymph, and was collected in a microcentrifuge 
tube. Each sample was immediately snap frozen in liquid nitrogen to disrupt the 
haemocytes, releasing any proPO or PO enzymes present, and then stored at -
20 °C for later analysis. 
Two spectrophotometry assays were used to measure: (i) PO activity; and (ii) 
total proPO and PO activity (based on Laughton and Siva-Jothy, 2011). 
Samples were centrifuged (9600 RPM, 10 minutes, 4 °C) and kept on ice. For 
the PO assay, 5 µl of phosphate buffer solution (PBS) were added to the bottom 
of each well in a 96-well plate. For the total proPO/PO assay, 5 µl of α-
chymotrypsin (5 mgml-1; Sigma C4129) were added to the bottom of each well. 
10 µl of sample (supernatant) were added to each well, the plate was then 
shaken and left at room temperature for five minutes to allow the α-
chymotrypsin to activate any proPO in the sample. The plate was then placed 
back on ice and 175 µl L-Dopa mastermix [containing 20 μl L-Dopa solution 
(saturated 11 mgml-1, then filtered; Acros Organics 167530050, Fisher 
Scientific, UK), 20 μl PBS, 135 μl water] were added to each well. The plate 
was then shaken and the reaction allowed to proceed at 25 °C in a 
spectrophotometer (ThermoMax microplate reader, Molecular Devices). 
Absorbance was measured at 490 nm every 15 seconds (shaking between 
reads) for 1 hour 15 minutes (= 4500 seconds). A blank was used containing 10 
µl NaCac in place of sample, but otherwise contained the same reaction 
mixture. Each sample was measured in duplicate for each assay and 
treatments were assigned across plates to minimise between plate variation. 
Softmax Pro v4.3 software (Molecular Devices, UK) was used to calculate 
enzyme activity measured as the maximum linear rate of substrate conversion 
(Vmax), using 100 Vmax points, across the 4500 s reaction period. 
4.4.5. Measurement of AMP activity 
155 
 
 
Haemolymph was collected from bees that had first been immobilised on ice. A 
small slit was made in the abdominal sternites using sterile dissecting scissors 
and gentle pressure to the thorax resulted in a bubble of haemolymph exiting 
this slit. 2-10 µl of this neat haemolymph were collected with a pipette and 
immediately stored at -20 °C for later analysis.  
AMP activity was measured using a bacterial inhibition assay (based on Korner 
and Schmid-Hempel, 2004). Here, antimicrobial proteins in the haemolymph 
inhibit the growth of the test bacteria, producing a clear zone in the bacterial 
culture that can be measured as an indicator of the relative antimicrobial activity 
of each sample (the greater the zone diameter the greater the antimicrobial 
activity). A fresh culture of Micrococcus luteus Schroeter was grown on 
Columbia Blood Agar. A single pure colony of M.luteus was placed into 10 ml 
nutrient broth and incubated overnight at 27 °C. 100 µl of this overnight culture 
were used to inoculate 100 ml sterile broth medium (containing 1 % agar). 6 ml 
of inoculated medium were immediately poured into a 9 cm-diameter petri dish 
and left to set. Ten wells (approximately 2 mm diameter) were bored on each 
plate. Neat haemolymph samples were thawed on ice and a 2 µl sample was 
added to each well. Plates were incubated at 27 °C for 24 h, and the diameter 
of the zones of inhibition then measured using digital callipers. 
4.4.6. Data analysis 
In the DR experiment, the effect of imidacloprid was non-monotonic with dose 
so dosages were treated as levels of a categorical variable and effects were 
therefore tested using one-way ANOVA. Where ANOVA results were 
significant, pairwise differences between treatments were tested by Tukey’s 
HSD.  
In the TC experiment, data did not meet the assumptions for parametric testing, 
so effects of injection, pesticide and time were tested using a Monte Carlo 
ANOVA implemented in R (R Core Team, 2013). Specifically, the data were 
pooled, randomly resampled and allocated among the treatments to recreate 
the dimensions of the original dataset, and then analysed by conventional 
factorial ANOVA with LPS challenge, neonicotinoid diet and duration of 
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exposure as fixed factors. For each randomization, the F-statistics were stored 
and 10,000 iterations of the resampling-ANOVA procedure were performed to 
produce the sampling distributions of the test statistics under the null 
hypotheses. These sampling distributions were then used to determine P values 
for the factor effects present in the observed data sets. 
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4.4. Results 
4.4.1. Treatment effects on feeding rates 
Dietary imidacloprid affected the bees’ consumption of feeder sucrose (Expt TC 
One-way ANOVA: F2,193 = 42.3, P ≤ 0.001; Expt DR Two-way ANOVA: F9,90 = 
7.24, P ≤ 0.001), but only at imidacloprid concentrations ≥ 6.5 ppb (Figure 4.3.). 
Injection treatment had no observable effect on feeding rate in the 48 h PIC 
(Figure 4.3.B). Despite the reduced feeding with increased imidacloprid 
concentration, bees exposed to the higher imidacloprid concentrations ingested 
larger amounts of imidacloprid (e.g. mean imidacloprid intake at 2.6 ppb = 0.34 
ng bee-1 day-1; at 102 ppb = 4.1 ng bee-1 day-1). 
 
 
 
 
Figure 4.3. Effects of dietary imidacloprid (x-axis, µgL-1) on daily consumption of 
feeder sucrose (y-axis, g bee-1 day-1). A. Daily sucrose consumption for the four 
days prior to injection treatment in Expt TC. B. Daily sucrose consumption for 
the 48 h PIC in Expt TC. In both panels, symbols indicate sample means and 
error bars depict 1 SE. Some data points are adjusted slightly on the x-axis to 
reveal error bars (for exact imidacloprid concentrations see text). Squares 
indicate LPS-injected bees and circles indicate naïve manipulation controls. 
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4.4.2. Time course of immune response to the simulated pathogen infection (TC 
experiment) 
Neither injection nor dietary imidacloprid affected immune potential, measured 
by total proPO/PO activity, or functional PO activity within the timescale tested 
(Figure 4.4.; total proPO/PO ANOVA Injection F1,89 = 1.46, Imidacloprid F2,89 = 
1.37; PO Monte Carlo ANOVA Injection F1,89 = 0.081, Imidacloprid F2,89 = 0.009, 
P values > 0.05). 
   
 
Figure 4.4. Measures of phenoloxidase activity (y-axis, Vmax) over time (x-axis, h 
PIC) in individual bumble bee workers. A. Total proPO/PO activity (‘immune 
potential’); and B. Functional PO activity. Squares indicate LPS-injected bees 
and circles indicate naïve manipulation controls. Only data for control sucrose 
(open symbols) and 102 ppb imidacloprid (closed symbols) presented. n = 4 to 
6 bees per treatment/time point combination. In both panels, symbols indicate 
sample means and error bars depict 1 SE. Some data points are adjusted 
slightly on the x-axis to reveal error bars (for exact times PIC see text).  
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Across the 8 - 24 h PIC, immune challenge induced AMP activity, with a mean 
increase in the LPS-injected bees of 6.1 mm (SE = 1.4, n = 20). Activity 
generally increased with time PIC (Figure 4.5.; Linear regression, F1,21 = 5.83, P 
= 0.025, R2 = 0.217). 
In the TC experiment, dietary imidacloprid had no significantly detectable effect 
on AMP activity (Monte Carlo ANOVA F2,60 = 0.045, P > 0.05), but this is 
probably because sample sizes were small. However, inspection suggests that 
bees exposed to the highest dose of imidacloprid (125 µgL-1; ≈ 102 ppb) may 
have showed a weaker AMP activity in response to LPS challenge. i.e. at 48 h 
PIC mean zones of inhibition were 4.7 mm (SE =  2.4, n = 3) in bees fed 125 
µgL-1 imidacloprid vs. 12.5 mm (SE = 3.2, n = 3) in bees fed control sucrose. 
 
Figure 4.5. AMP activity (y-axis, inhibition zone) over time (x-axis, h PIC) in 
individual bumble bee workers. Squares indicate LPS-injected bees and circles 
indicate naïve manipulation controls (naïve individuals showed no AMP activity 
in all cases). Symbols show mean activity in individual bees pooled from all 
three imidacloprid treatments and error bars depict 1 SE. n = 7 or 8 bees per 
injection/time combination. 
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4.4.3. Dose response effects (DR experiment) 
Based on TC (above), we selected 48 h PIC to investigate pesticide effects on 
AMP activity.  
Dietary imidacloprid affected AMP activity in LPS-challenged bumble bees 
(One-way ANOVA: F10,50 = 4.04, P ≤ 0.001; Figure 4.6.). However, the effects of 
dosage were not strictly monotonic (Figure 4.6.), although bees exposed to the 
highest dose of imidacloprid produced the lowest AMP activity PIC. Specifically, 
post hoc testing found significant pairwise differences in AMP activity only 
between 0.08 µgL-1 vs. 125 µgL-1 and 0.08 µgL-1 vs. 3.20 µgL-1, and there were 
no significant pairwise differences between control-fed and imidacloprid-fed 
bees. 
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Figure 4.6. Effects of dietary imidacloprid (x-axis, µgL-1) on AMP activity (y-axis, 
inhibition zone) in individual bumble bee workers 48 h PIC following LPS 
injection. Data for naïve manipulation controls are not shown, as typically no 
AMP activity was detectable. Symbols indicate sample means and error bars 
depict 1 SE. n = 5 bees per treatment. Some data points are adjusted slightly 
on the x-axis to reveal error bars (for exact imidacloprid concentrations see text. 
Open symbol indicates control sucrose and black closed symbol indicates 102 
ppb). Dashed horizontal line indicates mean for control sucrose. *Asterisks 
show post hoc testing significant pairwise differences in AMP activity between 
0.08 µgL-1 vs. 125 µgL-1 and 0.08 µgL-1 vs. 3.20 µgL-1. 
 
4.5. Discussion 
Our results show that bumble bee immunocompetence is resilient to an 
exposure of dietary imidacloprid at concentrations up to 102 ppb even though 
individual bees exhibited toxic responses in the form of reduced feeding at 
dosages as low as 6.5 ppb, which is consistent with previous studies (Cresswell 
et al., 2012, Laycock et al., 2012). Our attribution of resilience is based on the 
following two observations. 
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First, our results suggest that the phenoloxidase system provides constitutive 
immunity and that its status is resilient to imidacloprid exposures as high as 102 
ppb. Specifically, following an artificial immune challenge with bacterial LPS we 
found no increase in proPO or PO activity compared to baseline levels. 
Furthermore, we found no effect of imidacloprid exposure on total proPO/PO or 
PO activity whether the bees were challenged by LPS injection or not. These 
findings for the PO system are similar to a previous study of honey bees, in 
which a chronic exposure to imidacloprid had no effect on PO activity (Alaux et 
al., 2010). Although we found that the PO response was not inducible, previous 
studies have observed also that responses of the bee PO system to LPS 
injections are variable over time and difficult to interpret (e.g. Korner and 
Schmid-Hempel, 2004, Laughton et al., 2011). 
Second, we show that AMP induction in bumble bees is resilient to field relevant 
imidacloprid exposures. In fact, we found no significant differences in AMP 
activity between control-fed and imidacloprid-fed bumble bees up to 102 ppb. 
Although residues as high as 101 ppb have been found in pollen from 
transplant-dripped neonicotinoid-treated pumpkin crops (Dively and Kamel, 
2012), residues found in nectar and pollen in the field are typically much lower 
(1-10 ppb) (Blacquiere et al., 2012, Pohorecka et al., 2012). We found some 
evidence that imidacloprid exposure alters AMP activity, as AMP levels were 
found to be lower in bees exposed to 2.6 ppb and 102 ppb imidacloprid 
compared to 0.1 ppb imidacloprid in the DR experiment. In both experiments 
bees exposed to the highest dose of imidacloprid (102 ppb) produced the 
lowest AMP activity PIC, but the overall effects of dosage were not strictly 
monotonic. Our two experiments investigated effects on immunocompetence in 
individual bumble bees each from a single colony, using relatively small sample 
sizes. The experimental setup likely limits the power of our analyses to detect 
differences between treatment groups and our findings must be interpreted with 
caution when generalising to all bumble bee colonies in the field. Further 
studies are needed to better elucidate the potential effects on AMP activity 
observed at 2.6 and 102 ppb imidacloprid. Nevertheless, the weakened 
responses observed following exposure to 2.6 and 102 ppb imidacloprid offer 
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the first evidence in any insect species showing that an oral pesticide exposure 
may be capable of impairing the AMP component of the immune response. 
Based on our experiment, we can evaluate potential mechanisms underlying 
this apparent toxic effect as follows. Induction of an immune response is 
energetically costly (Moret and Schmid-Hempel, 2000) and dietary imidacloprid 
may have limited the resources available to induce the AMP system because it 
also reduced the feeding rates of individual bees. However, at imidacloprid 
concentrations between 6.5 and 41 ppb AMP levels were apparently sustained 
despite impaired feeding rates. Furthermore, there was no apparent increase in 
feeding rates in immune challenged bees to compensate for higher energy 
demands. We therefore conclude that limited energy resources alone do not 
appear to account for the variation in AMP induction. Instead, there may be 
trade-offs in the allocation of resources for pesticide detoxification and the AMP 
immune response when bumble bees are simultaneously exposed to a 
pesticide and pathogen infection. For example, exposure to imidacloprid 
degenerates the Malphigian tubules in honey bees (Rossi et al., 2013), and if 
this occurs also in bumble bees it could compromise AMP production. Other 
sites for potential trade-offs include the fat body, haemocytes and midgut, since 
these are all known to be involved in both AMP synthesis (Gillespie et al., 1997) 
and pesticide detoxification in honey bees (e.g. Mao et al., 2011, Hodgson, 
1983). 
 
4.5.1. Evaluation of the threat posed by dietary neonicotinoids to bee health 
Our findings begin to suggest that bumble bee immunocompetence is resilient 
to dietary neonicotinoids at field-relevant exposures, although there are several 
limitations to our study. First, we conducted imidacloprid exposures for periods 
of only 6 days, but bees may be exposed for longer periods in the wild. For 
example, oilseed rape (Brassica napus L.) blooms for several weeks (Pernal 
and Currie, 1998) so bumble bees foraging on treated crops could be exposed 
throughout their foraging life of 2 - 3 weeks (Rodd et al., 1980). Second, our 
study only measured AMP activity up to 48 h PIC, but the bumble bee AMP 
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response to LPS injection has been observed up to 14 days later (Korner and 
Schmid-Hempel, 2004). Consequently, it is possible that the resilience declines 
with time. Third, we did not measure colony-level responses, such as pathogen 
levels and the development of new bees and reproductive individuals, which are 
critical to population sustainability. Furthermore, it is acknowledged that our 
study investigated effects in individually housed bees in order to ensure each 
test individual was exposed to the imidacloprid-spiked sucrose, but in a colony 
setting bees will inevitably be in contact with other colony members. PO and 
AMP immune responses have been found to be dependent on the social 
context of bumble bees (Ruiz-Gonzalez et al., 2009) and therefore further 
understanding at the colony-level is important to better understand realistic 
scenarios of pathogen and pesticide exposure. In line with this, our laboratory 
study did not offer access to pollen feeding, but bumble bees deprived of a 
protein source have previously shown altered immune responses to infection 
(Brunner et al., 2014). It remains unclear whether the apparent resilience of the 
bumble bee immune response to dietary neonicotinoids can be generalised to 
both pollen-fed and socially-grouped bumble bees. 
The biological relevance of the PO and AMP responses to natural bumble bee 
infections needs further investigation. For example, here we cannot verify 
whether the AMP response was induced directly by the bacterial LPS molecules 
or wounding during injection. The increase in AMP activity relative to naïve 
manipulation controls is likely, however, a response to a combination of the 
wounding and LPS, as previous studies in bumble bees and honey bees have 
demonstrated induced AMP activity in response to placebo injection, with a 
further elevated reponse to LPS (e.g. Korner and Schmid-Hempel, 2004). Here, 
a wounding-like response may have some biological relevance as wounding is 
likely to occur when bees are parasitised by mites and flies, which are both 
common parasites of bumble bees (Kissinger et al., 2011, Shykoff and Schmid-
Hempel, 1991). Furthermore, the AMP response is probably a fundamental 
defence against a wide range of pathogens. There is molecular evidence that 
the AMP response is induced in bumble bees infected with the trypanosome gut 
parasite C. bombi (Riddell et al., 2011), although no induction has been 
165 
 
 
detected at the protein level (Brown et al., 2003). Similarly, there is molecular 
evidence for AMP induction in honey bees infected with natural bacterial, fungal 
and microsporidian pathogens (Evans, 2004, Evans, 2006, Antunez et al., 
2009). Further work should establish whether realistic pesticide exposures 
impair the immune response to natural pathogen infections and evaluate 
interactions between pesticides and pathogens using endpoints relevant to 
population dynamics. 
 
4.5.2. Implications for regulatory risk assessment 
Overall, our data gives little support for the use of PO and AMP immune 
endpoints in individual bees as a basis for the risk assessment of sublethal 
effects of pesticides on bumble bees. PO activity appears to be a constitutive 
system for defending against infection that is unresponsive to dietary 
imidacloprid in field-relevant exposures. By contrast, AMP activity was clearly 
induced by a simulated pathogen attack, but it too was generally unaffected by 
field relevant exposures. Our observations of the resilience of the systems that 
underpin bumble bee immunocompetence under field-relevant exposures 
provisionally provide no support for the use of immune endpoints in pesticide 
risk assessment, at least when measured by physiological titres as biomarkers. 
However, our results do not rule out the possibility that pesticide-pathogen 
interactions may impact detrimentally on bumble bees when the effects are 
measured in other ways, such as by colony performance or on other 
ecologically relevant endpoints. 
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5. Disruption of hypopharyngeal gland function in honey bees 
exposed to a dietary neonicotinoid (imidacloprid) 
5.1. Abstract 
The neonicotinoid imidacloprid impairs development of the honey bee (Apis 
mellifera) hypopharyngeal gland (HPG), but whether HPG function is 
correspondingly disrupted has been untested, which undermines the ecological 
relevance of HPG-related assays in pesticide risk assessment. To determine 
whether imidacloprid indeed disrupts HPG function, we therefore implemented 
laboratory and field studies, using enzymatic, molecular and behavioural 
endpoints. Specifically, we investigated whether dietary exposure affected 
temporal polyethism, and the enzyme systems that support larval nutrition 
(major royal jelly proteins, or MRJPs) and social immunity (glucose oxidase, or 
GOX). Dietary imidacloprid induced the upregulation of foraging genes, and we 
hypothesised a predisposition to precocious foraging. However, using Radio 
Frequency Identification (RFID) technology to track hive traffic in free-flying 
bees, we found no corresponding behavioural consequences at field-relevant 
exposures. We demonstrate for the first time that chronic imidacloprid exposure 
reduced the expression of genes for MRJPs, which could impact on the nutrition 
of larvae and queens. We found that GOX is a constitutive enzyme system but 
that imidacloprid exposure lowered levels of GOX in immune-challenged bees, 
which implicates disruption to the social immune response. Overall, we detected 
generalised disruption of HPG function following exposure to imidacloprid and 
we believe this provides new support for the ecological relevance of HPG-
related assays in pesticide risk assessment. Some disruption (temporal 
polyethism) was not evidently ecologically consequential, highlighting the need 
to cross reference gene expression bioassays with ecologically relevant 
behaviour. Disruption to other functions (namely nutrition and social immunity) 
is likely to be important and requires further field testing.   
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5.2. Introduction 
Declines in honey bee (Apis mellifera L.) health have been a focus of recent 
scientific and public concern due to the potential impact on the pollination of 
crops and wild flowering plants (Potts et al., 2010). Multiple stressors are likely 
contributing to declines in honey bee health, including habitat loss, pathogenic 
infection and pesticide application (Potts et al., 2010). One class of pesticides, 
the neonicotinoids, has been of particular concern due to the potential exposure 
of bees through residues in nectar and pollen of mass-flowering crops (e.g. 
Stoner and Eitzer, 2012). Several studies have reported sublethal effects of 
neonicotinoid exposure on honey bee physiology and behaviour, including a 
weakened immune response (Alaux et al., 2010), impaired learning ability 
(Decourtye et al., 2004) and decreased foraging success (Henry et al., 2012). 
Additionally, several studies have found that oral exposure to sublethal doses of 
a neonicotinoid pesticide, imidacloprid, reduced the size of honey bee 
hypopharyngeal glands (HPGs) (Heylen et al., 2011, Skerl and Gregorc, 2010, 
Hatjina et al., 2013). Disruption to the HPGs could have profound 
consequences for individual and colony function if these imidacloprid-induced 
changes alter normal HPG functioning, but these possible consequences have 
yet to be investigated. Here we consider three aspects of honey bee biology 
that are associated with HPG activity, and aim to address whether imidacloprid 
exposure impairs these processes. First we consider the HPGs’ role in honey 
bee worker temporal polyethism (i.e. the age-dependent division of labour). 
Then we consider the secretory role of HPGs for the production of enzymes 
involved in larval nutrition (major royal jelly proteins, or MRJPs) and social 
immunity (glucose oxidase, or GOX). These mechanisms are introduced below, 
along with the endpoints used in this study to measure their relative activity in 
honey bees exposed to different pesticide and immune treatments. 
We note that these hypothesised consequences of pesticide-induced 
physiological changes to HPGs explain the recommendation that HPG 
assessments be included in the European Union’s new protocols for the risk 
assessment of plant protection products on bees (European Food Safety 
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Authority, EFSA, 2013). However, there is a lack of studies validating these 
hypotheses and testing their environmental relevance, without which we cannot 
assess the colony-level impacts of pesticide-induced changes in HPG 
development. Our study aims to remedy these gaps in ecotoxicological 
understanding, thereby improving the established basis for regulatory testing. 
5.2.1. The role of HPG development in worker temporal polyethism 
The tasks performed by an individual worker change throughout her life (e.g. 
from nurse to forager) in an age-dependent manner known as temporal 
polyethism, which ensures a division of labour in the colony. The HPG has been 
implicated as a controller of these transitions (Free, 1961). Nurse workers 
typically have larger HPGs, which primarily secrete MRJPs of nutritional 
function. As workers age and increasingly adopt roles in the processing of 
nectar, typically as middle-age (in-hive) and forager workers, their HPGs have 
been found to reduce in size, in turn reducing MRJP production whilst 
increasing production of carbohydrate-metabolising enzymes, including GOX of 
social immune function (Ohashi et al., 1999, Feng et al., 2009). 
We hypothesised that an imidacloprid-induced reduction in HPG size could be 
associated with precocious foraging in worker honey bees, which could 
accelerate colony failure by reducing the population of nurses and in-hive 
workers (Henry et al., 2012) and increasing forager death rates (Perry et al. 
2015). To test whether imidacloprid exposure led to precocious foraging, we 
used physiological and molecular endpoints as proxy measures of the transition 
of honey bee workers from roles in in-hive tasks to the onset of foraging and 
then also tested the relevance of the proxy endpoints using a behavioural assay 
in the field. 
Specifically, we characterised the expression of two genes (Amfor and malvolio) 
in the honey bee brain, which are potentially valuable molecular markers for the 
onset of foraging behaviour (e.g. Alaux et al., 2012). Expression of Amfor is 
elevated in undertakers and foragers compared with nurse bees (Ben-Shahar et 
al., 2003, Ben-Shahar et al., 2002) and shows a peak in expression around the 
expected transition to foraging (Heylen et al., 2008). Upregulation of malvolio 
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has been associated also with foraging behaviour (Ben-Shahar et al., 2004). 
We tested whether Amfor and malvolio expression changed in an age-
dependent manner, and whether it increased following chronic imidacloprid 
exposure, as an indicator of precocious foraging. 
We aimed also to measure expression of MRJP and GOX genes in honey bee 
workers from 5-20 days old, to test whether their activity changed in an age-
dependent manner as would be indicative of an age-dependent shift in nursing 
and foraging roles (via nutritional and social immune functions respectively). We 
then tested whether the phenology of these endpoints altered following a 
sustained exposure to dietary imidacloprid. 
To confirm the ecological relevance of responses by the molecular endpoints, 
we conducted a field study to test whether the enzymatic and molecular 
responses measured in the laboratory studies corresponded with behavioural 
effects in free-flying workers in the field. Acute neonicotinoid exposures have 
been observed to alter the foraging behaviour of honey bee workers across 
short timescales (Bortolotti et al., 2003, Henry et al., 2012, Fischer et al., 2014, 
Schneider et al., 2012), but there has been no investigation of long term 
changes in individual’s foraging activity. We therefore tested whether dietary 
exposure to imidacloprid altered the normal foraging behaviour of workers 
throughout their life using a novel approach that utilised Radio Frequency 
Identification (RFID) technology. 
5.2.2. Secretory role of HPGs in nutrition: Major royal jelly proteins 
MRJPs are typically secreted by nurse workers and fed to the developing brood 
and adult queen and they therefore play an important role in honey bee 
nutrition. These proteins are thought to account for 82 – 90 % of total larval jelly 
protein and they contain relatively high amounts of essential amino acids 
(Schmitzova et al., 1998). Furthermore, royal jelly is thought to play a critical 
role in regulating female caste differentiation of honey bee larvae into either 
workers or egg-laying queens (Kamakura, 2011). 
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Here, we aimed to test whether a chronic exposure to imidacloprid reduced 
expression of four MRJP genes, as an indicator of an altered nutritional function 
of the HPGs. 
5.2.3. Secretory role of HPGs in social immunity: Glucose oxidase 
GOX enzymes, along with other carbohydrate-metabolising enzymes secreted 
by the HPG (Ohashi et al., 1999), are involved in the processing of nectar to 
honey. Specifically, GOX catalyses the conversion of glucose to gluconic acid 
and hydrogen peroxide, which give honey antimicrobial properties, thereby 
sterilising brood food and colony honey supplies and so acting as a form of 
social immunity (White et al., 1963). 
We hypothesised that imidacloprid-induced changes in HPG development could 
impair the production of GOX, with the potential to increase the susceptibility of 
the colony to pathogenic attack, but this is yet to be fully investigated. To date, a 
single study has observed reduced GOX activity only when honey bee workers 
were exposed to imidacloprid in combination with pathogenic infection (Alaux et 
al., 2010). Here, we aimed to test whether chronic imidacloprid exposure at 
environmentally relevant exposures reduced enzymatic activity of GOX both 
with and without an accompanying immune challenge, as an additional indicator 
of an altered function of the HPGs. 
Fewer immune-related genes have been identified in the honey bee compared 
to other solitary insect species (Evans et al., 2006), which may reflect the 
importance of social mechanisms in the honey bee’s defence against 
pathogenic attack. However, the role of social immunity has received relatively 
little attention in the literature compared to the immune responses of individual 
bees (e.g. Laughton et al., 2011) and so whilst GOX is recognised for its social 
immune role, there are few studies investigating the regulation of GOX activity. 
Indeed, it has been unclear whether individual bees respond to individual or 
colony infection by increasing GOX levels or whether, instead, GOX is a 
constitutive defence. In the one previous study to test this, no effect of Nosema 
infection on GOX activity was observed (Alaux et al., 2010). In our study we 
took the opportunity to test also whether GOX activity responded to an 
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individual artificial bacterial-like challenge with lipopolysaccharides (LPS) as an 
indicator of the regulation of social immunity. 
5.3. Materials and Methods 
Below, we describe laboratory experiments, denoted ‘L’, and field experiments, 
denoted ‘F’. Different experiments of each type are distinguished by subscripts 
indicating the concentration of dietary neonicotinoid; for example, L102 indicates 
the laboratory experiment where imidacloprid was in dietary sucrose at 102 
parts per billion (ppb). Subsets of these experiments are denoted by acronyms 
indicating the endpoints tested in each study. In experiment L102-N several 
endpoints were measured; expression of genes for MRJPs, as well as genes for 
GOX and foraging, and enzymatic activity of GOX. F10-B indicates the field 
experiment in which behavioural endpoints were measured. L102-GOX and L0.1-102-
GOX indicate the experiments in which enzymatic activity of GOX was measured 
only.  
5.3.1. Honey bee provenance and husbandry – general protocol 
Honey bees (Apis mellifera L.) were obtained from colonies of British hybrid 
bees maintained at the Food and Environment Research Agency (Fera), York, 
UK. Brood frames were collected from colonies between April and September of 
any given year and placed in an environmental chamber (34 °C, 60 % relative 
humidity (RH), constant darkness; Versatile Environmental Test Chamber, 
Sanyo, UK). Workers were collected from these frames as they emerged and 
were housed in modified plastic cages (FK-RD8 clear PET containers, Ambican 
Ltd, UK) in an environmental chamber (34 °C, 60 % RH, constant darkness), 
with ad libitum access to a sucrose solution (50 % w/v) through a modified 
microcentrifuge tube (1.5 ml; Eppendorf Ltd, UK). In L102-N and F10-B, each cage 
also allowed ad libitum access to a pollen paste (Organic Spanish Bee Pollen, 
BodyMe, UK). Experiments were conducted between August 2013 and 
September 2014 and therefore workers for each experiment were derived from 
a different single honey bee colony. 
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5.3.2. Neonicotinoid exposure – general protocol 
In all studies, we exposed bees to sublethal pesticide concentrations as an oral 
exposure to simulate a field situation in which bees consume residues in the 
nectar and pollen of treated mass-blooming crops, such as oilseed rape. Stock 
solutions of imidacloprid were made up in acetone and used to dissolve known 
concentrations in sucrose solution (50% w/v). Treated sucrose solution was 
spiked with 0.08, 0.20, 0.51, 1.28, 3.20, 8.00, 20.00, 50.00 or 125.00 µgL-1 
imidacloprid (Fluka Analytical 37894, Sigma-Aldrich, UK) (≈ 0.1, 0.2, 0.4, 1.0, 
2.6, 6.5, 16.3, 40.7 and 101.7 ppb, respectively). Control cages contained 
sucrose with appropriate aliquots of acetone to control for the solvent in which 
pesticide stocks were dissolved. The feeder of each cage was weighed every 
other day and any dead bees were removed to allow calculation of feeding 
rates. 
5.3.3. The role of HPG development in worker temporal polyethism 
5.3.3.1. Laboratory endpoints as biomarkers for age-dependent tasks 
As below, L102-N measured enzymatic activity of GOX and expression of genes 
for Amfor, malvolio,  GOX and MRJPs (Table 5.1.) in honey bee workers from 5 
- 20 days old to test whether their activity changed in an age-dependent 
manner, as potential markers of the onset of foraging behaviour. For all 
endpoints, we tested whether a long term exposure to 102 ppb imidacloprid 
altered activity/expression compared to bees fed on control sucrose, as an 
indicator of impacts on temporal polyethism. 
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Table 5.1. Oligonucleotide primers used in qPCR assays in experiment L102-N. 
Gene 
Gene 
category/ 
pathway 
Forward primer (5’ → 3’) Reverse primer (5’ → 3’) 
Concentration 
(nM) 
Reference 
GOX 
Glucose 
oxidase- social 
immunity 
GAGCGAGGTTTCGAATTG
GA 
GTCGTTCCCCCGAGATTC
TT 
900 
Yang and 
Cox-Foster 
(2005) 
Amfor 
cGMP-
dependent 
protein kinase 
(PKG)-
Transition to 
foraging 
AATATAACTTCCGGTGCA
ACGTATT 
CGTTTGGATCACGGAAGA
AAG 
300 
Alaux et al. 
(2012) 
malvolio 
Manganese 
transport- 
Transition to 
foraging 
CCTTGGTATAAAGATTAT
GACAGGAATATG 
CAAGAGCACTGTGAAGAT
ACAAGTTATG 
300 
Alaux et al. 
(2012) 
mrjp1 
Major Royal 
Jelly Protein- 
larval feeding 
TGACATACATTACGAAGG
AGTCCA 
ATCCGAAGAAGAGAACGC
CA 
300 
Buttstedt et 
al. (2013) 
mrjp2 
Major Royal 
Jelly Protein- 
larval feeding 
CGTCCAATACCAAGGATC
CGAA 
ACAAGTCCGACGAAGAG
GAC 
300 
Buttstedt et 
al. (2013) 
mrjp3 
Major Royal 
Jelly Protein- 
larval feeding 
TGGACAGATGGCGTGATA
AGAC 
GAGGTCCACCTTTGCCCT
TT 
300 
Buttstedt et 
al. (2013) 
mrjp4 
Major Royal 
Jelly Protein- 
larval feeding 
AGACAAAATATCGATGTC
GTAGCTC 
TGCCAGATTGTGGAACGT
TTT 
300 
Buttstedt et 
al. (2013) 
Actin 
Structural 
protein- 
reference 
TGCCAACACTGTCCTTTC
TG 
AGAATTGACCCACCAATC
CA 
1400 
Lourenco 
et al. 
(2008) 
Ef1-α 
Protein 
synthesis- 
reference 
GGAGATGCTGCCATCGTT
AT 
CAGCAGCGTCCTTGAAAG
TT 
1400 
Lourenco 
et al. 
(2008) 
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5.3.3.2. Behavioural endpoints in field colonies 
In F10-B, we tested whether the enzymatic and molecular responses measured 
in laboratory study L102-N corresponded with behavioural effects in a field 
setting. Newly emerged workers fitted with RFID transponders (‘tags’) were 
exposed for five days (d) in the laboratory to imidacloprid (10 ppb) to ensure 
dietary exposure to a concentration within a realistic range typical of residues 
found in nectar and pollen in the field. After this initial exposure, workers were 
introduced into hives in the field and their activity (departures and returns to the 
hive) was recorded over a period of six weeks to quantify the onset of foraging 
behaviour. 
On emergence, workers were immobilised using CO2, for approximately 45 
seconds, and an RFID tag (16k bit, dimensions 2.0 x 1.7 x 0.8 mm; mic3-TAG, 
Microsensys, Germany) was secured to the thorax with shellac adhesive 
(Figure 5.1.). Two cohorts were used across a one week interval, with workers 
in each cohort derived from a different honey bee colony. In each cohort, 400 
bees were tagged and 200 were subsequently fed on control sucrose and 200 
on an imidacloprid-spiked sucrose solution (10 ppb). After initial exposure, 
tagged bees were immobilised with CO2 for approximately one minute and 
placed into queen cages for introduction into field colonies. The initial spell in 
the queen cage enables the workers to be accepted into the recipient hive 
without aggression. The queen cages were inserted between brood frames 
(Figure 5.1.) and their entrances were initially blocked by a fondant icing, which 
bees chewed through, resulting in their eventual release into the hive. Cohorts 1 
and 2 were placed into colonies on 11th and 19th August 2014, respectively. In 
each cohort, 50 control-fed and 50 imidacloprid-fed bees were introduced to 
each of four colonies, which were adjacent to one another in the apiary at Fera, 
York, UK. None of these recipient colonies was the parent colony of the 
experimental bees. Each recipient colony was fitted with an RFID reader at the 
hive entrance through which every bee had to pass when leaving or entering 
the hive. These readers operated for six weeks until 26th September 2014. 
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To test whether the activity of tagged bees was artifactually affected by transfer 
to a new hive, we also introduced 20 foragers that were collected from the flight 
board of their parent colony as they returned home. These were immediately 
taken to the laboratory, immobilised with CO2 and an RFID tag secured to the 
thorax. These foragers were then immediately returned to their original colony 
and released on the flight board (within 2 hours, h, of their capture) and their 
activity levels were also monitored by an entrance reader.  
A ‘read’ was recorded when a tagged bee entered or left the colony. A bee was 
described as ‘active’ if it made a trip in which it left the colony and subsequently 
returned. 33 trips were excluded from the analysis as anomalies because the 
trip duration exceeded 5 h.  Anomalous trips were distributed across all 
colonies, cohorts and treatments without apparent pattern and excluding them 
therefore does not bias our analysis. Similarly, intermittent technical failure 
among the RFID readers meant that some short periods (less than one day) 
went unrecorded, but these too were independent of treatment and introduced 
no bias. 
55 % of the 800 young tagged bees recorded a read and 32 % were active 
(Figure 5.2.). We did not find that reintroduction affected the activity levels, 
because the proportion of active individuals was very similar among bees 
tagged as foragers and released into their natal hive (mean ± SE = 27.5 ± 8.3 
%).The number of active bees varied among cohorts (Figure 5.2.) and given 
these differences in sample sizes between cohorts, further analyses of pesticide 
treatment differences were performed for each cohort separately. 
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Figure 5.1. (a) Honey bee with RFID tag secured to thorax. (b) RFID reader on 
hive (arrow shows entrance). (c) Yellow queen cages placed between frames to 
introduce tagged bees. (d) Schematic of setup of Experiment F10-B. 
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Figure 5.2. Proportion of the 800 tagged young bees that were ever recorded, 
and to make a return trip to the colony. NB. 50 control and 50 imidacloprid (IMI)-
exposed bees were initially tagged in each colony/cohort. 
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5.3.4. Secretory role of HPGs in nutrition: MRJPs 
In L102-N, worker bees were housed 10 per cage and exposed to imidacloprid 
(102 ppb) for up to 20 d and the expression of four genes, mrjp -1, -2, -3 and -4, 
was measured at sampling intervals of 5, 10, 15 or 20 d. 
5.3.4.1. Measurement of gene expression 
At the appropriate sampling times, experimentally treated bees were placed 
directly into a -80 °C freezer until RNA extraction. Total RNA was extracted from 
six heads pooled from a single cage, with four cages (biological replicates) per 
treatment/age combination. Total RNA was extracted using the mirVana miRNA 
Isolation Kit (Ambion AM1561; Life technologies, UK) and RNA quantity was 
measured using a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific, 
UK). cDNA was synthesised from 2 µg RNA using the High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems 4368814; Life technologies, UK) 
and a C1000 Thermal Cycler (Bio-Rad Laboratories, UK) under the following 
cycling conditions: 10 minutes 25 °C, 120 minutes 37 °C, 5 minutes 85 °C, 
stored at 4 °C. 
Real-time quantitative PCR (qPCR) was performed using the SYBR Green PCR 
Master Mix (Applied Biosystems 4309155; Life technologies, UK). 
Oligonucleotide primers used to amplify genes are shown in Table 5.1. Each 
sample was run in duplicate, with treatments randomly assigned across plates. 
PCR reactions were carried out in a ViiA 7 Real-Time PCR System (Applied 
Biosystems; Life technologies, UK) under standard cycling conditions (2 
minutes 50 °C, 10 minutes 95 °C and 40 cycles of 15 seconds 95 °C and 1 
minute 60 °C). 
The threshold cycle (Ct) value for each sample was calculated only if the 
standard deviation of the two replicates was ≤ 0.5, and transformed into an 
input quantity value using the relative standard curve method. Input quantities 
were normalised using the geometric mean of Actin and Ef1-α, which were 
identified as appropriate reference genes using GeNorm (Vandesompele et al., 
2002). Normalised input quantities were used for statistical analysis. 
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5.3.5. Secretory role of HPGs in social immunity: GOX 
In L102-GOX and L0.1-102-GOX, workers were housed six per cage and exposed to 
dietary imidacloprid for an initial period of four days, then subjected to an 
immune challenge on day five, and subsequently exposed as before for up to 
48 h. L102-GOX tested the effects of a single concentration of imidacloprid (102 
ppb) and an immune challenge, across a time course of 8 - 48 h post immune 
challenge (PIC). To determine whether the effects were also observed at field-
relevant levels, in L0.1-102-GOX workers were exposed to one of ten imidacloprid 
concentrations (0.1, 0.2, 0.4, 1.0, 2.6, 6.5, 16.3, 40.7 and 101.7 ppb), and 
assays were conducted at a single time point, 24 h PIC. For both studies, GOX 
activity was measured from 4-6 individual bees from a single cage at the 
appropriate time points. The cage mean acted as the biological replicate for 
statistical analysis, with three replicates of each immune-challenge treatment, 
dosage and time point. 
5.3.5.1. Immune challenge 
To immobilise workers for injection, bees were placed in a freezer (-20 °C) for 
two to five minutes until torpid. Injections were performed using a fine needle on 
a Hamilton syringe with a repeating dispenser. Bees were injected with 2 µl of 
solution through the pleural membrane between the tergites of the abdomen. 
Bees received one of three treatments, with all workers within a cage subjected 
to the same treatment. To invoke a bacterial-like immune response, ‘LPS’ bees 
were injected with 0.5 mgml-1 lipopolysaccharides from Escherichia coli 
0128:B12 (Sigma L2755, Sigma-Aldrich, UK) dissolved in Insect Ringers. 
‘Ringers’ bees were injected with Insect Ringers solution (1:1:1 156 mM NaCl : 
3 mM KCl : 2 mM CaCl2) to control for any effects of the injection process. 
‘Naïve’ bees were ice-immobilised but received no other treatment 
(unchallenged control).  
5.3.5.2. Measurement of GOX enzymatic activity 
Experimentally treated bees were ice-immobilised and decapitated using sterile 
dissecting scissors. Each head, which contained the HPG, was homogenised 
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by hand in 200 µl phosphate buffer solution (PBS) using a micro-pestle, and 
centrifuged (9600 RPM, 10 minutes, 4 °C). 100 µl of supernatant was 
immediately stored at -20 °C for later analysis. 
GOX activity was measured using a spectrophotometric assay (based on Alaux 
et al., 2010). Samples were thawed on ice and 20 µl added to a 96-well plate. 
180 µl of reaction mixture [20 µl β-D-glucose (18 mgml-1; Sigma G8270), 100 µl 
dH2O, 50 µl PBS, 10 µl horseradish peroxidase (4.8 mgml
-1; Sigma P8125)] 
were placed in each well, the plate was shaken, then incubated at 37 °C for 10 
minutes. The plate was placed back on ice and 20 µl of o-dianisidine [saturated 
(0.7 mgml-1) and filtered; Sigma D9143] added to each well. The plate was 
shaken and the reaction allowed to proceed at 37 °C in a spectrophotometer 
(ThermoMax microplate reader, Molecular Devices, UK). Absorbance was 
measured at 405 nm every 20 seconds for 1 hour 45 minutes. Each sample was 
measured in duplicate and treatments were assigned across plates to minimise 
between-plate variation. Softmax Pro v4.3 software (Molecular Devices, UK) 
was used to calculate enzyme activity measured as the maximum linear rate of 
substrate conversion (Vmax). 
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5.4. Results 
5.4.1. Effect of imidacloprid on general health indicators during laboratory 
exposures 
Our experimental honey bees exhibited good health, because across the 
experiments, only 31/2086 bees (1.5 %) died during the laboratory exposure 
period and the limited mortality was not associated with experimental treatment 
effects. Imidacloprid effects on feeding rates were inconsistent across 
experiments. Bees sometimes consumed less sucrose containing 102 ppb (L102-
GOX : Wilcoxon Rank Sum: W = 1010.5, P ≤ 0.001;  and L102-N : Kruskal-Wallis 
rank sum tests: 5 – 9 d χ2df1 = 8.08, P = 0.004, 10 – 14 d χ
2
df1 = 11.3, P ≤ 0.001), 
but otherwise no treatment effects were observed. 
5.4.2. The role of HPG development in worker temporal polyethism 
5.4.2.1. Laboratory endpoints as biomarkers for age-dependent tasks 
The enzymatic activity of GOX did not vary with the age of the honey bee, nor 
did GOX gene expression. The youngest workers (5 days old) had higher 
transcripts of three MRJP genes (mrjp -2, -3 and -4) compared with older 
workers (L102-N: ANOVAs mrjp2 F3,21 = 8.81, P ≤ 0.001; mrjp3 F3,20 = 3.23, P = 
0.044; mrjp4 F3,23 = 4.75, P = 0.010) and there was a general pattern of reduced 
expression with increased worker age for all four MRJP genes investigated 
(Figures 5.3.E-H). Expression of Amfor was independent of worker age. 
Expression of malvolio was higher only among the oldest workers (20 days old) 
in imidacloprid-exposed bees (L102-N: Figure 5.3.D, ANOVA age*pesticide F3,24 = 
5.19, P = 0.007). 
Imidacloprid exposure increased expression of Amfor (L102-N: Figure 5.3.C, 
ANOVA F1,24 = 29.2, P ≤ 0.001), and exposure increased expression of malvolio 
in 20 day old workers only (L102-N: Figure 5.3.D, ANOVA age*pesticide F3,24 = 
5.19, P = 0.007). 
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Figure 5.3. See figure legend overleaf. 
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Figure 5.3. A) Enzymatic GOX activity; B-H) Relative gene expression in honey 
bee workers exposed to 125 µgL-1 (102 ppb) imidacloprid for 5-20 days post 
emergence (experiment L102-N). The mean fold-change in expression was 
calculated for each pesticide/age compared to the mean expression of the 
control-fed/5-day-old group. Data presented as Mean ± SE (n = 4). 
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5.4.2.2. Behavioural endpoints in field colonies 
Imidacloprid exposure did not affect the number of reads recorded within each 
cohort (χ2 tests P > 0.05), or the proportion of active bees. The exception to this 
was the second cohort in Colony 2, in which fewer bees were active in the 
control group compared to imidacloprid-exposed bees (F10-B: Figure 5.2., 
Binomial test χ2 1df
 = 4.77, P = 0.029). 
In general, imidacloprid did not affect the age of first emergence from the colony 
(Figure 5.4.A). There were two exceptions to this that were each specific to a 
cohort and colony, where imidacloprid-exposed bees were significantly older 
than control bees when they first left the colony (F10-B: Colony 2 Cohort 2: 
Welch’s t 61.7df = -2.54, P = 0.014; Colony 3 Cohort 1: Welch’s t 63.3df = -2.51, P = 
0.015). 
Imidacloprid did not affect the mean number of trips taken per active bee 
(Figure 5.4.B), with one exception in which imidacloprid-exposed bees took 
significantly more trips than control-fed bees (F10-B: Colony 2 Cohort 2: Welch’s t 
67.0df = -2.32, P = 0.023). 
Imidacloprid did not affect the mean duration of trips (Figure 5.4.C), with one 
exception in which imidacloprid-exposed bees took significantly longer trips than 
control-fed bees (F10-B: Colony 1 Cohort 1: Welch’s t 22.9df = -2.90, P = 0.008). 
Imidacloprid exposure had no consistent effects on the temporal pattern of trips 
taken (Figure 5.5.). 
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Figure 5.4. See figure legend overleaf. 
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Figure 5.4. A) Mean ± SE number of days for tagged bees to first record to 
leave the colony following their introduction to the colony at 6 days old. B) Mean 
± SE number of trips recorded by each bee. C) Mean ± SE duration of trips 
recorded by each bee. Numbers in each bar represent the number of bees 
recorded in each cohort (n). * Asterisks show significant differences between 
control and imidacloprid groups. 
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Figure 5.5. Cumulative number of trips recorded in each cohort over the 6+ 
weeks of the study. 
  
194 
 
 
5.4.3. Secretory role of HPGs in nutrition: MRJPs 
Imidacloprid exposure lowered expression of mrjp1 (L102-N: Figure 5.3.E, 
ANOVA F1,24 = 11.2, P = 0.003) and mrjp4 (L102-N: Figure 5.3.H, ANOVA F1,23 = 
4.40, P = 0.047). A similar trend was observed in the expression profiles of 
mrjp2 and mrjp3 in the 5- and 15- day old workers (Figures 5.3.F and 1G). 
5.4.4. Secretory role of HPGs in social immunity: GOX 
Overall, imidacloprid exposure increased enzymatic GOX activity, but activity 
was significantly greater than control-fed bees only for 41 ppb and 102 ppb 
imidacloprid treatments (LGOX-102: Figure 5.6., ANOVA pesticide F1,54 = 30.1, P ≤ 
0.001; LGOX-0.1-102: Figure 5.7., ANCOVA pesticide concentration F1,85 = 27.6, P 
≤ 0.001, Tukey HSD post hoc tests P ≤ 0.05 for pairwise comparisons of 0 - 41 
ppb and 0 - 102 ppb only). In contrast, there were no significant effects of 102 
ppb imidacloprid across an exposure of 5 - 20 d (L102-N), although there was a 
general trend towards increased GOX activity in imidacloprid-exposed bees 
(Figure 5.3.). Furthermore, in one case the increase in GOX activity following 
imidacloprid exposure was not observed when bees were simultaneously 
challenged with LPS-injection (L102-GOX: Figure 5.6.; ANOVA injection*pesticide 
F2,54 = 3.57, P = 0.035). There was a significant trend towards lower expression 
of the GOX gene in imidacloprid-exposed bees (L102-N: Figure 5.3.B, ANOVA 
F1,23 = 4.08, P = 0.055). 
Overall, immune challenge lowered GOX activity compared with naïve controls 
(L102-GOX: Figure 5.6., ANOVA injection F2,54 = 8.90, P ≤ 0.001; L0.1-102-GOX: 
Figure 5.7., ANCOVA injection F2,85 = 6.48, P = 0.002). This effect was 
observed at 24 and 48 h PIC only (L102-GOX: Figure 5.6., ANOVA injection*time 
F6,54 = 4.65, P ≤ 0.001). However, LPS-injection lowered GOX activity 
compared to naïve controls only when coupled with imidacloprid exposure (L102-
GOX: ANOVA injection*pesticide F2,54 = 3.57, P = 0.035). In L0.1-102-GOX there was 
no injection*pesticide interaction, although the differences in GOX activity 
following injection treatment were not observed in control-fed bees (Figure 5.7.). 
195 
 
 
 
 
Figure 5.6. Enzymatic activity of GOX measured 0-48 hours PIC, following 
exposure to 125 µgL-1 (102 ppb) imidacloprid (IMI) (experiment L102-GOX). Data 
presented as Mean ± SE (n = 3). 
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Figure 5.7. Enzymatic activity of GOX measured 24 hours PIC, following 
exposure to 0.08 - 125 µgL-1 (0.1 – 102 ppb) imidacloprid (IMI) (experiment L0.1-
102-GOX). Data presented as Mean ± SE (n = 3), and linear lines of best fit. 
 
 
5.5. Discussion 
Our results show molecular evidence that imidacloprid exposure has potential to 
disrupt the control of temporal polyethism and induce precocious behavioural 
transitions. Specifically, we found that imidacloprid exposure increased 
expression of two foraging genes (Amfor and malvolio), which supports the 
proposition that it could cause precocious onset of foraging, perhaps as a result 
of an imidacloprid-induced reduction in HPG size. Similarly, we also found that 
imidacloprid exposure reduced the expression of MRJP genes and increased 
correspondingly the enzymatic activity of the GOX system. These latter effects 
appear to indicate that individual bees are exhibiting a precocious shift from 
nursing roles (providing MRJP nutrition to brood) to foraging (processing nectar 
to honey using GOX). However, we recognise here that differential expression 
was observed only following exposure to imidacloprid at a concentration of 102 
ppb and in a laboratory setting in which bees were unable to undertake nursing 
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or foraging activities. These exposures are likely to be higher than those that 
workers would be exposed to in realistic natural scenarios. Residues found in 
nectar and pollen in the field are typically 1-10 ppb (Blacquiere et al., 2012), 
although residues as high as 101 ppb have been found in pollen from 
transplant-dripped pumpkin crops (Dively and Kamel, 2012). 
Our results indicate that ecotoxicological responses in molecular endpoints may 
not be reflected in corresponding behavioural endpoints. For example, in our 
field study we found no corresponding behavioural effects in free-flying workers 
following a field relevant exposure, so we could not confirm the behavioural 
relevance of the enzymatic and molecular responses associated with temporal 
polyethism in the laboratory. Specifically, we found no consistent effects of 
chronic exposure to 10 ppb imidacloprid on foraging behaviour. Most 
importantly, exposure to imidacloprid failed to induce the precocious transition 
to foraging behaviour that had been strongly indicated by our molecular 
endpoints. Since our laboratory and field studies tested effects following 
exposure to 102 and 10 ppb imidacloprid respectively, we cannot verify whether 
the non-correspondence between molecular and behavioural endpoints is a 
result of a dose-dependent effect on temporal polyethism or whether the 
molecular endpoints are not useful indicators of ecologically relevant foraging 
behaviour. Nevertheless, within the limitations of the study our data offers 
promise that field relevant exposures may not disrupt foraging behaviour at the 
colony level. 
The failure to detect precocious foraging may have arisen from shortcomings in 
our experimental field setup. For example, we were not able to account for the 
relatively low overall returns for tagged bees. This was not thought to be as a 
consequence of the tagging process causing mortality directly, nor the 
detachment of tags, as this did not occur during the laboratory exposure period. 
It is possible that introduced bees may have been rejected and killed by the 
recipient colony, however, newly emerged bees are typically accepted into 
foreign colonies as they lack the colony-specific odours (recognition 
pheromones) that are acquired through contact with the nesting material of a 
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particular colony (Breed et al., 2004). We introduced bees into the colonies as 
young as possible, whilst still enabling a chronic imidacloprid exposure period in 
the laboratory. We did so using a well-established beekeeping method to 
introduce new queens, using a fondant sugar screen to enable odour contact 
and exchange before any physical contact, enabling time for acceptance of the 
introduced bees by the recipient colony. It is also possible that the dearth of 
bees recorded resulted from a lack of technical reads rather than a lack of 
active bees. For example, whilst substantial efforts were made to ensure there 
was only a single access point to bees in and out of each hive (passing through 
the RFID reader) some bees were occasionally observed entering or leaving the 
hive through other small holes in the hive structure. In this case, bees may have 
been actively foraging, but their activity went unrecorded by the RFID reader. 
This occurrence may have been particularly prevalent during periods of high 
activity, such as warm weather conditions favourable for foraging, and hence 
the high traffic of bees in and out of the hive led to bees seeking alternative 
entrances to by-pass the limited flow offered by a single RFID reader at the 
main hive entrance. Whilst relatively small nucleus colonies were used in this 
study to minimise the build-up of hive traffic, future studies may benefit from the 
use of multiple RFID readers (and therefore entrances) per colony to better 
address this limitation. The relatively low activity levels recorded may have 
limited the statistical power of the study to detect major impacts on temporal 
polyethism had they existed, and further work is needed to truly establish the 
sample sizes necessary in RFID studies to reliably detect changes in foraging 
behaviour. Foraging behaviour is inherently variable, driven by multiple factors, 
including colony demands for food, genetic variability, hormonal regulation, and 
HPG development (Calderone, 1998; Johnson, 2010). Therefore, future studies 
would benefit from power analyses, taking into account the relative importance 
of the number of bees within colonies, the number of colonies and seasonal 
variations. Here too we made several assumptions in the interpretation of the 
data. Specifically, we assumed that the first emergence of a given bee from the 
colony represented a shift from in-hive (e.g. nursing or comb-building) tasks to 
out-of-hive (e.g. foraging) tasks, and that a trip represented a foraging trip. 
Nevertheless, this preliminary study presents the first insights into imidacloprid 
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effects on foraging behaviour throughout honey bee worker life, and our findings 
offer promise that field relevant exposures may not disrupt foraging behaviour. 
In the future, coupling the RFID approach adopted here with behavioural 
observations should enhance studies of this nature and better enable 
understanding as to whether imidacloprid and other pesticide exposures can 
lead to impacts on foraging and survivorship in bees in the natural environment. 
We have demonstrated for the first time that chronic exposure to imidacloprid 
reduced expression of MRJP genes, but we did not test the production of 
MRJPs at the protein level and in field realistic scenarios. A reduced production 
of MRJPs by nurse workers has the potential to impact on larval and queen 
development by restricting their nutritional supply of proteins, including essential 
amino acids (Schmitzova et al., 1998), and altering the regulation of female 
caste differentiation (Kamakura, 2011). This in turn could have colony- and 
population- level implications if reduced development slows colony growth and 
queen production. Given the potential non-correspondence between molecular 
and physiological markers (see above), we therefore recommend that further 
work should prioritise the investigation of imidacloprid effects on the nutritional 
supply of proteins to developing larvae and subsequent effects on larval 
development in field realistic scenarios. Follow-up work to investigate MRJPs at 
the protein level could benefit from the use of highly specific antibodies against 
MRJPs, for use in western blotting (e.g. Shen et al., 2015). 
Our results show also that, overall, dietary imidacloprid altered GOX activity, 
which implies that neonicotinoid exposure can cause disruption to the social 
immune response. However, the effects observed were not always consistent 
and were observed only when coupled with an immune challenge. This could be 
important in realistic field scenarios in which bees are likely exposed to multiple 
stressors, but we did not test the impacts of changes in GOX levels on the 
realised levels of in-hive social hygiene and on the susceptibility of the colony to 
pathogen infection under realistic conditions. Consequently, the ecological 
relevance of our findings remains to be fully demonstrated. In the absence of 
immune challenge dietary imidacloprid at concentrations exceeding 40 ppb 
caused increased levels of GOX, somewhat consistent with previous 
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observations that imidacloprid at concentrations as low as 0.5 ppb reduces 
HPG size (Heylen et al., 2011, Skerl and Gregorc, 2010, Hatjina et al., 2013) 
and in line with our hypothesis of precocious foraging. However, imidacloprid 
exposures as low as 0.1 ppb lowered GOX levels in immune-challenged bees, 
consistent with a previous study in which GOX activity was lowered in bees 
exposed to imidacloprid only when coupled with an immune challenge to 
Nosema (Alaux et al., 2010). We propose that there may be a trade-off in the 
allocation of a limited resource pool towards costly detoxification systems and 
the social immune response. There remains no evidence that individual bees 
induce GOX production from the HPGs in response to immune challenge, 
suggesting GOX acts as a constitutive social immune response, but further 
investigation is needed to better understand the role of GOX in social immunity. 
Our experimental design did not elicit the full range of normal physiological age-
dependent changes and it remains unclear whether the expression of the genes 
tested provides a useful indicator of disruption to the normal functioning of the 
HPG. Even in the confined conditions of the laboratory experiment we detected 
a reduction in expression of MRJP genes in older honey bee workers, 
demonstrating an innate underlying age-dependent regulation of MRJP 
expression, consistent with changes observed at the proteomic level (Feng et 
al., 2009). In contrast, we failed to detect an age-dependent increase in 
expression of GOX, Amfor and malvolio genes that normally occurs during the 
transition of worker honey bees from nursing to foraging roles in the wild (Ben-
Shahar et al., 2003, Ben-Shahar et al., 2004, Ohashi et al., 1999), implying this 
differential expression is likely driven by more complex mechanisms than simply 
an age-dependent regulation. The imidacloprid-induced increase in enzymatic 
activity of GOX was not correlated with expression of the GOX gene, which was 
reduced following imidacloprid exposure, but it is possible that mRNA titres that 
were translated to GOX enzymes were not replenished. Given the 
inconsistencies in our findings, we welcome further work to elucidate the 
biological relevance of the molecular changes observed. 
Overall, we have demonstrated that dietary exposure of honey bees to 
neonicotinoid pesticide is potentially capable of causing generalised disruption 
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of HPG function, which implies that imidacloprid-induced changes in HPG 
development can lead to detrimental effects on colony function. We believe this 
provides some overall support for the ecological relevance of HPG-related 
assays in pesticide risk assessment involving sublethal effects on honey bees. 
It is evident that further work is needed to test the field-relevance of some of our 
findings (namely imidacloprid-induced disruption to nutrition and social 
immunity), as in some cases (temporal polyethism) transcriptional responses 
that we observed did not translate into functionally significant impacts on bee 
health, highlighting the need to cross reference gene expression bioassays with 
ecologically relevant behaviour. Our work highlights the potential utility of new 
enzymatic, molecular and behavioural ecotoxicological endpoints for risk 
assessment of sublethal effects on honey bees, if further work can clarify their 
ecological relevance to colony-level impacts on bee health under more field 
realistic exposures. 
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6. Transcriptome sequencing analysis of the honey bee 
following exposure to immune and chemical stressors 
 
6.1. Abstract 
Pathogen infection and exposure to neonicotinoid pesticides have the potential 
to impact on bee health, but little is known about the molecular response to 
combinations of these stressors in adult honey bee workers. A new opportunity 
to understand these molecular mechanisms has been made possible by the 
sequencing of the honey bee genome and advances in transcriptome-
sequencing technology. Using RNA-Sequencing, we identified a suite of genes 
that were differentially expressed in adult honey bee workers in response to 
immune stress, dietary neonicotinoid exposure (including field relevant 
concentrations) or a combination of both immune and chemical stressors. As 
expected, immune stress imposed by wounding and bacterial-like infection led 
to upregulation of genes with known immune function, including a peptidoglycan 
recognition protein and antimicrobial effectors. Transcriptional changes 
occurred also in genes not previously associated with immune stress, for 
example a laccase-1-like gene, LOC724890. Exposure to a dietary 
neonicotinoid, either thiamethoxam or imidacloprid, led to downregulation of 
genes associated with several metabolic pathways, such as oxidative 
phosphorylation, pathways associated with pyruvate and purine metabolism, 
and ribosomal activity, and to upregulation of three cytochrome P450 genes, 
including CYP6AS16P and CYP6AS15. The combined stress of dietary 
neonicotinoid and artificial infection dramatically changed the expression of 
immune-related genes that previously had responded to immune challenge 
alone.  Similarly, transcriptomic responses to neonicotinoid exposure were 
altered with the additional stress of an immune challenge. However, the 
implications of these transcriptomic manifestations of an interaction between 
stressors are difficult both to interpret and to relate to bee health. Nevertheless, 
our study has identified some candidate genes for further study to better 
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understand health outcomes and for development as potential biomarkers for 
use in pesticide risk assessment. 
6.2. Introduction 
The sequencing of the honey bee genome (Weinstock et al., 2006) and the 
increasing availability and affordability of next-generation sequencing 
technologies has provided a new opportunity to investigate the molecular 
mechanisms underlying key questions in the study of honey bees. Several 
studies have demonstrated the value of RNA-Sequencing (RNA-Seq) for 
identifying mRNA transcripts involved in honey bee responses to different diets 
(Mao et al., 2013, Wheeler and Robinson, 2014), to immune challenge (Ryabov 
et al., 2014, Nazzi et al., 2012, Cornman et al., 2013) and to chemical stressors, 
such as dietary pesticides (Derecka et al., 2013). However, the transcriptome-
wide analysis of differential gene expression in response to a bacterial infection 
or neonicotinoid exposure previously has been investigated in honey bee larvae 
only (Derecka et al., 2013, Cornman et al., 2013). Furthermore, RNA-Seq 
studies have been applied to investigate differential expression in response to 
single stressors, rather than to a combination of both immune and chemical 
stressors. Whilst there is growing interest in understanding the effects of 
pathogen-pesticide interactions on bee health, most studies have approached 
investigations of these interactions by testing whether pesticide exposure alters 
bees’ ability to mount an immune response (e.g. Alaux et al., 2010, Di Prisco et 
al., 2013, Garrido et al., 2013). There has been some, but far less, 
consideration of a second hypothesis in pathogen-pesticide interactions; 
immune stress alters bees’ ability to respond to pesticide exposure. For 
example, Vidau et al. (2011) found no strong decrease in detoxification systems 
when bees were simultaneously exposed to immune and pesticide stressors. 
Here, we aimed to characterise the transcriptomic responses of adult honey bee 
workers when exposed to an immune challenge, a neonicotinoid exposure, or 
both stressors in combination. Furthermore, we aimed to assign functional 
annotations to the differentially expressed genes (DEGs) that we identified in 
order to elucidate potential functions and molecular pathways that were affected 
by these stressors. We investigated the combination of stressors by assessing 
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first whether the response to immune challenge was altered in the presence of 
dietary pesticide, and second whether the response to dietary pesticide was 
altered in the presence of immune challenge. 
We used an unbiased RNA-Seq approach for this work for the following 
reasons. First, our earlier work using a qPCR approach found evidence for 
differential gene expression in adult workers exposed to a combination of 
immune and neonicotinoid stressors (Chapter 3), but these data were restricted 
to a very small set of targeted genes that had been selected for investigation 
based on an a priori interest in these genes. In the present study, an RNA-Seq 
approach allows investigation of transcriptional responses across the whole 
transcriptome because it is not limited to a subset of genes. Certainly, the 
alternative approach of a genomic tiling DNA microarray approach might have 
allowed measurement of expression levels of large numbers of genes 
simultaneously by using a set of overlapping oligonucleotide probes that 
represent a large subset of the genome at high resolution. However, we chose 
instead to use RNA-Seq over a microarray approach as this offers several 
advantages. Firstly, RNA-Seq is not limited to detecting transcripts that 
correspond to existing genomic sequence and also it can be used to map 
transcriptomes of large genomes at much lower costs with a smaller input of 
RNA than the alternative microarray approaches. Secondly, RNA-Seq has little, 
if any, background signal, and has no upper limit of quantification, which 
provides the advantage of much higher sensitivity for genes expressed at either 
low or high levels and hence a much larger dynamic range than DNA 
microarrays (Wang et al., 2009). 
6.3. Materials and Methods 
We performed a laboratory experiment whereby newly emerged adult honey 
bee workers were exposed to a neonicotinoid-spiked sucrose feed for an initial 
period of 4 days, and then experienced an immune challenge the next day, i.e. 
five days post eclosion. The bees were fed continuously with the same 
neonicotinoid treatment throughout the experimental period until collection of 
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samples for RNA extraction, at either 8 or 24 hours (h) post immune challenge 
(PIC) (see Supporting Information: Figure 6.5.). 
6.3.1. Honey bee provenance and husbandry 
All honey bees were from a single Apis mellifera colony maintained in an apiary 
at the Food and Environment Research Agency, Sand Hutton, York, UK. Two 
brood frames were collected (September 2013) and placed in an environmental 
chamber (34°C, 60% relative humidity (RH), constant darkness) (Sanyo 
Versatile Environmental Test Chamber). Workers were collected from these 
frames as they emerged and housed in groups of 10 workers in plastic cages 
(modified 8 oz clear PET containers; FK-RD8 Ambican UK Ltd). The use of late-
season workers gives added value to this study because in field scenarios, 
brood developing later in the season are likely to be exposed to the season’s 
accumulation of agrochemicals, and the health of these workers is important for 
the over-wintering survival of the colony. Each cage allowed workers ad libitum 
access to a sucrose solution (50% w/v) through a modified microcentrifuge tube 
(1.5ml; Eppendorf UK Ltd) and all cages were maintained in an environmental 
chamber throughout the experimental period (34°C, 60% relative humidity (RH), 
constant darkness). For each feeding/injection treatment combination, three 
cages were used at the 8 h sampling point and two cages were used at the 24 h 
sampling point, giving three/two biological replicates for analysis respectively. 
6.3.2. Neonicotinoid exposure 
In order to simulate field-relevant exposures to residues in the nectar and pollen 
of neonicotinoid-treated crops, bees were exposed to sublethal concentrations 
of pesticides as a chronic oral exposure. Bees were exposed to either 
thiamethoxam at 10 parts per billion (ppb) (e.g mean ± SD thiamethoxam 
residues in squash of 11 ± 6 ppb; Stoner and Eitzer, 2012), or imidacloprid at 
102 ppb, which is at least ten-fold higher than typical residues in the field 
(typically 1-10 ppb; Blacquiere et al., 2012), but which may represent a ‘worst-
case’ scenario (residues as high as 101 ppb have been found in pollen from 
imidacloprid-treated transplant-dripped pumpkin crops; Dively and Kamel, 
2012).  Stock solutions of neonicotinoids were made up in acetone, and stocks 
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were subsequently used to create known concentrations in sucrose solution (50 
% w/v). Treated sucrose was spiked with either 12 µgL-1 (= 10 ppb) 
thiamethoxam (Fluka Analytical 37924) or 125 µgL-1 (= 102ppb) imidacloprid 
(Fluka Analytical 37894). Treated sucrose replaced control sucrose in the 
cages, in which bees were allowed ad libitum access to the spiked-sucrose 
throughout the experimental period. Control cages contained sucrose with < 0.1 
% acetone to control for the solvent in which pesticide stocks were dissolved. 
The feeder of each cage was weighed every other day and any dead bees were 
removed and recorded to allow the mean daily sucrose consumption per bee to 
be calculated. When calculating consumption rates, we accounted for 
evaporation using reference feeders kept in empty cages.  
6.3.3. Immune challenge 
In order to invoke a standardised immune response across individual bees, 
bees were injected with bacterial lipopolysaccharides (LPS) to mimic a 
bacterial-like infection because this artificial stimulus activates the immune 
response while excluding the dynamic behaviour of a real pathogen. To 
immobilise bees for injection, experimental cages were placed briefly in a 
freezer (-20 °C) for approximately two to five minutes or until bees were 
immobile. All injections were performed using a fine needle on a Hamilton 
syringe. Honey bees were injected with 2 µl of solution through the pleural 
membrane between the tergites (dorsal side) of the abdomen. Bees received 
one of three immune treatments, with all workers within a cage subjected to the 
same treatment. The ‘LPS’ treatment group were injected with 0.5 mgml-1 LPS 
(Sigma L2755- Lipopolysaccharides from Escherichia coli 0128:B12) dissolved 
in Insect Ringers solution. The ‘Ringers’ treatment group were injected with a 
placebo dose of Insect Ringers solution (1:1:1 156 mM NaCl: 3 mM KCl: 2 mM 
CaCl2) to control for any effects observed as a result of the injection process 
itself. ‘Naïve’ bees were ice-immobilised but received no further treatment as an 
unchallenged control. 
6.3.4. RNA Extraction, Library Preparation, and Sequencing 
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At each sampling point, bees were frozen at -80 °C and stored until RNA 
extraction. Total RNA was extracted from pools of 6 whole bees from a single 
cage. Pooling of 6 bees per replicate cage served to minimise between-bee 
variation in gene expression profiles. Total RNA was extracted using the 
mirVana miRNA Isolation Kit (Ambion AM1561; Life technologies). 1 µg of total 
RNA was DNase-treated to remove any genomic DNA in the RNA extract using 
RNase-free DNase I (Fermentas; EN0521) according to the manufacturer’s 
protocol. Prior to library preparation, 1 µg of DNA-free RNA was treated to 
remove rRNA using the Ribo-Zero Magnetic rRNA Removal Kit 
(Human/Mouse/Rat) Low Input (Epicentre Biotechnologies; MRZH11124) 
according to the manufacturer’s protocol. This rRNA-depleted sample was 
purified using the Agencourt RNAClean XP Kit (Beckman Coulter; A63987). 
RNA-Seq libraries were subsequently prepared from 1 µg Ribo-Zero treated 
RNA using the ScriptSeq v2 RNA-Seq Library Preparation Kit (Epicentre 
Biotechnologies; SSV21124) according to the manufacturer’s protocol. During 
library amplification, a unique Index was added to each library (ScriptSeq Index 
PCR Primers (All Sets) - Epicentre Biotechnologies; SSIP1234). On completion, 
the concentration of DNA in each individual sample library was quantified using 
a Qubit 2.0 Fluorometer (Life technologies). 15 libraries were pooled to give a 
pooled library containing equal concentrations of each individual library. The 
DNA concentration of the pooled library was subsequently quantified by Qubit, 
and the quality and size distribution of the library assessed using a 2200 
Tapestation (Agilent technologies). The DNA concentration and average size of 
the library were then used to calculate the target template concentration for 
RNA-sequencing.  Each pooled library was sequenced using a paired-end 
100bp lane on the Illumina HiSeq 2500 system (sequencing was performed by 
staff at the University of Exeter’s Sequencing Service). 
6.3.5. Validation of RNA-Seq data with qPCR 
The results of the RNA-Seq analysis (see below) identified DEGs of interest for 
further study, including an aldehyde dehydrogenase gene, ALDH1L2. This gene 
was found to be upregulated following immune challenge, and the data 
indicated a potential impairment of this response to immune challenge when 
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bees were simultaneously exposed to thiamethoxam (see Results). To further 
test this hypothesis, ALDH1L2 was selected for further investigation across a 
greater range of time points PIC (0 to 48 h) and changes in its expression were 
measured using qPCR, following the methods described in Chapter 3. 
Oligonucleotide primers were used to amplify genes at a concentration of 900 
nM (ALDH1L2 Forward primer: GGGCCACAGAACCATAAAGC, ALDH1L2 
Reverse primer: CGCCACGTTCCACAAATTTC). 
6.4. Data analysis 
6.4.1. Data processing for read counts 
For each of the 45 sample libraries, the total number of raw sequencing reads 
obtained was on average 19699691 (± SE 2028338), ranging from 5962002 to 
73572872. To remove error-prone regions of sequence, the original data reads 
were trimmed and filtered using sickle (Joshi and Fass, 2011), with a Phred-
scaled quality threshold of 30 and a minimum length threshold of 50. Any reads 
shorter than this minimum length cutoff, and any reads left unpaired after 
trimming, were excluded from further analysis (excluding an average of 15 % of 
reads per library; see Supporting Information: Figure 6.6.). 
Since initial analysis of two libraries recognised that > 50 % of reads did not 
align to the A. mellifera genome (see below), the following steps were included 
prior to A.mellifera alignment in attempt to account for some of the unmapped 
reads. The Bowtie2 alignment tool (version 2.1.0; Langmead et al., 2009) was 
used to first align any reads to genomes of the bacteriophage PhiX174 and the 
bacteria Escherichia coli O157. SAMtools (Li et al., 2009) was then used to filter 
reads that did not map to either of these genomes and these remaining reads 
were used for subsequent analyses. Alignment to PhiX was included as a 
precaution since samples were spiked with a 1 % PhiX sequence as a quality 
control during sequencing, but these sequences should have been filtered out 
prior to receiving the sequencing files. Alignment to E.coli was included as a 
precaution in case of E.coli sequence contamination given that some bees were 
injected with LPS from E.coli as part of the experimental design. However, < 2 
% of reads aligned to the PhiX and E.coli genomes (see Supporting Information: 
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Figure 6.6.), confirming that neither the PhiX spike, nor LPS injection, 
significantly contaminated reads.  
In order to align reads to honey bee genes, the splice aware mapping tool, 
Tophat (version 2.0.11; Kim et al., 2013), was used to align reads to the Apis 
mellifera reference genome (assembly Amel_4.5) (Honey Bee Genome 
Sequencing Consortium, 2014) and SAMtools (Li et al., 2009) was used to filter 
for paired aligned reads. Of the original raw reads, approximately 30 % aligned 
to the A.mellifera genome, of which two thirds were paired reads (black sections 
of Supporting Information: Figure 6.6.), and subsequently used in the analysis 
of read counts and differential expression. In general the percentage of 
sequenced reads that aligned to the A. mellifera genome was similar across 
samples, but over 50 % of reads remained unmapped (see Supporting 
Information: Figure 6.6.), with their identity unclear. It is possible that some of 
these reads could map to natural sources of infection in honey bees, such as 
bacterial and fungal spores that these experimental bees could have been 
exposed to as larvae in the field prior to their emergence in the laboratory. 
Furthermore, it is recognised that adult honey bee workers typically harbour a 
characteristic gut microbiota, including at least nine bacterial phylotypes 
(Martinson et al., 2011, Martinson et al., 2012, Moran et al., 2012). Many of 
these bacteria may have a mutualistic relationship with their bee host by aiding 
in the metabolism of carbohydrates and/or producing inhibitory compounds 
against pathogens (Martinson et al., 2011). In the present study RNA was 
extracted from whole bee samples so it is hypothesised that a large proportion 
of the sequences unaccounted for by the current analysis are associated with 
the gut microbiota. Further work could benefit from annotating the unmapped 
reads in these samples to elucidate their origin, as this too could provide new 
insights, particularly if treatment effects are present, such as a differential gut 
microbiota activity associated with immune/pesticide treatments. Nevertheless, 
there will be no further discussion of those unmapped reads here, and for the 
purposes of the current investigation it was assumed that the unmapped reads 
could be overlooked given that the percentage of raw sequence reads that were 
aligned to the reference honey bee genome was relatively consistent across 
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samples, and any differences in library size were accounted for by the 
normalisation step of the DESeq2 pipeline below. 
In order to count how many reads mapped to each honey bee gene, we used 
HTSeq (version 0.6.0; Anders et al., 2014). 
6.4.2. Statistical analysis for identification of differentially expressed genes 
In order to analyse variation among treatments in gene expression, the raw 
counts of sequencing reads obtained from HTSeq were used as count values 
for the analysis of differential gene expression using the R package DESeq2 
(Version_1.2.10; Anders and Huber, 2010). A gene was considered as 
differentially expressed when the log2 fold change was ≥ 1 or ≤ -1 (i.e. at least a 
two-fold increase or decrease in expression) and when the false discovery rate 
(FDR)- adjusted P-value was ≤ 0.05. DEGs were identified for contrasts of 
interest by first sub-setting the sample set (see below). This multiple testing 
approach was corrected for in the adjusted P value/ FDR estimation performed 
automatically in the DESeq2 pipeline. 
First, to analyse whether there was a transcriptional response to immune 
challenge, we identified DEGs between injection treatments in bees fed only on 
control sucrose (i.e. in the absence of any pesticide exposure) for each time 
PIC in turn. Pairwise comparisons (contrasts) identified genes that were 
differentially expressed i) following Ringers-injection compared to naïve 
unchallenged controls, ii) following LPS-injection compared to naïve controls, 
and iii) following LPS-injection compared to Ringers-injection. 
Second, to analyse whether there was a transcriptional response to pesticide 
exposure, we identified DEGs between pesticide treatments in naïve bees (in 
the absence of an additional immune challenge). Here, we were interested in 
whether genes were differentially expressed in imidacloprid- or thiamethoxam- 
exposed bees compared to control-fed bees, so only two contrasts were tested. 
Third, to analyse whether the transcriptional response to immune challenge was 
maintained when bees were also exposed to neonicotinoid treatment, we 
focussed our analysis on the Ringers vs LPS contrast 8 h PIC, to identify 
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whether the particular DEGs in this contrast varied for each pesticide treatment. 
This immune contrast was seen of most biological relevance as it reflected 
transcriptional responses only to the bacterial molecules (albeit artificial), but 
not to the injection procedure itself. 
Lastly, to analyse whether the transcriptional response to pesticide exposure 
was maintained when bees were also exposed to immune challenge, we 
compared the DEGs in each control-imidacloprid or control-thiamethoxam 
contrast for each injection treatment group. 
6.4.3. Functional analysis of differentially expressed genes 
In order to identify the molecular function and/or molecular pathways to which 
the DEGs are associated, we performed functional analyses. This involved first 
assigning each honey bee gene to known functions (‘gene ontology, GO, 
annotation’) and then assessing whether any functions were under- or over-
represented in the DEGs compared to the honey bee genome as a whole (‘GO 
enrichment analysis’). Honey bee genes were also assigned to known 
molecular pathways using the Kyoto Encyclopaedia of Genes and Genomes 
(KEGG) pathway database. 
We compared two annotation methods to best assign functions to each honey 
bee gene, as the honey bee genome remains relatively poorly annotated so the 
functional role of expressed genes remains poorly understood.  
The first annotation method used a TBLASTX search to tentatively assign 
molecular function terms to each honey bee gene based on the GO terms 
associated with their Drosophila melanogaster fruit fly orthologues. Honey bee 
RNA-Seq studies have typically assigned functional terms to honey bee genes 
based on orthology to fruit fly genes (e.g. Cornman et al., 2013, Derecka et al., 
2013), as the fly has been used as a model insect species in molecular studies 
and has a greater percentage of functionally annotated sequences. A TBLASTX 
seach of all A.mellifera translated sequences was run against a list of 
D.melanogaster translated sequences. Annotation of honey bee genes with 
FlyBase IDs was taken only when TBLASTX matches had an E value ≤ 1e -10, 
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matched across 90 % of the gene length, and had a one-to-one orthology 
relationship between bee and fly genes. However, it is well recognised that this 
approach poses limitations on the functional annotation of honey bee genes 
(e.g. Chan et al., 2011), not least because the evolutionary distance between 
Drosophila and Apis is relatively large (≈ 300 million years). This likely explains 
the low number of honey bee genes (16 % of the 15304) we found to match to 
fly genes and the poor annotation of only 14 % of bee sequences that were 
assigned GO terms using this approach (see Supporting Information: Figure 
6.7.). 
To aim to assign GO terms to a greater proportion of honey bee genes, we 
used a second alternative annotation method in which genes were matched to 
protein orthologues of other species (not limited to Drosophila) and annotated 
with GO terms using BLAST2GO. We performed a BLASTX of all A.mellifera 
gene sequences against the non-redundant coding sequence database, nr 
(downloaded from NCBI on 5th June 2014). As expected, this gave a greater 
percentage of successful hits (54 %), and amongst the top species to which 
honey bee genes matched included other bee species (Bombus spp. and 
Megachile spp.), and other Hymenopteran social insects including ants (e.g. 
Cerapachys biroi, Camponotus floridanus) and wasps (e.g. Nasonia vitripennis). 
The hits obtained from this BLAST search were then mapped and annotated 
using Blast2GO (Conesa et al., 2005) and the InterPro annotation function to 
retrieve GO terms that were tentatively assigned to the A.mellifera gene 
sequences. Nevertheless, functional annotation was still highly restricted, with 
only 44 % of the 15304 bee gene sequences tentatively assigned GO terms, 
giving a reference set of 6779 sequences for subsequent GO term enrichment 
analysis (see Supporting Information: Figure 6.7.). This annotation is 
comparable with a previous annotation of honey bee protein sequences based 
on orthology to other species using BLAST2GO, in which 37 % of honey bee 
sequences were assigned GO terms (Chan et al., 2011). We encourage future 
studies to adopt this annotation approach in preference to a Drosophila-
orthology based method as here we demonstrate the improved annotation this 
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approach offers, and hence further GO and pathway enrichment analysis was 
based on this second annotation method. 
GO enrichment analysis was performed by comparing lists of DEGs to the 
background set of annotated hits using a Fisher’s Exact Test and correction for 
multiple testing in Blast2GO. Enriched GO terms were reported at an FDR of 
0.05. 
Similarly, pathway annotation was performed by assigning honey bee genes 
with enzyme codes using Blast2GO, and pathway maps were retrieved from the 
KEGG database to list any pathways containing the enzyme code numbers of 
selected sequences. 
 
6.5. Results 
We first characterised the transcriptomic responses of adult honey bee workers 
when exposed either to an immune challenge or a neonicotinoid exposure 
alone. We then assessed whether the response to immune challenge was 
altered in the presence of neonicotinoid exposure, and similarly whether the 
response to neonicotinoid exposure was altered in the presence of immune 
challenge. 
6.5.1. Transcriptional response to immune challenge without neonicotinoid 
exposure 
Overall, a greater number of DEGS were found 8 h PIC compared to 24 h, with 
more genes upregulated in response to immune challenge than were 
downregulated (Figure 6.1.). Focussing on the 8 h dataset, five genes were 
upregulated irrespective of the specific immune challenge (i.e. whether injected 
with Ringers placebo or bacterial LPS), but LPS injection led to greater 
upregulation than Ringers injection alone (Figure 6.1.). These five upregulated 
genes included three well-known immune genes associated with the Toll 
pathway (Evans et al., 2006)- a peptidoglycan recognition protein (Pgrp-s2) and 
two antimicrobial effector proteins, apidaecin (Apid1) and hymenoptaecin 
(LOC406124). Additionally, the ETS homologous factor-like gene (LOC552797) 
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was recognised from GO annotation for its role in the regulation of transcription, 
whilst the laccase-1-like gene (LOC724890) is thought to be involved in copper 
ion binding and oxidoreductase activity. 
Overall, 25 genes were upregulated and 15 genes were downregulated in LPS-
injected bees compared to those challenged only with a Ringers placebo, and 
the top five up- and down- regulated genes (based on the largest fold-changes 
in expression) are summarised in Table 6.1., along with their associated GO 
annotations, but no enriched gene functions or pathways were identified. 
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Figure 6.1. Top: Number of DEGs between pairwise comparisons of injection 
treatment in control-fed bees, 8 and 24 h PIC. e.g. the Naïve vs Ringers 
comparison refers to no. of genes up- or down- regulated in Ringers-injected 
samples compared to naïve samples. Black bars = Upregulated genes, White 
bars = Downregulated genes. Bottom: Venn diagram to show the number of 
DEGs in the 8 h samples that overlap among the injection treatment 
comparisons. Bar chart to show the magnitude of expression between the three 
injection contrasts for each of the five DEGs that were shared between these 
contrasts in control-fed bees 8 hours PIC. Log2 fold-change mean ± SE. 
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Table 6.1. Summary of the top five upregulated and top five downregulated 
genes in the control-fed Ringers vs LPS injection contrast 8 h PIC. 
Gene Beebase ID NCBI Official Full Name Annotated GO terms Log2 fold 
change 
SE of fold-
change 
LOC414027 GB51005 
n-alpha-acetyltransferase 
20, NatB catalytic subunit-
like 
C:cytoskeleton 2.402168 0.795074 
LOC410884 GB50722 
phospholipase A1 member 
A-like 
P: lipid metabolic process; F: 
catalytic activity 
2.285008 0.692504 
ALDH1L2 GB43892 
aldehyde dehydrogenase 
1 family, member L2 
F: hydroxymethyl-, formyl- and 
related tranferase activity; P: 
biosynthetic process; P:oxidation-
reduction process; F: 
oxidoreductase activity, acting on 
the aldehyde or oxo group of donors, 
NAD or NADP as acceptor; F: 
methyltransferase activity 
2.030762 0.180568 
LOC1005765
92 
GB50550 uncharacterised none 1.997877 0.404135 
LOC727401 GB43783 uncharacterised none 1.866179 0.255861 
GB40915 GB40915 uncharacterised none -2.24068 0.733396 
LOC410870 GB49753 otopetrin-3-like none -1.89129 0.498082 
LOC726283 GB46153 
neuronal calcium sensor 
2-like 
calcium ion binding -1.88963 0.64018 
GB40683 GB40683 uncharacterised 
P: transmembrane transport; F: 
transmembrane transporter activity; 
C: integral to membrane 
-1.58177 0.536571 
LOC726790 GB54723 uncharacterised 
F: ATP binding; P: protein 
phosphorylation; F: protein 
serine/threonine kinase activity 
-1.58072 0.481059 
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6.5.2. Transcriptional response to immune challenge with neonicotinoid 
exposure 
The transcriptional response to LPS challenge was dependent on the feeding 
regime of the adult bees (Figure 6.2.). Inspection of fold-changes in expression 
suggests that the upregulation of three genes (Rel, LOC100577430 and 
ALDH1L2) may be weakened in thiamethoxam-exposed bees (Figure 6.2.). We 
tested this further only for the ALDH1L2 gene, using a qPCR approach. We 
thereby confirmed that ALDH1L2 was upregulated in response to immune 
challenge in a time-dependent manner (ANOVA; Injection*Time F10,82 = 8.75, P 
≤ 0.001), but we could not verify that this response was detectably altered by 
neonicotinoid exposure (Figure 6.3.).  
22 DEGs that were identified in response to LPS injection without neonicotinoid 
exposure were not identified when bees were simultaneously exposed to either 
of the two neonicotinoids (Figure 6.2. Venn Diagram). No enriched GO terms 
were identified for this set of 22 DEGs, but further inspection identified several 
potential genes of interest. This included the upregulated antimicrobial peptide 
genes apidaecin (Apid1) and hymenoptaecin (LOC406142), and the 
downregulated scavenger receptor class C gene (SCR-C), which was 
annotated with an ‘immune response’ GO term and has previously been found 
to be downregulated in honey bees infected with an entomopathogenic fungus 
(Bull et al., 2012). Similarly, we found genes that responded to immune 
challenge only when exposed to imidacloprid or thiamethoxam (Figure 6.2.), but 
no enriched GO terms were identified. 
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Figure 6.2. Top: Number of genes up- or down- regulated in LPS-injected 
samples compared to Ringers-injected samples 8 hours PIC in each pesticide 
group. Venn diagram shows the number of these DEGs that overlap among 
these contrasts in each pesticide treatment. Bottom: Bar chart to show the 
magnitude of expression following LPS injection compared to Ringers injection 
in each pesticide treatment, for each of the five DEGs that were shared 
between these contrasts. Log2 fold-change mean ± SE. 
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Table 6.2. Description of the five genes that were upregulated in LPS-injected 
bees compared to Ringers- injected bees in all three pesticide groups (i.e. the 
five genes that overlap in Figure 6.2.) 
GeneID 
BeeBase 
ID 
NCBI Official 
full name GO terms 
LOC408532 GB50123 myophilin-like none 
Rel GB40654 
NF-kappaB 
transcription 
factor relish 
F: protein binding; P: regulation of transcription, 
DNA-dependent; F: sequence-specific DNA binding 
transcription factor activity; C: nucleus 
LOC100577430 GB43784 uncharacterised none 
ALDH1L2 GB43892 
aldehyde 
dehydrogenase 
1 family, 
member L2 
F: hydroxymethyl-, formyl- and related transferase 
activity; P: biosynthetic process; P: oxidation-
reduction process; F: oxidoreductase activity, acting 
on the aldehyde or oxo group of donors, NAD or 
NADP as acceptor; F: methyltranferase activity 
Pgrp-s2 GB47805 
peptidoglycan 
recognition 
protein S2 
F: N-acetylmuramoyl-L-alanine amidase activity; P: 
peptidoglycan catabolic process; F: zinc ion binding 
 
 
Figure 6.3. Relative expression of ALDH1L2 gene in response to immune 
challenge over a period of 2 - 48 h PIC. Mean ± SE fold-changes are shown 
relative to expression in control-fed, naïve (unchallenged) bees at the 0 h time 
point. Left plot shows expression profile for control and imidacloprid-exposed 
bees. Right plot shows expression profile for control and thiamethoxam-
exposed bees. 
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6.5.3. Transcriptional response to pesticide exposure without immune challenge 
Thiamethoxam exposure led to 31 DEGs in the 8 h samples and 164 DEGs in 
the 24 h samples. Further analysis of the differential expression to 
thiamethoxam was focussed on the 24 h samples. Among the164 DEGs, 80 % 
were downregulated following thiamethoxam exposure. Genes found in the 
ribosome and mitochondrion were over-represented in this data set, including 
genes involved in maintaining the structure of the ribosome, the translation of 
proteins in the ribosome, and the catalysis of redox reactions (see Supporting 
Information: Figure 6.8.). Six genes were associated with a single pathway 
(oxidative phosphorylation), and several others were associated with other 
metabolic processes (Table 6.3.). Only a single gene (GstO1) was associated 
with drug metabolism pathways, and here this gene was downregulated in the 
thiamethoxam-exposed bees. 
Imidacloprid caused a different pattern in differential expression. Overall, 27 
genes were upregulated and five genes were downregulated in imidacloprid-
exposed bees in the 8 h samples, whilst only 23 genes were downregulated in 
the 24 h samples, and there were no enriched gene functions. Nine genes had 
identifiable associations with several metabolic pathways, including pyruvate-, 
purine-, glycine-, serine-, threonine-, cysteine-, and propoanoate- metabolism, 
glycolysis/ gluconeogenesis and oxidative phosphorylation. Imidacloprid 
exposure led also to upregulation of two genes (CYP6AS16P and CYP6AS15) 
with known function as cytochrome P450s and another gene (LOC726222) 
associated with the P450 pathway, which has a known role in detoxification of 
xenobiotics.  
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Table 6.3. KEGG pathways associated with DEGs in the Control-Thiamethoxam 
contrast (naïve bees only, 24 h sample set). 
KEGG Pathway 
No. of 
DEGs 
associated 
with 
pathway 
Enzyme Enzyme ID 
DEGs 
associated with 
pathway 
Pathway 
ID 
Carbon fixation pathways in 
prokaryotes 1 hydratase ec:4.2.1.3 LOC408446 map00720 
Oxidative phosphorylation 6 
reductase (H+-
translocating) ec:1.6.5.3 
LOC724827, 
Ndufs7 map00190 
Oxidative phosphorylation 6 dehydrogenase ec:1.6.99.3 GB55150 map00190 
Oxidative phosphorylation 6 oxidase ec:1.9.3.1 
Cox5b, Cox6c, 
LOC552829 map00190 
Drug metabolism - cytochrome 
P450 1 transferase ec:2.5.1.18 GstO1 map00982 
Citrate cycle (TCA cycle) 1 hydratase ec:4.2.1.3 LOC408446 map00020 
Metabolism of xenobiotics by 
cytochrome P450 1 transferase ec:2.5.1.18 GstO1 map00980 
Phenylalanine metabolism 1 lactoperoxidase ec:1.11.1.7 LOC412774 map00360 
Glycosaminoglycan 
degradation 1 hexosaminidase ec:3.2.1.52 LOC726818 map00531 
Alanine, aspartate and 
glutamate metabolism 1 carbamoyltransferase ec:2.1.3.2 Cad map00250 
Aminobenzoate degradation 1 acetylphosphatase ec:3.6.1.7 LOC724904 map00627 
Glutathione metabolism 1 transferase ec:2.5.1.18 GstO1 map00480 
Pyruvate metabolism 1 acetylphosphatase ec:3.6.1.7 LOC724904 map00620 
Various types of N-glycan 
biosynthesis 1 hexosaminidase ec:3.2.1.52 LOC726818 map00513 
Other glycan degradation 1 hexosaminidase ec:3.2.1.52 LOC726818 map00511 
Purine metabolism 1 kinase ec:2.7.4.6 awd map00230 
Glycine, serine and threonine 
metabolism 2 dehydrogenase ec:1.1.99.1 
GMCOX3, 
GMCOX12 map00260 
Glycosphingolipid biosynthesis 
- ganglio series 1 hexosaminidase ec:3.2.1.52 LOC726818 map00604 
Glycosphingolipid biosynthesis 
- globo series 1 hexosaminidase ec:3.2.1.52 LOC726818 map00603 
Glyoxylate and dicarboxylate 
metabolism 1 hydratase ec:4.2.1.3 LOC408446 map00630 
Phenylpropanoid biosynthesis 1 lactoperoxidase ec:1.11.1.7 LOC412774 map00940 
Amino sugar and nucleotide 
sugar metabolism 1 hexosaminidase ec:3.2.1.52 LOC726818 map00520 
Pyrimidine metabolism 2 kinase ec:2.7.4.6 awd map00240 
Pyrimidine metabolism 2 carbamoyltransferase ec:2.1.3.2 Cad map00240 
Porphyrin and chlorophyll 
metabolism 1 ceruloplasmin ec:1.16.3.1 fh map00860 
 
 
  
229 
 
 
6.5.4. Transcriptional response to pesticide exposure with immune challenge 
The transcriptional response to thiamethoxam exposure was dependent on the 
immune treatment of the adult bees (Figure 6.4.). Specifically, there was a trend 
towards fewer DEGs when thiamethoxam-exposed bees were immune 
challenged (Figure 6.4.).  
The proportion of genes up- or down- regulated in response to thiamethoxam 
exposure was not consistent across immune treatments. For example, in naïve 
bees 80 % of the 164 DEGs were downregulated, compared to the 80 % of the 
63 DEGs that were upregulated in Ringers-challenged bees. In the 24 h 
samples, only three DEGs were identified irrespective of the immune challenge 
received (GB48920 upregulated, GB47541 and LOC726228 downregulated), 
and immune challenged bees did not share the same enriched GO terms as 
those identified in naïve bees (see above; Supporting Information: Figure 6.8.). 
The transcriptional response to imidacloprid exposure was also dependent on 
the immune treatment of the adult bees, but the pattern varied to that seen for 
thiamethoxam exposure. A larger number of DEGs were identified in the 8 h 
samples than the 24 h samples, with the majority of these in LPS-challenged 
bees (70 upregulated, 64 downregulated; Figure 6.4.), where almost all were 
expressed uniquely compared to naïve or Ringers-challenged bees, but no 
enriched functions were identified. 
230 
 
 
 
Figure 6.4. Number of up- or down-regulated genes in (left) thiamethoxam-
exposed bees; and (right) in imidacloprid-exposed bees, for each injection 
treatment and time PIC. 
 
6.6. Discussion 
By using next generation sequencing technology, this study discovered 
differentially expressed genes (DEGs) and then identified their potential 
functions in adult honey bee workers exposed to an immune stressor, a dietary 
neonicotinoid stressor or a combination of both. Below, we discuss the 
functional implications of the DEGs detected for each stressor taken separately 
and we explore also the complex effects of the interactions between stressors. 
In particular, we pursue molecular evidence for the propositions that 
neonicotinoids affect the immunocompetence of honey bees, and that immune 
challenge affects the ability of honey bees to respond to neonicotinoid 
exposure. 
Immune stress led to upregulation of genes with known immune function, 
including a peptidoglycan recognition protein, a NF-кB transcription factor and 
antimicrobial effectors. The response to LPS injection was typically stronger 
than to Ringers buffer alone. These findings support previous work targeting 
expression profiles of antimicrobial effector genes using qPCR (chapter 3), 
which begins to validate the use of the RNA-Seq approach to identify 
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functionally relevant DEGs. Different genes were expressed in response to a 
placebo injection challenge and an injection with bacterial LPS molecules, 
which demonstrates the importance of using relevant controls when using 
artificial methods to apply stressors. Additionally, the differential responses to 
wounding and bacterial infection highlight the possible importance of stressor 
combinations to individual bee health, which we discuss further below. 
Transcriptional changes also occurred in genes that have not been previously 
associated with immune stressors, including an ETS homologous factor-like 
gene (LOC552797), a laccase-1-like gene (LOC724890), a myophilin-like gene 
(LOC408532) and the uncharacterised LOC100577430. We found also 
upregulation of an aldehyde dehydrogenase (ALDH1L2), corresponding with 
findings of a previous proteomic study, in which infection with the natural 
bacterium Paenibacillus larvae led to upregulation of an aldehyde 
dehydrogenase enzyme in honey bee larvae (Chan et al., 2009). These genes 
warrant further investigation to elucidate their role in responding to immune 
stressors. 
The transcriptional response to immune challenge was dramatically changed 
when bees were also exposed to a dietary neonicotinoid, but the biological 
implications of this remain difficult to unravel. Specifically, 22 genes were 
identified that were differentially expressed in response to immune challenge 
alone, but others were additionally expressed when the immune stressor was 
coupled with dietary imidacloprid or thiamethoxam. Imidacloprid increased the 
number of DEGs in response to immune challenge, whereas thiamethoxam 
exposure had the opposite effect. These observations begin to suggest that the 
toxicants interact differently with bee metabolism despite their common 
neurotoxic mechanism.  There was some indication that dietary thiamethoxam 
weakened the upregulation of Relish, which is a transcription factor in the NF-кB 
immune signalling pathway that has previously shown neonicotinoid sensitivity 
(Di Prisco et al., 2013). We suggest that further investigation of the 
neonicotinoid sensitivity of Relish could shed new light on the sublethal effects 
of insecticides on bee immunocompetence. 
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We found that a dietary neonicotinoid alone could alter the honey bee 
transcriptome, which begins to suggest that DEGs could be used as biomarkers 
of pesticide exposure. However, the pattern of gene expression differed across 
the two time points tested, highlighting the potential importance of the exposure 
period to effects on bee health. 
Among the DEGs downregulated by dietary thiamethoxam, functional analysis 
found that several were associated with the translation of proteins in the 
ribosome, catalysis of redox reactions and metabolic pathways, including 
oxidative phosphorylation. Our results are similar to the only previous 
transcriptome-wide study of neonicotinoid exposure, which investigated 
imidacloprid (Derecka et al., 2013). Collectively, these results begin to suggest 
that neonicotinoids may have some common effects on the metabolism of 
honey bees. In bumble bees, neonicotinoid exposure can induce torpor 
(Cresswell et al., 2012) and honey bees may be showing a similar decrease in 
overall metabolic activity.   
We found that dietary imidacloprid also altered genes associated with various 
metabolic pathways, including the upregulation of three genes involved in 
cytochrome P450 pathways. Our results are consistent with those of Derecka et 
al. (2013), who found nine cytochrome P450 genes that were upregulated in 
response to imidacloprid exposure in honey bee larvae. Cytochrome P450s are 
thought to be important in the detoxification of natural xenobiotics and synthetic 
insecticides in many insect species (Li et al., 2007), including pyrethroid and 
organophosphate metabolism in honey bees (Mao et al., 2011) and 
neonicotinoid resistance in Drosophila (Daborn et al., 2002). The 6AS subfamily 
of P450s is probably an important group of P450 genes in xenobiotic 
metabolism in honey bees (Mao et al., 2009), and it may be particularly 
important in the honey bee compared to other Hymenopteran insects. Our 
finding of the upregulation of two 6AS P450s in response to imidacloprid may 
provide new evidence in support of their role in the apparently rapid 
detoxification of neonicotinoids by honey bees (Cresswell et al., 2014).  
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The transcriptional response to neonicotinoid exposure was also altered when 
coupled with an immune challenge, but the interaction is difficult to interpret 
because the functional significance of the DEGs is largely obscure. Our study 
emphasises the need for further work to understand combinations of stressors, 
not least because our current ignorance confounds the development of 
biomarkers of pesticide exposure as bees are exposed to multiple stressors in 
many realistic scenarios. 
The currently incomplete annotation of the honey bee genome has hindered the 
functional analyses of DEGs in our study. It is likely that given a greater 
percentage of GO-annotated sequences more enriched GO terms would have 
been identified.  We therefore expect that the low number of enriched GO terms 
identified in the analysis is conservative for this reason. Similarly, the retrieval of 
KEGG pathways relies upon well annotated enzyme codes in the study set of 
genes, which also was not the case in our study. With this limitation to statistical 
tests of functional analysis, our assessment of DEGs was limited largely to a 
descriptive analysis, in which potential genes of interest were highlighted based 
on a priori interest in these genes, such as antimicrobial effector proteins, 
and/or recognition of their candidate functions where GO terms were assigned 
to individual genes. Given predicted improvements in gene ontology 
annotations, coupled with further bioinformatics expertise, we expect that future 
applications of the promising methodologies used in our study will provide 
further insights into the mechanisms by which pesticides and infections affect 
an economically and ecologically valuable pollinator, the honey bee. 
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6.9. Supporting information 
 
Figure 6.5. Schematic of experimental design. For each pesticide exposure (top 
white boxes), bees received one of three immune challenges (middle grey 
boxes). For each pesticide/immune combination, samples were collected at 
either 8 or 24 h PIC. 
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Figure 6.6. Percentage breakdown of raw sequencing reads following trimming 
and alignment pipeline. A. Pie chart depicting average of all reads across the 45 
samples. B. Bar chart depicting breakdown for each sample in turn. 
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Figure 6.7. Pie chart representing the data distribution of Apis mellifera 
sequences following the functional analysis pipelines i) (Top chart) using a 1:1 
homology TBLASTX against Drosophila melanogaster and annotation using 
GOrilla (Eden et al., 2009); and ii) (Bottom chart) using a BLASTX against the 
NCBI non-redundant coding sequence database and annotation using 
Blast2GO. 
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Figure 6.8. Summary of GO terms enriched across the 163 DEGs in the Naïve 
24 h Control vs Thiamethoxam subset, at an FDR of 0.05. 
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7. General Discussion 
 
7.1. Introduction and overview of main findings 
In recent years there has been worldwide interest in understanding the 
stressors driving declines in bee health due to the environmental and economic 
implications of impacts on the pollination of crops and wild flowering plants 
(Potts et al., 2010). Two stressors implicated for their potential impact on bee 
health include pathogen infection and pesticide exposure, and in particular the 
neonicotinoid class of insecticides has been the focus of public and scientific 
concern. Neonicotinoid effects on honey bees and bumble bees have been well 
studied (Desneux et al., 2007, Goulson, 2013, Blacquiere et al., 2012), but there 
remains many uncertainties and knowledge gaps in the field. Recognition of a 
need for further research to address these uncertainties and knowledge gaps 
led to a two-year restriction on the use of three neonicotinoid pesticides on bee-
attractive crops by the European Commission (2013). 
Recent guidance recommended also an improved scheme for the risk 
assessment of plant protection products, including neonicotinoid pesticides, on 
bees (EFSA, 2013). An improved risk assessment includes the need for better 
understanding of the sublethal effects of pesticides on honey bees and bumble 
bees. 
The central aim of this thesis therefore was to investigate sublethal effects of 
neonicotinoid exposure on honey bees and bumble bees, and to establish the 
relevance of different sublethal endpoints as appropriate ecotoxicological 
markers for risk assessment. In particular, this thesis focussed on the study of 
neonicotinoid exposure in combination with immune stressors, as a combination 
of stressors more likely reflects realistic ecological scenarios. 
The first objective was to establish whether neonicotinoid exposure impacts on 
immune-related gene expression and enzymatic activity in adult workers of the 
honey bee, Apis mellifera. I found that exposures to imidacloprid and 
thiamethoxam impaired the transcriptional response of antimicrobial effector 
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genes to an artificial immune challenge, but no adverse effects were observed 
on antimicrobial enzyme activity or the phenoloxidase component of the insect 
immune response (Chapter 3). 
Second, I established that exposure to the neonicotinoid, imidacloprid, impaired 
the physiological response of antimicrobial proteins to an artificial immune 
challenge in adult workers of the bumble bee, Bombus terrestris, but this 
adverse effect was not observed at realistic concentrations of neonicotinoid 
exposure. I found also no adverse effects on the phenoloxidase system 
(Chapter 4). 
Third, I found impacts of imidacloprid exposure on gene expression and 
enzymatic activity associated with the development of the hypopharyngeal 
glands and their role in temporal polyethism, nutrition and social immunity in the 
honey bee, A. mellifera, but found no adverse effects on foraging behaviour at 
the colony level (Chapter 5). 
Lastly, I identified transcriptome-wide transcriptional changes in adult honey 
bee workers following immune challenge and/or neonicotinoid exposure, 
elucidating potential gene functions and candidate ecotoxicological biomarkers 
(Chapter 6). 
Here I discuss these findings and their implications in the broader context of the 
research field, and suggest areas where future work could provide valuable new 
insights and understanding. 
 
7.2. Implications for pesticide risk assessment schemes 
The most recent guidance document on the risk assessment of plant protection 
products on bees (EFSA, 2013) suggested the implementation of a tiered risk 
assessment scheme in which a simple, cost-effective screening and ‘first tier’ 
scheme is followed by more complex higher tier semi-field and field studies. The 
scientific opinion on the science behind the development of this risk 
assessment scheme (EFSA, 2012) recommended that appropriate sublethal 
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effect studies should be incorporated into the first tier of testing and recognised 
a research priority to determine biologically relevant endpoints that could be 
easily measured and interpreted. Amongst the suggestions included the 
development of behavioural methodologies and potential biomarkers, including 
enzymatic/protein and molecular markers that could enable prediction of 
physiological sublethal effects, such as immune system changes. Biomarkers 
could be a valuable addition to the risk assessment scheme if they could be 
easily obtained from a small sample of individual bees and high-throughput 
assays could be carried out using routine laboratory techniques. 
In any branch of toxicology it is recognised that biomarkers should meet several 
basic criteria if they are to be appropriate in measuring the extent of a toxic 
response, including that they should be quantitative, sensitive, non-invasive, 
specific, easily measurable; and should relate to biological mechanisms and 
work at realistic doses (Timbrell, 1998). The data available to assess these 
criteria in candidate bee biomarkers are insufficient to warrant their inclusion in 
current risk assessment schemes (EFSA, 2013). 
It is hoped that data in this thesis contributes towards the assessment of several 
potential endpoints. Overall I found little support for the use of any given 
biomarker in this thesis, largely as any observed responses were typically at 
doses above realistic exposure scenarios. However, my work does support the 
need for inclusion of non-Apis bee species in risk assessment schemes as I 
found that responses to imidacloprid differed between honey bees and bumble 
bees, specifically in feeding rates and antimicrobial protein activity, providing 
further evidence that the sensitivity and the endpoints appropriate for risk 
assessment vary between bee species. This thesis also highlights the 
importance of verifying the functional biological relevance of endpoints, as 
contrary to expectation, transcriptional changes were not always found to relate 
to physiological changes in protein activity or behavioural modifications. 
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7.3. Pesticide effects on insect immunity 
Research into the interactions between multiple stressors impacting on bee 
health, including pathogen infection and pesticide exposure, has gained 
momentum only in the last five years or so and studies specifically investigating 
pesticide effects on bee immunity remain sparse. Furthermore, despite the 
significant increase in the use of neonicotinoids since their introduction in the 
1990s, investigations of neonicotinoid effects on insect immunity in general are 
comparatively sparse compared to the effects of other pesticide classes (James 
and Xu, 2012). Neonicotinoids target receptors in the insect nervous system, 
but their effects on bees have been found to be manifold, including impairments 
of brood production (Laycock et al., 2012), foraging efficiency (Gill et al., 2012) 
and learning (Decourtye et al., 2004). 
Investigations of neonicotinoid effects on the immune system seem appropriate 
given previously observed links between the insect nervous and immune 
systems (Mallon et al., 2003, Riddell and Mallon, 2006). In this respect this 
thesis provides valuable data to the limited field of knowledge. In particular, one 
major component of the insect immune response- the induction of antimicrobial 
protein activity- has not been previously studied in any insect species in respect 
to effects of any pesticide class, although some effects of neonicotinoid 
exposure on expression of bee AMP genes have been observed (e.g. Di Prisco 
et al., 2013). Here, as expected, an artificial wounding and/or bacterial-like 
challenge was consistently found to induce upregulation in expression of AMP 
genes and/or protein activity in honey bees and bumble bees. This thesis 
presents the first evidence showing that an oral imidacloprid exposure may 
impair the antimicrobial protein component of the immune response in bumble 
bees, although similar effects were not observed in honey bees. Over 100 
insect antimicrobial proteins have been identified across several peptide 
classes (Hoffmann et al., 1996), and honey bees have been found to possess 
comparatively fewer antimicrobial proteins than other insect species, such as 
mosquitoes and flies (Evans et al., 2006). Further studies of the pesticide 
effects on the antimicrobial protein component of the insect immune response 
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could be valuable to a broader research field beyond bee ecotoxicology. In 
particular, an understanding of pesticide effects on the immune response of 
pest insect species could be valuable to improving their control, helping to 
safeguard agricultural crop production and control the transmission of insect-
borne human disease through integrated pest management (IPM) systems. For 
example, the bacteria Bacillus thuringiensis (Bt) or Bt toxins can be used as 
biopesticides, but in some lepidopteran pests the induction of antimicrobial 
proteins or the phenoloxidase cascade in response to Bt infection can increase 
the tolerance of the pests to the biopesticide (Hwang and Kim, 2011, Rahman 
et al., 2011). If sublethal neonicotinoid concentrations were found to impair the 
immune response of these lepidopteran pests they could be used in 
combination with biopesticides to improve pest control by reducing pest 
resistance to Bt. In fact, Bt-toxins and imidacloprid are already used in some 
IPM systems (e.g. Bambawale et al., 2004). Insect pest management requires a 
balance between maintaining pest control whilst minimising the loss of 
beneficial insects, such as pollinators. New information could be gained through 
further investigation of the effects of different pesticides on the immune 
responses of both pest and beneficial insects to evaluate both the effectiveness 
and sustainability of IPM systems. 
Here, I suggest three recommendations of work to include in any further 
investigation of pesticide effects on insect immunity. Firstly, future work would 
benefit from including measures of pesticide concentrations within the test 
animals. This will be informative in understanding the concentrations of 
pesticide leading to observed effects, as well as understanding specific tissues 
at risk of exposure. For example, in honey bees orally exposed to radio-labelled 
imidacloprid, higher imidacloprid concentrations were found in the midgut and 
rectum compared with the haemolymph (Suchail et al., 2004). This could be 
important in understanding the nature of a possible effect of oral imidacloprid 
exposure on the immune response as, for example, the midgut is a site of 
antimicrobial peptide synthesis. Whilst most studies have orally exposed bees 
to a pesticide via a sub-lethal chronic exposure, some have investigated effects 
of an acute topical (contact) exposure (e.g. Di Prisco et al., 2013). Different 
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routes of pesticide exposure potentially lead to differences in the 
toxicodynamics and the target tissues for the pesticide. It seems appropriate 
also to compare pesticide concentrations in bees exposed orally compared to 
those exposed topically to investigate this. 
Secondly, as our understanding of the relevant tissues at risk and/or the roles of 
specific tissues improves, future work would benefit from testing protein activity 
and/or gene expression within the relevant tissues rather than composite 
structures, such as the whole bee or the whole head. Whilst the use of 
composite structures is a valuable starting point for initial studies with limited 
resources, this approach may confuse interpretation, for example if genes have 
variable patterns of expression in different tissues (Johnson et al., 2013). Within 
this thesis it is recognised that the observed effects of imidacloprid exposure on 
mrjp, Amfor, malvolio and GOX expression were observed only in the qPCR 
assays using mRNA extractions from bee heads (Chapter 5), but not in the 
RNA-Seq study using extractions from whole bees (Chapter 6), and it is 
possible that the different composite structures used in the studies influenced 
these results. 
Lastly, when attempting to understand the mechanisms behind pesticide-
disease interactions, most studies to date have approached this by testing the 
hypothesis that pesticide exposure leads to reduced immunocompetence. 
Pesticide exposure could potentially result in an increase of resource allocation 
towards detoxification systems in a trade-off through a reduction of resource 
allocation towards immune responses. There has been less attention directed 
towards testing the alternative hypothesis that pathogenic infection and/or 
parasitic attack could result in an increased allocation of resources towards 
immune responses in a trade-off through a reduction of resource allocation 
towards detoxification systems. Further consideration is warranted on the 
effects of pathogen infection on bee detoxification mechanisms. 
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7.4. Questions raised 
Here I propose key areas of research that would address some of the questions 
raised in this thesis and improve our understanding of the implications of 
neonicotinoid exposure on bee health. 
7.4.1. Does field relevant neonicotinoid exposure affect bee nursing roles and 
larval development? 
Work in this thesis (Chapter 5) found the first evidence that an imidacloprid 
exposure likely at a concentration exceeding realistic concentrations in field 
residues impaired the gene expression of major royal jelly proteins, which are 
typically produced by nurse bees to feed developing larvae. A separate study of 
immune-related genes (Chapter 3), examining the relationship between 
transcriptional and physiological responses to imidacloprid exposure, found that 
changes at the gene level were not detected at the protein level. There, as yet, 
has been no investigation of the effects of neonicotinoid exposure on the 
production of major royal jelly proteins, nor of the implications of changes in 
protein production to the development of larvae. A study of this kind would 
benefit from investigation of several neonicotinoid pesticides, including field 
relevant exposure scenarios, and could provide valuable insights into the 
transgenerational effects of neonicotinoids on the developing brood as a result 
of exposure to adult workers. This work would be valuable to regulators and 
policy makers due to its relevance to the risk assessment of honey bee 
hypopharyngeal glands, and the potential impact of neonicotinoid exposure at 
the colony- and population- levels. Changes in larval development have the 
potential to impact colony sizes, and consequently colony production and 
overwintering success, as well as the production of queens, and consequently 
population success. 
Further studies to improve our understanding of hypopharyngeal gland 
secretions and nursing roles in non-Apis bee species will enable a better 
evaluation of the endpoints appropriate for pesticide risk assessment in different 
bee species. For example, the role of the bumble bee hypopharyngeal gland 
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has been poorly studied in comparison to that in the honey bee, but it warrants 
further investigation given the observed effects of imidacloprid exposure on 
honey bee hypopharyngeal glands (Heylen et al., 2010; Smodis Skerl and 
Gregorc, 2010; Hatjina et al., 2013) and their recommended inclusion in 
pesticide risk assessments (EFSA, 2013). The bumble bee hypopharyngeal 
gland is known to be comparatively smaller than those of honey bees, and only 
a single major royal jelly protein (BtRJPL) has been identified, which may not 
have a nutritive role as in honey bees (Kupke et al., 2012). Comparative 
glucose oxidase levels have been found also in honey bee and bumble bee 
honey (Dornhaus and Chittka, 2004), but there has been no investigation of the 
role of glucose oxidase, or neonicotinoid effects on hypopharyngeal gland 
secretions, in bumble bees. Furthermore, bumble bee workers are not thought 
to show the same temporal polyethism as honey bees, and bumble bees more 
typically maintain a given role in the colony throughout their life (Free, 1955). 
Unlike the uniformity in size of honey bee workers, bumble bee workers within a 
single nest can vary in mass by approximately 10-fold (Alford, 1975), and small 
bumble bees are more likely to be nurse workers than foragers (Goulson et al., 
2002). Further investigations of hypopharyngeal gland secretions and nursing 
roles in non-Apis bee species, and how they respond to neonicotinoid exposure, 
would provide valuable new insights to the research field. 
7.4.2. Does neonicotinoid exposure impair the immune response to natural 
pathogen infections and parasitic attack? 
This thesis (Chapters 3 and 4) presents the first investigations of pesticide 
effects on the physiological antimicrobial protein response of any insect species 
following an artificial immune challenge. However, these studies did not aim to 
investigate the biological mechanisms associated with any specific natural 
infection. Laboratory studies using artificial immune challenges remain valuable 
because this approach allows standardisation of the stimulus used to invoke an 
immune response, minimising the treatment variation inherent in using a real 
pathogen, which can be logistically difficult to control. This approach allows also 
the isolation of possible pesticide effects acting on the host versus the 
pathogen/parasite.  For example, it has been found that exposure of the 
253 
 
 
parasitoid wasp, Leptopilina boulardi, to the insecticide chlorpyrifos, increased 
the encapsulation of its eggs by its Drosophila host (Delpuech and Tekinel-
Ozalp, 1991 cited in Desneux et al., 2007). 
Laboratory studies can establish the direction of future work by elucidating 
potential pesticides of concern to bee health and recognising informative 
endpoints. Work in this thesis has recognised the potential for imidacloprid to 
affect antimicrobial protein activity and demonstrated the utility of bacterial-
clearance assays to measure pesticide effects on antimicrobial activity at the 
enzymatic/protein level. Further research would be valuable to establish the 
relationships between immune responses to natural pathogen infections and 
parasitic attack in honey bees and bumble bees exposed also to field relevant 
pesticide concentrations as this would reflect more realistic scenarios of 
potential stressors impacting bee health in the wild. In particular, upregulation of 
antimicrobial proteins is thought to be important in response to bacterial 
infection, as supported by the clear temporal response to bacterial 
lipopolysaccharides in this thesis. The main bacterial infections of bees are 
Paenibacillus larvae and Melissococcus plutonius, which are symptomatic in 
honey bee larvae. Established methods can be used to experimentally rear 
honey bee larvae in the laboratory in the presence of a pesticide exposure 
(Hendriksma et al., 2011, Aupinel et al., 2007), and a bacterial-clearance assay 
could be used also to measure antimicrobial protein activity in the haemolymph 
of larvae. Fungal, microsporidian, trypanosomal and mite parasites have been 
found also to upregulate expression of AMP genes at the molecular level 
(Evans, 2004, Evans, 2006, Antunez et al., 2009, Riddell et al., 2011, 
Khongphinitbunjong et al., 2015), so these too would be useful systems to 
investigate the effects of pesticide exposure on antimicrobial protein activity. 
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